<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">95411</article-id><article-id pub-id-type="doi">10.7554/eLife.95411</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.95411.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>3D genomic features across &gt;50 diverse cell types reveal insights into the genomic architecture of childhood obesity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Trang</surname><given-names>Khanh B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9434-508X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Pahl</surname><given-names>Matthew C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Pippin</surname><given-names>James A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Su</surname><given-names>Chun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Littleton</surname><given-names>Sheridan H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Prabhat</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kulkarni</surname><given-names>Nikhil N</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ghanem</surname><given-names>Louis R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7723-5241</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Terry</surname><given-names>Natalie A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>O'Brien</surname><given-names>Joan M</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wagley</surname><given-names>Yadav</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1261-4267</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hankenson</surname><given-names>Kurt D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6361-143X</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jermusyk</surname><given-names>Ashley</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hoskins</surname><given-names>Jason</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Amundadottir</surname><given-names>Laufey T</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Mai</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Kevin</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Stewart</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Wenli</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Titchenell</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Seale</surname><given-names>Patrick</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7119-1615</contrib-id><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kaestner</surname><given-names>Klaus H</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1228-021X</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Cook</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="aff" rid="aff18">18</xref><xref ref-type="fn" rid="con23"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Levings</surname><given-names>Megan</given-names></name><xref ref-type="aff" rid="aff19">19</xref><xref ref-type="aff" rid="aff20">20</xref><xref ref-type="aff" rid="aff21">21</xref><xref ref-type="fn" rid="con24"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zemel</surname><given-names>Babette S</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff22">22</xref><xref ref-type="fn" rid="con25"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Chesi</surname><given-names>Alessandra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff23">23</xref><xref ref-type="fn" rid="con26"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wells</surname><given-names>Andrew D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff23">23</xref><xref ref-type="aff" rid="aff24">24</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con27"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Grant</surname><given-names>Struan FA</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2025-5302</contrib-id><email>grants@chop.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="aff" rid="aff22">22</xref><xref ref-type="aff" rid="aff25">25</xref><xref ref-type="aff" rid="aff26">26</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con28"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Center for Spatial and Functional Genomics, The Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Division of Human Genetics, The Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Genetics, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Department of Pathology, The Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>Penn Medicine Center for Ophthalmic Genetics in Complex Disease</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Department of Orthopedic Surgery University of Michigan Medical School Ann Arbor</institution></institution-wrap><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00vkwep27</institution-id><institution>Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Department of Child and Adolescent Psychiatry, Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Physiology, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/016899r71</institution-id><institution>Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>Department of Critical Care, Melbourne Medical School, University of Melbourne</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rmrcq20</institution-id><institution>Division of Infectious Diseases, Department of Medicine, University of British Columbia</institution></institution-wrap><addr-line><named-content content-type="city">Vancouver</named-content></addr-line><country>Canada</country></aff><aff id="aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rmrcq20</institution-id><institution>Department of Surgery, University of British Columbia</institution></institution-wrap><addr-line><named-content content-type="city">Vancouver</named-content></addr-line><country>Canada</country></aff><aff id="aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01xesb955</institution-id><institution>BC Children's Hospital Research Institute</institution></institution-wrap><addr-line><named-content content-type="city">Vancouver</named-content></addr-line><country>Canada</country></aff><aff id="aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rmrcq20</institution-id><institution>School of Biomedical Engineering, University of British Columbia</institution></institution-wrap><addr-line><named-content content-type="city">Vancouver</named-content></addr-line><country>Canada</country></aff><aff id="aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Pathology, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Institute for Immunology, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Division Endocrinology and Diabetes, The Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Parker</surname><given-names>Stephen CJ</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>University of Michigan</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Sussel</surname><given-names>Lori</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03wmf1y16</institution-id><institution>University of Colorado Anschutz Medical Campus</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>15</day><month>01</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP95411</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-02-04"><day>04</day><month>02</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-02-05"><day>05</day><month>02</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.30.23294092"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-08-05"><day>05</day><month>08</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.95411.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-11-27"><day>27</day><month>11</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.95411.2"/></event></pub-history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-95411-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-95411-figures-v1.pdf"/><abstract><p>The prevalence of childhood obesity is increasing worldwide, along with the associated common comorbidities of type 2 diabetes and cardiovascular disease in later life. Motivated by evidence for a strong genetic component, our prior genome-wide association study (GWAS) efforts for childhood obesity revealed 19 independent signals for the trait; however, the mechanism of action of these loci remains to be elucidated. To molecularly characterize these childhood obesity loci, we sought to determine the underlying causal variants and the corresponding effector genes within diverse cellular contexts. Integrating childhood obesity GWAS summary statistics with our existing 3D genomic datasets for 57 human cell types, consisting of high-resolution promoter-focused Capture-C/Hi-C, ATAC-seq, and RNA-seq, we applied stratified LD score regression and calculated the proportion of genome-wide SNP heritability attributable to cell type-specific features, revealing pancreatic alpha cell enrichment as the most statistically significant. Subsequent chromatin contact-based fine-mapping was carried out for genome-wide significant childhood obesity loci and their linkage disequilibrium proxies to implicate effector genes, yielded the most abundant number of candidate variants and target genes at the <italic>BDNF</italic>, <italic>ADCY3</italic>, <italic>TMEM18,</italic> and <italic>FTO</italic> loci in skeletal muscle myotubes and the pancreatic beta-cell line, EndoC-BH1. One novel implicated effector gene, <italic>ALKAL2</italic> – an inflammation-responsive gene in nerve nociceptors – was observed at the key <italic>TMEM18</italic> locus across multiple immune cell types. Interestingly, this observation was also supported through colocalization analysis using expression quantitative trait loci (eQTL) derived from the Genotype-Tissue Expression (GTEx) dataset, supporting an inflammatory and neurologic component to the pathogenesis of childhood obesity. Our comprehensive appraisal of 3D genomic datasets generated in a myriad of different cell types provides genomic insights into pediatric obesity pathogenesis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>pancreatic cells</kwd><kwd>immune cells</kwd><kwd>iPSC</kwd><kwd>hepatic cells</kwd><kwd>neurons</kwd><kwd>mesenchymal stem cells</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>R01 HD056465</award-id><principal-award-recipient><name><surname>Zemel</surname><given-names>Babette S</given-names></name><name><surname>Chesi</surname><given-names>Alessandra</given-names></name><name><surname>Wells</surname><given-names>Andrew D</given-names></name><name><surname>Grant</surname><given-names>Struan FA</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01 DK122586</award-id><principal-award-recipient><name><surname>Wells</surname><given-names>Andrew D</given-names></name><name><surname>Grant</surname><given-names>Struan FA</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>UM1 DK126194</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Wenli</given-names></name><name><surname>Titchenell</surname><given-names>Paul</given-names></name><name><surname>Seale</surname><given-names>Patrick</given-names></name><name><surname>Kaestner</surname><given-names>Klaus H</given-names></name><name><surname>Wells</surname><given-names>Andrew D</given-names></name><name><surname>Grant</surname><given-names>Struan FA</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Integration of GWAS summary statistics with extensive 3D genomic datasets generated in a myriad of different cell types provides genomic insights into pediatric obesity pathogenesis.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The prevalence of obesity has risen significantly worldwide (<xref ref-type="bibr" rid="bib54">NCD Risk Factor Collaboration (NCD-RisC), 2017</xref>), especially among children and adolescents (<xref ref-type="bibr" rid="bib7">Bryan et al., 2021</xref>). Obesity is associated with chronic diseases, such as diabetes, cardiovascular diseases, and certain cancers (<xref ref-type="bibr" rid="bib29">GBD 2015 Obesity Collaborators, 2017</xref>; <xref ref-type="bibr" rid="bib68">Singh et al., 2013</xref>; <xref ref-type="bibr" rid="bib87">Wormser et al., 2011</xref>; <xref ref-type="bibr" rid="bib41">Lauby-Secretan et al., 2016</xref>), along with mechanical issues including osteoarthritis and sleep apnea (<xref ref-type="bibr" rid="bib25">Fontaine and Barofsky, 2001</xref>).</p><p>Modern lifestyle factors, including physical inactivity, excessive caloric intake, and socioeconomic inequity, along with disrupted sleep and microbiome, represent environmental risk factors for obesity pathogenesis. However, genetics also play a significant role, with the estimated heritability ranging from 40% to 70% (<xref ref-type="bibr" rid="bib47">Loos and Yeo, 2022</xref>; <xref ref-type="bibr" rid="bib49">Maes et al., 1997</xref>; <xref ref-type="bibr" rid="bib22">Elks et al., 2012</xref>). Studies show that body weight and obesity remain stable from infancy to adulthood (<xref ref-type="bibr" rid="bib19">Demerath et al., 2007</xref>; <xref ref-type="bibr" rid="bib21">Dubois et al., 2007</xref>; <xref ref-type="bibr" rid="bib85">Wardle et al., 2008</xref>; <xref ref-type="bibr" rid="bib5">Bouchard, 2009</xref>), but variation between individuals does exist (<xref ref-type="bibr" rid="bib45">Littleton et al., 2020</xref>). Genome-wide association studies (GWAS) have improved our understanding of the genetic contribution to childhood obesity (<xref ref-type="bibr" rid="bib83">Vogelezang et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Yaghootkar et al., 2020</xref>; <xref ref-type="bibr" rid="bib16">Couto Alves et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Fu et al., 2019</xref>; <xref ref-type="bibr" rid="bib81">Turcot et al., 2018</xref>; <xref ref-type="bibr" rid="bib46">Littleton and Grant, 2022</xref>). However, the functional consequences and molecular mechanisms of identified genetic variants in such GWAS efforts are yet to be fully elucidated. Efforts are now being made to predict target effector genes and explore potential drug targets using various computational and experimental approaches (<xref ref-type="bibr" rid="bib92">Yu et al., 2022</xref>; <xref ref-type="bibr" rid="bib2">Avsec et al., 2021</xref>; <xref ref-type="bibr" rid="bib28">Gazal et al., 2022</xref>; <xref ref-type="bibr" rid="bib93">Zhou and Troyanskaya, 2015</xref>; <xref ref-type="bibr" rid="bib53">Nasser et al., 2021</xref>), which subsequently warrant functional follow-up efforts.</p><p>With our extensive datasets generated on a range of different cell types, by combining 3D chromatin maps (Hi-C, Capture-C) with matched transcriptome (RNA-seq) and chromatin accessibility data (ATAC-seq), we investigated heritability patterns of pediatric obesity-associated variants and their gene-regulatory functions in a cell type-specific manner. This approach yielded 94 candidate causal variants mapped to their putative effector gene(s) and corresponding cell type(s) setting. In addition, using methods comparable to our prior efforts in other disease contexts (<xref ref-type="bibr" rid="bib11">Chesi et al., 2019</xref>; <xref ref-type="bibr" rid="bib74">Su et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Pahl et al., 2021</xref>; <xref ref-type="bibr" rid="bib15">Cousminer et al., 2021</xref>; <xref ref-type="bibr" rid="bib84">Vujkovic et al., 2022</xref>; <xref ref-type="bibr" rid="bib58">Pahl et al., 2022</xref>; <xref ref-type="bibr" rid="bib76">Su et al., 2022</xref>; <xref ref-type="bibr" rid="bib59">Palermo et al., 2023</xref>), we also uncovered new variant-to-gene combinations within specific novel cellular settings, most notably in immune cell types, which further confirmed the involvement of the immune system in the pathogenesis of obesity in the early stages of life.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Enrichment assessment of childhood obesity variants across cell types</title><p>To explore the enrichment of childhood obesity GWAS variants across cell types, we carried out Partitioned Linkage Disequilibrium Score Regression (LDSR) (<xref ref-type="bibr" rid="bib24">Finucane et al., 2015</xref>) on all ATAC-seq-defined OCRs for each cell type. We assessed cell-type-specific enrichment of GWAS signals in four main categories of genomic regions (<xref ref-type="fig" rid="fig1">Figure 1A</xref>): (1) Total OCRs: open chromatin regions defined by ATAC-seq; (2) Promoter OCRs: the subset of OCRs overlapping a gene promoter; (3) cREs: the subset of OCRs that form chromatin loops (as determined by Hi-C/Promoter Capture-C) with a gene promoter, and are therefore considered putative enhancers or suppressors regulating gene expression; (4) cREs ±500bases: extended cREs by 500 bases in both directions. The rationale behind this approach is that different GWAS variants can influence phenotypes by regulating gene expression in a cell-type specific manner through various regulatory mechanisms. For example, they may alter enhancer function (cREs category) or affect the binding of a transcription factor at a gene’s promoter (Promoter OCRs category).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Partitioned Linkage Disequilibrium Score Regression analysis for open chromatin regions of all cell types.</title><p>(<bold>A</bold>) The schematic shows the different types of regions defined in our study and 3 different ways overlapping chromatin contact regions – OCRs – gene promoters define cREs. (<bold>B</bold>) Heritability enrichment by LDSC analysis for each cell type. (<bold>a</bold>) Bar-plot shows the total number of OCRs identified by ATAC-seq for each cell type on bulk cells - blue, or on single cells – red; and the portion of OCRs that fall within cREs identified by incorporating Hi-C (green) or by Capture-C (orange). 4 panels of dot-plots show heritability enrichment by LDSC analysis for each cell type, with standard error whiskers. Dots’ colors correspond to -log10(p-values), dots with white asterisks are significant <italic>P</italic>-values &lt;0.05, and dots’ sizes corresponding to the proportion of SNP contribute to heritability. Dash line at 1, i.e., no enrichmen. (<bold>b</bold>) Analysis done on whole OCRs set of each cell type (whiskers colors match with bulk/single cell from bar-plot a); (<bold>c</bold>) On only OCRs that overlapped with promoters (whiskers’ colors match with 623 bulk/single cell from bar-plot a); (<bold>d</bold>) On the putative cREs of each cell type (whiskers’ colors match with Hi-C/Capture-C from bar-plot a); (<bold>e</bold>) On the same cREs as (<bold>c</bold>) panel with their genomic positions expanded ±500 bases on both sides (whiskers’ colors match with Hi-C/Capture-C from bar-plot a).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig1-v1.tif"/></fig><p>We observed that 41 of 57 cell types – including 22 metabolic, 21 immune, 7 neural cell types, and 7 independent cell lines (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>) – showed at least a degree of directional enrichment with the total set of OCRs (<xref ref-type="fig" rid="fig1">Figure 1B</xref> <bold>–</bold> Total OCRs). However, only four cell types – two pancreatic alpha and two pancreatic beta cell-based datasets – had statistically significant enrichments (p&lt;0.05). These enrichments were less pronounced when focusing on promoter OCRs only (<xref ref-type="fig" rid="fig1">Figure 1B</xref> <bold>–</bold> Promoter OCRs). To further limit the LD enrichment assessment to just those OCRs that can putatively regulate gene expression via chromatin contacts with gene promoters, we used the putative cREs (<xref ref-type="bibr" rid="bib11">Chesi et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Pahl et al., 2021</xref>). This reduced the number of cell types showing at least nominal enrichment (31 of 57), enlarged the dispersion of enrichment ranges across different cell types, increased the 95% confidence intervals (CI) of enrichments, and hence increased the <italic>P</italic>-value of the resulting regression score. cREs from pancreatic alpha cells derived from single-cell ATAC-seq were the only dataset that remained statically significant (<xref ref-type="fig" rid="fig1">Figure 1B</xref> <bold>–</bold> putative cREs).</p><p>The original reported LDSR method analyzed enrichment in the 500 bp flanking regions of their regulatory categories (<xref ref-type="bibr" rid="bib24">Finucane et al., 2015</xref>). However, when we expanded our analysis to the ± 500 bp window for our cREs, albeit incorporating more weighted variants into the enrichment (represented by larger dots in <xref ref-type="fig" rid="fig1">Figure 1B</xref> <bold>–</bold> cREs ± 500 bases), this resulted in a decrease in the number of cell types yielding at least nominal enrichment (26 cell types), the enrichment range across cell types, the 95% CI, and level of significance. The pancreatic alpha cell observation also dropped below the bar for significance with this expanded window definition.</p></sec><sec id="s2-2"><title>Consistency and diversity of childhood obesity proxy variants mapped to cREs</title><p>Despite the enrichments above only being limited to just a small number of cell types, it is likely that individual loci have differing levels of contributions in various cellular contexts and could not be detected at the genome wide assessment scale. As such we elected to further explore the candidate effector genes that are directly affected by cREs harboring childhood obesity-associated variants by systematically mapping the genomic positions of the LD proxies onto each cell type’s cREs. Most proxies fall within chromatin contact regions (blue area in Venn diagram <xref ref-type="fig" rid="fig2">Figure 2A</xref>) or OCRs (yellow area) or open chromatin contact regions (red area), or completely outside (white area) any defined region. Only 94 proxies fall within our defined cREs (overlapped area with dotted green border in <xref ref-type="fig" rid="fig2">Figure 2A</xref>), they clustered at 13 original loci (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> outlines the number of signals at each locus included or excluded based on the criteria we defined for our regions of interest. The <italic>TMEM18</italic> locus yielded the most variants through cREs mapping, with 46 proxies for the two lead independent variants, rs7579427 and rs62104180. The second most abundant locus was <italic>ADCY3</italic>, with 21 proxies for lead variant rs4077678 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The higher number of variants at one locus did not correlate with implicating more genes or cell types through mapping. The mapping frequency of various variants within a specific locus exhibited substantial differences (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Mapping 771 proxies to the open chromatin regions of each cell type.</title><p>(<bold>A</bold>) Venn diagram shows how 771 proxies mapped to the OCRs: · Blue area: 758 proxies were located within contact regions of at least one cell type regardless of chromatin state; · Red area: 417 proxies were located within contact regions marked as open by overlapping with OCR; · Yellow area: If we only considered open chromatin regions, 178 proxies were included; · Dotted green bordered area: To focus on just those variants residing within open chromatin and contacting promoter regions in any cell type, we overlapped the genomic positions of these proxies with each cell type’s cRE set, yielding 90 variants (3 from the 99% credible set) directly contacting open gene promoters (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>), with 10 of which located within a promoter of one gene but contacting another different gene promoter. There were an additional 4 variants located within gene promoters but in chromatin contact with promoter(s) of nearby transcript(s) of the same gene (correspond to 3 cREs illustrations in <xref ref-type="fig" rid="fig1">Figure 1A</xref>). · White area: proxies that fall into neither defined region of interest. (<bold>B</bold>) Bar-plot shows number of proxies, cell types and target genes mapped at each locus. (<bold>C</bold>) The upSet plot shows the degree of overlap across cell types of the variants; ranked from the most common variant (red) – rs61888800 from <italic>BDNF</italic> locus, a well-known 5' untranslated region variant of this gene that is associated with anti-depression and therapeutic response (<xref ref-type="bibr" rid="bib44">Licinio et al., 2009</xref>; <xref ref-type="bibr" rid="bib14">Colle et al., 2015</xref>) – appeared in 39 cell types, to the group of variants (grey) which appeared in only one cell type.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Venn diagrams show intersections and the number of proxies within each locus were mapped in different scenarios as illustrated in <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</title><p>Colors of the areas corresponding to different subset of OCRs, the white areas show proxies that unmapped to any OCR.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>The upSet plot outlines in which cell type(s) each locus appeared.</title><p>The 46 variants at the <italic>TMEM18</italic> locus appeared in 31 cell types and implicated 16 genes, while only 5 variants of <italic>BDNF</italic> locus appeared in 42 cell types and implicated 23 genes, or 2 variants of <italic>FAIM2</italic> locus with 26 cell types and 15 implicated genes. Seven variants of the <italic>FTO</italic> locus though appeared in only 7 cell types, but targeted promoters of up to 18 genes. At five loci <italic>ADCY9</italic>, <italic>GPR1</italic>, <italic>MC4R</italic>, <italic>METTL15</italic>, and <italic>TFAP2B</italic>, only one single proxy – but not the lead variant in each case – was mapped. Of these, the variant from <italic>METTL15</italic> locus only implicated the <italic>BDNF</italic> gene but appeared in four different cell types. In contrast, the variant from <italic>ADCY9</italic> locus appeared in five different cell types and implicated up to 10 different genes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Examples of 2 variants mapped to only one gene promoter.</title><p>(<bold>A</bold>) At <italic>TFAP2B</italic> locus on chromosome 6, rs62405437 was found only in a human embryonic stem cell line, within the body of transcription factor AP-2 beta (<italic>TFAP2B</italic>) contacting the promoter of <italic>TFAP2D</italic> (red arc). Interestingly, there were many contacts identified by our Capture-C assay between these two members of the transcription factor AP-2 family (blue arcs), and many of our proxies were located within these loop ends, albeit outside any defined open chromatin region – red regions in illustration <xref ref-type="fig" rid="fig1">Figure 1A</xref>. (<bold>B</bold>) At the <italic>GPR1</italic> locus on chromosome 2, rs115319174 was identified only within Nigerian melanocytes cREs, positioned in an open region within the body of the <italic>CMKLR2</italic> gene and contacting (red arc) the promoter of <italic>GPR1</italic> – a gene for G-protein-coupled receptors known to increase its expression in obese phenotypes14. Blue arcs represented other chromatin contacts identified within this window. <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>. Dot-plot with each variant colored by their locus shows the number of genes and cell types each proxy mapped into our cREs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Dot-plot with each variant colored by their locus shows the number of genes and cell types each proxy mapped into our cREs.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig2-figsupp4-v1.tif"/></fig><fig id="fig2s5" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 5.</label><caption><title>Bar plots for the number of cell types and number of genes implicated by each variant.</title><p>Bar-plots show some variants found in multiple cell types were more selective with respect to their target genes (red arrow) – such as rs11030197 at the <italic>METTL15</italic> locus – or conversely more selective in given cell types but implicated multiple genes (blue arrow) – such as 21 other variants from the 66 mentioned earlier that appeared in only one cell type but contacted multiple genes within that cellular setting. These 21 variants included one from <italic>BDNF</italic> locus, one from <italic>FAIM2</italic> locus, two from <italic>TNNI3K</italic>, five from <italic>FTO</italic>, and twelve from the <italic>TMEM18</italic> locus.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig2-figsupp5-v1.tif"/></fig><fig id="fig2s6" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 6.</label><caption><title>TMEM18 locus: within this locus where there were 45 proxies in LD with the sentinel SNP rs7579427 that mapped to the cREs of 31 cell types; 35 of these proxies were found exclusively in only one unique cell type (10 in pre-adipocytes only, 9 in adipocytes only, 8 in EndoC-BH1 only, 2 in hESC-derived hypothalamic neurons only, 2 in natural killer cells only, and 4 in activated regulatory T cells only); however, their target gene promoters were also frequently contacted by other different proxies in other cell types.</title><p>Example in blue window. The green window: The SH3YL1 open promoter was contacted within 25 cell types, including eleven immune cell types (mostly T-cells), six metabolic cell types (adipocytes, different pancreatic cell types, differentiated osteoblasts), and three neural cell types (primary astrocytes, hESC-derived hypothalamic neurons, and neural progenitors). Similarly, the ACP1 promoter was contacted in 14 cell types across three systems, except for adipocytes and astrocytes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig2-figsupp6-v1.tif"/></fig></fig-group><p>Inspecting individual variants regardless of their locus, we found that 28 of 94 proxies appeared in cREs across multiple cell types, with another 66 observed in just one cell type (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). 45 variants of these 66 just contacted one gene promoter, such as at the <italic>GPR1</italic> and <italic>TFAP2B</italic> loci (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>).</p><p>Overall, the number of cell types in which a variant was observed in open chromatin correlated with the number of genes contacted via chromatin loops (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). However, we also observed that some variants found in cREs in multiple cell types were more selective with respect to their candidate effector genes (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref> - red arrow), or conversely, more selective across given cell types but implicated multiple genes (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref> - blue arrow). <xref ref-type="fig" rid="fig2s6">Figure 2—figure supplement 6</xref> outlines our observations at the <italic>TMEM18</italic> locus – an example locus involved in both scenarios.</p></sec><sec id="s2-3"><title>Implicated genes cluster at loci strongly associated with childhood obesity consistently across multiple cell types</title><p>Mapping the variants across all the cell types resulted in a total of 111 implicated childhood obesity candidate effector genes (<xref ref-type="table" rid="table1">Table 1</xref>). Among these, 45 genes were specific to just one cell type (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), including 13 in myotubes and 7 in natural killer cells. Conversely and notably, <italic>BDNF</italic> appeared across 42 different cell types. Across the metabolic, neural, and immune systems and seven other cell lines, there were nine genes consistently implicated in all four categories (top panel <xref ref-type="fig" rid="fig3">Figure 3</xref> <bold>–</bold> red stars, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref> ‘all’), while five genes were consistently implicated in metabolic, neural, and immune systems (top panel <xref ref-type="fig" rid="fig3">Figure 3</xref> – blue stars, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref> ‘all_main’). Two genes, <italic>ADCY3</italic> and <italic>BDNF</italic>, had variants both at their promoters and contacted variants in cREs via chromatin loops (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Profiles of 111 implicated genes by 94 proxies through cREs of each cell type.</title><p>Main panel: Bubble plot show corresponding expression level (size) and number of variants (color) target each implicated gene of each cell type. Squares represent genes with variants at their promoters. Circles represent genes with variants contacted through chromatin loops. Some genes were implicated by both types, these ‘double implications’ are represented as diamond shapes, and were identified across several cell types: two cell types (plasmacytoid dendritic cells and pre-differentiated adipocytes) for <italic>ADCY3</italic> gene, and five for <italic>BDNF</italic> (human embryonic stem cells - hESC, differentiated human fetal osteoblast cells - hFOB_Diff, neural progenitor cells derived from induced pluripotent stem cells - NPC_iPSC, PANC-1, and NCIH716 cell lines). Genes with expression undetected in our arrays are shown as triangles. Top panel: bar-plot shows numbers of cell types each gene was implicated within, color-coded by which systems the cell types belong to. Right panel: bar-plot shows numbers of genes implicated by the variants with each cell type.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Bar-plot shows number of genes implicated in how many cell types.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Bar-plot shows number of genes implicated in cell types of each combination of metabolic, immune, neural system and other cell lines groups.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Double-implicated genes.</title><p>Genomic views of two loci where genes promoters both harbor childhood obesity variants (solid arrows) and were contacted by OCRs harboring variants though chromatin contacts (hollow arrows), hence “double-implicated”. Top panel: <italic>BDNF</italic> locus where <italic>BDNF</italic> gene promoters harbor two variants rs61888800 and rs75707145 that overlapped with OCRs of three cell types. In differentiated hFOB cell and iPSC-derived neural progenitor cells, different <italic>BDNF</italic> promoters were contacted through chromatin loops in different cell types. Lower panel: <italic>ADCY3</italic> locus where <italic>ADCY3</italic> gene promoters were double-implicated by two variants in plasmacytoid dendritic cells and 8 other variants in pre-differentiated adipocytes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig3-figsupp3-v1.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>PubMed-query known functions for 111 genes implicated by obesity variants.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Locus</th><th align="left" valign="bottom">Implicated genes</th><th align="left" valign="bottom">Obesity or related traits</th><th align="left" valign="bottom">Different traits</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="6"><bold>TNNI3K</bold></td><td align="left" valign="middle">LRRIQ3</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Associated with opioid usage [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41380-021-01335-3">PMID:34728798</ext-link>] and MDD <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038%2Fs41398-019-0613-4">[PMID: 31748543</ext-link>]</td></tr><tr><td align="left" valign="middle">FPGT</td><td align="left" valign="middle" rowspan="2">Predict BMI in Korean pop. [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7717%2Fpeerj.3510">PMID: 28674662</ext-link>]</td><td align="left" valign="middle">(NA)</td></tr><tr><td align="left" valign="middle">FPGT-TNNI3K</td><td align="left" valign="middle">Associated with MDD [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038%2Fs41398-019-0613-4">PMID: 31748543</ext-link>]</td></tr><tr><td align="left" valign="middle">LRRC53</td><td align="left" valign="middle">Associated with high BMI increased risk heart attack [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12872-020-01542-w">PMID: 32471361</ext-link>]</td><td align="left" valign="middle">(NA)</td></tr><tr><td align="left" valign="middle">ASTN1</td><td align="left" valign="middle">Identified as obesity QTL in rat [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038%2Fs41598-022-14316-5">PMID: 35729251</ext-link>]</td><td align="left" valign="middle">Associated with neurodevelopmental traits [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddt669">PMID: 24381304</ext-link>] and variety of cancers <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892%2For.2020.7704">[PMID: 32945491</ext-link>]</td></tr><tr><td align="left" valign="middle">BRINP2</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Associated with neurodevelopmental traits [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038%2Fs41598-021-93555-4">PMID: 34267256</ext-link>]</td></tr><tr><td align="left" valign="middle" rowspan="2"><bold>SEC16B</bold></td><td align="left" valign="middle">AL122019.1</td><td align="center" valign="middle" rowspan="2" colspan="2">(NA)</td></tr><tr><td align="left" valign="middle">AL162431.1</td></tr><tr><td align="left" valign="middle" rowspan="16"><bold>TMEM18</bold></td><td align="left" valign="middle">FAM110C</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Overexpression induces microtubule aberrancies [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ygeno.2007.03.002">PMID: 17499476</ext-link>], involved in cell spreading and migration [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cellsig.2009.08.001">PMID: 19698782</ext-link>]</td></tr><tr><td align="left" valign="middle">SH3YL1</td><td align="left" valign="middle">Associated with BMI in type 2 diabetes nephropathy [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.numecd.2020.09.024">PMID: 33223406</ext-link>]</td><td align="left" valign="middle">Influence on T cell activation [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41598-019-48493-7">PMID: 31427643</ext-link>], involved in different cancer types [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/me.2015-1079">PMID: 26305679,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cellsig.2014.01.027">24508479</ext-link>]</td></tr><tr><td align="left" valign="middle">ACP1</td><td align="left" valign="middle">Associated with early-onset obesity [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ejhg.2013.189">PMID: 24129437</ext-link>], correlated with cardiovascular risks [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.metabol.2009.05.007">PMID: 19570551</ext-link>], drive adipocyte differentiation via control of pdgfrα signaling [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jcp.30307">PMID: 33615467</ext-link>]</td><td align="left" valign="middle">Associated with bipolar disorder [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jpsychires.2019.11.009">PMID: 31830721</ext-link>]</td></tr><tr><td align="left" valign="middle">ALKAL2</td><td align="left" valign="middle">Associated with childhood BMI [PMID: 33627773]</td><td align="left" valign="middle">Enhance expression in response to inflammatory pain in nociceptors [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/jci154317">PMID: 35608912,</ext-link> <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/17448069221106167">35610945</ext-link>]</td></tr><tr><td align="left" valign="middle">MYT1L</td><td align="left" valign="middle">Associated with early-onset obesity [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ejhg.2013.189">PMID: 24129437</ext-link>]</td><td align="left" valign="middle">(NA)</td></tr><tr><td align="left" valign="middle">AC079779.1</td><td align="center" valign="middle" rowspan="11" colspan="2">(NA)</td></tr><tr><td align="left" valign="middle">AC079779.2</td></tr><tr><td align="left" valign="middle">AC079779.3</td></tr><tr><td align="left" valign="middle">AC079779.4</td></tr><tr><td align="left" valign="middle">LINC01865</td></tr><tr><td align="left" valign="middle">AC105393.2</td></tr><tr><td align="left" valign="middle">AC105393.1</td></tr><tr><td align="left" valign="middle">LINC01874</td></tr><tr><td align="left" valign="middle">LINC01875</td></tr><tr><td align="left" valign="middle">AC093326.1</td></tr><tr><td align="left" valign="middle">AC141930.2</td></tr><tr><td align="left" valign="middle" rowspan="9"><bold>ADCY3</bold></td><td align="left" valign="middle">ITSN2</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Regulate T-cells function [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15252/msb.20209524">PMID: 32618424</ext-link>] and help the interaction with B-cells [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/elife.26556">PMID: 29337666</ext-link>]</td></tr><tr><td align="left" valign="middle">NCOA1</td><td align="left" valign="middle">Meta-inflammation gene [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/me.2015-1005">PMID: 25647480</ext-link>], reduce adipogenesis, shift the energy balance between white and brown fat [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jiph.2019.05.011">PMID: 31133421</ext-link>]</td><td align="center" valign="middle" rowspan="5">(NA)</td></tr><tr><td align="left" valign="middle">ADCY3</td><td align="left" valign="middle">Regulate/impair MC4R within energy-regulating melanocortin signaling pathway [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41588-017-0020-9">PMID: 29311635,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/elife.55851">32955435</ext-link>]</td></tr><tr><td align="left" valign="middle">DNAJC27-AS1</td><td align="left" valign="middle">Linked to obesity, diabetes traits [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2018.00423">PMID: 30131766</ext-link>]</td></tr><tr><td align="left" valign="middle">DNAJC27</td><td align="left" valign="middle">Linked to obesity, diabetes traits [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2018.00423">PMID: 30131766</ext-link>]</td></tr><tr><td align="left" valign="middle">EFR3B</td><td align="left" valign="middle">Associated with T1D [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1002293">PMID: 21980299</ext-link>], down-regulated in rare obesity-related disorder [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2147/agg.s74598">PMID: 25705109</ext-link>]</td></tr><tr><td align="left" valign="middle">WDR43</td><td align="left" valign="middle">(NA)</td><td align="left" valign="middle">Associated with breast cancer [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms11375">PMID: 27117709</ext-link>]</td></tr><tr><td align="left" valign="middle">AC013267.1</td><td align="left" valign="middle" rowspan="2" colspan="2">(NA)</td></tr><tr><td align="left" valign="middle">RF00016</td></tr><tr><td align="left" valign="middle"><bold>GPR1</bold></td><td align="left" valign="middle">GPR1</td><td align="left" valign="middle">Increase expression in obese phenotype [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.pharmthera.2021.107928">PMID: 34174278</ext-link>]</td><td align="left" valign="middle">(NA)</td></tr><tr><td align="left" valign="middle"><bold>TFAP2B</bold></td><td align="left" valign="middle">TFAP2D</td><td align="center" valign="middle" rowspan="4">(NA)</td><td align="left" valign="middle">Involve in embryogenesis [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s1567-133x(02)00067-4">PMID: 12711551</ext-link>]</td></tr><tr><td align="left" valign="middle" rowspan="9"><bold>CALCR</bold></td><td align="left" valign="middle">HEPACAM2</td><td align="left" valign="middle">Associated with colorectal cancer [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cam4.1484">PMID: 29659199,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.12659/msm.907224"> 29973580</ext-link>]</td></tr><tr><td align="left" valign="middle">VPS50</td><td align="left" valign="middle">Involve in neurodevelopmental disorders and defects [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13039-019-0421-9">PMID: 30828385,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/brain/awab206"> 34037727</ext-link>]</td></tr><tr><td align="left" valign="middle">MIR653</td><td align="left" valign="middle">Involve in different types of cancer [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canep.2022.102208">PMID: 35777307</ext-link>]</td></tr><tr><td align="left" valign="middle">MIR489</td><td align="left" valign="middle">Promote adipogenesis in mice [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.lfs.2021.119620">PMID: 34004251</ext-link>]</td><td align="left" valign="middle" rowspan="2">(NA)</td></tr><tr><td align="left" valign="middle">CALCR</td><td align="left" valign="middle">Associated with BMI and control of food-intake [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-021-25525-3">PMID: 34462445,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.abf8683"> 34210852,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmet.2019.12.012"> 31955990,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/en.2017-03259"> 29522093</ext-link>]</td></tr><tr><td align="left" valign="middle">TFPI2</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Involved in colorectal cancer [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2021.706754">PMID: 35004840,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3233/cbm-203259"> 34092617,</ext-link> <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00432-015-1972-8">25902909</ext-link>]</td></tr><tr><td align="left" valign="middle">BET1</td><td align="left" valign="middle">Involved in triacylglycerol metabolism [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2013-3962">PMID: 24423365</ext-link>]</td><td align="left" valign="middle">Associated with muscular dystrophy [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.expneurol.2021.113815">PMID: 34310943,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15252/emmm.202013787"> 34779586</ext-link>]</td></tr><tr><td align="left" valign="middle">AC003092.1</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Association with glioblastoma [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2021.633812">PMID: 33815468,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41419-018-1183-8"> 30442884</ext-link>]</td></tr><tr><td align="left" valign="middle">AC002076.1</td><td align="center" valign="middle" colspan="2">(NA)</td></tr><tr><td align="left" valign="middle" rowspan="23"><bold>BDNF</bold></td><td align="left" valign="middle">LIN7C</td><td align="left" valign="middle">Associated in T2D [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2009-2077">PMID: 20215397</ext-link>], obesity [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archgenpsychiatry.2012.660">PMID: 23044507</ext-link>]</td><td align="left" valign="middle">Associated with psychopathology [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archgenpsychiatry.2012.660">PMID: 23044507</ext-link>]</td></tr><tr><td align="left" valign="middle">BDNF-AS</td><td align="left" valign="middle">Regulate <italic>BDNF</italic> and <italic>LIN7C</italic> expression <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1534/genetics.112.145128">[PMID: 22960213,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nbt.2158"> 22446693</ext-link>]</td><td align="left" valign="middle" rowspan="2">(NA)</td></tr><tr><td align="left" valign="middle">BDNF</td><td align="left" valign="middle">Regulate eating behavior and energy balance <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41576-021-00414-z">[PMID: 34556834</ext-link>]</td></tr><tr><td align="left" valign="middle">MIR610</td><td align="center" valign="middle" rowspan="2">(NA)</td><td align="left" valign="middle">Involve in different types of cancer [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2147/ijn.s323671">PMID: 34408418,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.22125"> 29228616,</ext-link><ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26885452/"> 26885452</ext-link>]</td></tr><tr><td align="left" valign="middle">KIF18A</td><td align="left" valign="middle">Involve in different types of cancer [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2022.852049">PMID: 35591854,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.jmedchem.1c02030"> 35286090</ext-link>]</td></tr><tr><td align="left" valign="middle">METTL15</td><td align="left" valign="middle">Associated with childhood obesity [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddz161">PMID: 31504550</ext-link>]</td><td align="left" valign="middle">(NA)</td></tr><tr><td align="left" valign="middle">AC090124.1</td><td align="center" valign="middle" rowspan="4">(NA)</td><td align="left" valign="middle">Reported to differentially prognostic of pancreatic cancer [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2021.698296">PMID: 34307375</ext-link>]</td></tr><tr><td align="left" valign="middle">ARL14EP</td><td align="left" valign="middle">Involve in WAGR syndrome [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/genes13081431">PMID: 36011342,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-019-12013-y"> 31511512</ext-link>]</td></tr><tr><td align="left" valign="middle">DCDC1</td><td align="left" valign="middle">Involvement with eyes anomalies [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ajmg.a.62559">PMID: 34773354,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.isci.2021.103191"> 34703991</ext-link>]</td></tr><tr><td align="left" valign="middle">THEM7P</td><td align="left" valign="middle">Associated with mechanisms underlying inguinal hernia [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ebiom.2021.103532">PMID: 34392144</ext-link>]</td></tr><tr><td align="left" valign="middle">AL035078.2</td><td align="center" valign="middle" rowspan="13" colspan="2">(NA)</td></tr><tr><td align="left" valign="middle">ELP4</td></tr><tr><td align="left" valign="middle">LINC00678</td></tr><tr><td align="left" valign="middle">AC023206.1</td></tr><tr><td align="left" valign="middle">RN7SKP158</td></tr><tr><td align="left" valign="middle">AC104978.1</td></tr><tr><td align="left" valign="middle">MIR8068</td></tr><tr><td align="left" valign="middle">AC013714.1</td></tr><tr><td align="left" valign="middle">AC100773.1</td></tr><tr><td align="left" valign="middle">AC090833.1</td></tr><tr><td align="left" valign="middle">AC090791.1</td></tr><tr><td align="left" valign="middle">AC110056.1</td></tr><tr><td align="left" valign="middle">AL035078.2</td></tr><tr><td align="left" valign="middle" rowspan="15"><bold>FAIM2</bold></td><td align="left" valign="middle">PRPF40B</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Splicing regulator involved in T-cell development [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1261/rna.069534.118">PMID: 31088860,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dev.199754"> 34323272</ext-link>]</td></tr><tr><td align="left" valign="middle">TMBIM6</td><td align="left" valign="middle">Deficiency leads to obesity by increasing Ca2+-dependent insulin secretion [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00109-020-01914-x">PMID: 32394396</ext-link>]</td><td align="left" valign="middle">Immune cell function and survival [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cdd.2015.115">PMID: 26470731</ext-link>]</td></tr><tr><td align="left" valign="middle">BCDIN3D</td><td align="left" valign="middle">Associated with obesity, T2D [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2009-2077">PMID: 20215397</ext-link>]</td><td align="center" valign="middle" rowspan="3">(NA)</td></tr><tr><td align="left" valign="middle">FAIM2</td><td align="left" valign="middle">Associated with childhood obesity [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddz161">PMID: 31504550</ext-link>]</td></tr><tr><td align="left" valign="middle">AQP2</td><td align="left" valign="middle">Associated with obesity, diabetes [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ndt/gfaa243">PMID: 33367818</ext-link>]</td></tr><tr><td align="left" valign="middle">AQP5</td><td align="left" valign="middle">Associated with non-obese diabetes [<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25635992/">PMID: 25635992,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1601-0825.2012.01909.x">22320885</ext-link>]</td><td align="left" valign="middle">Responsible for transporting water, involve in Sjogren’s syndrome <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25635992/">[PMID: 25635992,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms20194750"> 31557796</ext-link>]</td></tr><tr><td align="left" valign="middle">AQP6</td><td align="left" valign="middle">Down-regulated in retina in diabetes [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/02713683.2011.593108">PMID: 21851171</ext-link>]</td><td align="left" valign="middle">Associated with renal diseases [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms20020366">PMID: 30654539</ext-link>]</td></tr><tr><td align="left" valign="middle">RACGAP1</td><td align="left" valign="middle">Involve in diabetes nephropathy [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2022.781806">PMID: 35222021</ext-link>]</td><td align="left" valign="middle" rowspan="2">(NA)</td></tr><tr><td align="left" valign="middle">ASIC1</td><td align="left" valign="middle">Inhibition increase food intake and decrease energy expenditure [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/endocr/bqac115">PMID: 35894166</ext-link>]</td></tr><tr><td align="left" valign="middle">LSM6P2</td><td align="center" valign="middle" rowspan="6" colspan="2">(NA)</td></tr><tr><td align="left" valign="middle">RPL35AP28</td></tr><tr><td align="left" valign="middle">LINC02396</td></tr><tr><td align="left" valign="middle">LINC02395</td></tr><tr><td align="left" valign="middle">AC025154.1</td></tr><tr><td align="left" valign="middle">AC025154.2</td></tr><tr><td align="left" valign="middle" rowspan="10"><bold>ADCY9</bold></td><td align="left" valign="middle">SLX4</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Associated with blood pressure [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00439-019-01975-0">PMID: 30671673</ext-link>]</td></tr><tr><td align="left" valign="middle">DNASE1</td><td align="left" valign="middle">Associated with obesity hypertension [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.14341/probl10236">PMID: 33351325</ext-link>]</td><td align="center" valign="middle" rowspan="4">(NA)</td></tr><tr><td align="left" valign="middle">TRAP1</td><td align="left" valign="middle">Involve in global metabolic network, deletion reduce obesity incidence [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2014.06.061">PMID: 25088416</ext-link>]</td></tr><tr><td align="left" valign="middle">CREBBP</td><td align="left" valign="middle">Associated with high adiposity and low cardiometabolic risk [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s42255-021-00346-2">PMID: 33619380</ext-link>]</td></tr><tr><td align="left" valign="middle">ADCY9</td><td align="left" valign="middle">Asoociated with BMI, obesity [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s42255-021-00346-2">PMID: 33619380,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.2606"> 23563607</ext-link>]</td></tr><tr><td align="left" valign="middle">SRL</td><td align="center" valign="middle" rowspan="2">(NA)</td><td align="left" valign="middle">Involve in cardiac dysfunction [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ceca.2011.10.003">PMID: 22119571</ext-link>]</td></tr><tr><td align="left" valign="middle">LINC01569</td><td align="left" valign="middle">Associated with cancer and endometriosis [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.rbmo.2021.11.019">PMID: 35341703,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fonc.2021.727698"> 34422671</ext-link>]</td></tr><tr><td align="left" valign="middle">TFAP4</td><td align="left" valign="middle">Associated with BMI, birth weight, maternal glycemic [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2337/dc21-2662">PMID: 35708509</ext-link>]</td><td align="center" valign="middle">(NA)</td></tr><tr><td align="left" valign="middle">AC012676.1</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Involve in hepatocellular carcinoma [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.16288/j.yczz.21-416">PMID: 35210216</ext-link>]</td></tr><tr><td align="left" valign="middle">AC009171.2</td><td align="center" valign="middle" colspan="2">(NA)</td></tr><tr><td align="left" valign="middle" rowspan="18"><bold>FTO</bold></td><td align="left" valign="middle">FTO</td><td align="left" valign="middle">Most extensively studied obesity locus [PMID: 34556834]</td><td align="center" valign="middle" rowspan="3">(NA)</td></tr><tr><td align="left" valign="middle">IRX3</td><td align="left" valign="middle" rowspan="2">Obesogenic effects in adipocytes [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/nejmc1513316">PMID: 26760096</ext-link>], brain [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature13138">PMID: 24646999</ext-link>], pancreas[93]</td></tr><tr><td align="left" valign="middle">IRX5</td></tr><tr><td align="left" valign="middle">AC018553.1</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Associated with melanoma [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.12998/wjcc.v10.i11.3334">PMID: 35611195</ext-link>]</td></tr><tr><td align="left" valign="middle">CRNDE</td><td align="left" valign="middle">Regulator of angiogenesis in obesity-induced diabetes [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41598-019-56030-9">PMID: 31863035</ext-link>]</td><td align="center" valign="middle" rowspan="2">(NA)</td></tr><tr><td align="left" valign="middle">MMP2</td><td align="left" valign="middle">Involve in obesity-relate angiogenesis [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3746/pnf.2022.27.2.172">PMID: 35919566</ext-link>]</td></tr><tr><td align="left" valign="middle">CAPNS2</td><td align="left" valign="middle">(NA)</td><td align="left" valign="middle">Associated with thyroid-related traits [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1003266">PMID: 23408906</ext-link>]</td></tr><tr><td align="left" valign="middle">AMFR</td><td align="left" valign="middle">Involve in hepatic lipid metabolism [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1009357">PMID: 33591966</ext-link>]</td><td align="center" valign="middle" rowspan="2">(NA)</td></tr><tr><td align="left" valign="middle">CETP</td><td align="left" valign="middle">Involve in monogenic hyperalphalipoproteinemia [<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/nbk575729/">PMID: 34878751</ext-link>]</td></tr><tr><td align="left" valign="middle">RPGRIP1L</td><td align="left" valign="middle">Hypomorphism of this ciliary gene linked to morbid obesity [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/jci85526">PMID: 27064284,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/gepi.22179"> 30597647,</ext-link><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1507/endocrj.ej17-0554"> 29657248</ext-link>]</td><td align="left" valign="middle">Required for hypothalamic arcuate neuron development [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/jci.insight.123337">PMID: 30728336</ext-link>]</td></tr><tr><td align="left" valign="middle">LINC02169</td><td align="center" valign="middle">(NA)</td><td align="left" valign="middle">Associated with occupational exposure to gases/fumes and mineral dust [<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddz067">PMID: 31152171</ext-link>]</td></tr><tr><td align="left" valign="middle">AC007491.1</td><td align="center" valign="middle" rowspan="7" colspan="2">(NA)</td></tr><tr><td align="left" valign="middle">AC018553.2</td></tr><tr><td align="left" valign="middle">LINC02140</td></tr><tr><td align="left" valign="middle">AC106738.1</td></tr><tr><td align="left" valign="middle">AC106738.2</td></tr><tr><td align="left" valign="middle">MTND5P34</td></tr><tr><td align="left" valign="middle">AC007336.1</td></tr><tr><td align="left" valign="middle"><bold>MC4R</bold></td><td align="left" valign="middle">AC090771.1</td><td align="center" valign="middle" colspan="2">(NA)</td></tr></tbody></table></table-wrap><p>At the <italic>TMEM18</italic> locus on chr 2p25.3, a highly significant human obesity locus that has long been associated with both adult and childhood obesity, we observed differing degrees of evidence for 16 genes, but noted that rs6548240, rs35796073, and rs35142762 consistently contacted the <italic>SH3YL1, ACP1</italic>, and <italic>ALKAL2</italic> promoters across multiple cell types (<xref ref-type="fig" rid="fig2">Figure 2C</xref> -third and fourth column).</p><p>At the chr 2p23 locus, <italic>ADCY3</italic> yielded the most contacts (i.e. many proxies contacting the same gene via chromatin loops), suggesting this locus acts as a regulatory hub. However, we observed a similar composition in cell types for four other genes: <italic>DNAJC27</italic>, <italic>DNAJC27-AS1</italic> (both previously implicated in obesity and/or diabetes traits <xref ref-type="bibr" rid="bib10">Cherian et al., 2018</xref>), <italic>AC013267.1</italic>, and <italic>SNORD14</italic> (<italic>RF00016</italic>). <italic>ITSN2</italic>, <italic>NCOA1</italic>, and <italic>EFR3B</italic> were three genes within this locus that were only implicated in immune cell types. <italic>NCOA1</italic> encodes a prominent meta-inflammation factor (<xref ref-type="bibr" rid="bib65">Rollins et al., 2015</xref>) known to reduce adipogenesis and shift the energy balance between white and brown fat, and its absence known to induce obesity (<xref ref-type="bibr" rid="bib50">Mohsen G et al., 2019</xref>).</p><p><italic>CALCR</italic> was the most frequently implicated gene at its locus, supported by 20 cell types across all systems. While within the <italic>BDNF</italic> locus, <italic>METTL15</italic> and <italic>KIF18A</italic> – two non-cell-type-specific genes - plus some lncRNA genes, were contacted by childhood obesity-associated proxies within the same multiple cell types as <italic>BNDF</italic>, again suggesting the presence of a regulatory hub.</p><p>At the <italic>FAIM2</italic> locus on chr 12q13.12, we observed known genes associated with obesity, eating patterns, and diabetes-related traits, including <italic>ASIC1</italic>, <italic>AQP2</italic>, <italic>AQP5</italic>, <italic>AQP6, RACGAP1</italic>, and <italic>AC025154.2 (AQP5-AS1</italic>) along with <italic>FAIM2</italic> (<xref ref-type="table" rid="table1">Table 1</xref>). These genes were harbored within cREs of astrocytes, neural progenitors, hypothalamic neurons, and multiple metabolic cell types. Plasmacytoid and CD1c+conventional dendritic cells were the only two immune cell types that harbored such proxies within their cREs, implicating <italic>ASIC1</italic>, <italic>PRPF40B</italic>, <italic>RPL35AP28</italic>, <italic>TMBIM6</italic>, <italic>and LSM6P2</italic> at the <italic>FAIM2</italic> locus.</p><p>The independent <italic>ADCY9</italic> and <italic>FTO</italic> loci are both located on chromosome 16. Genes at the <italic>ADCY9</italic> locus were only implicated in a subset of immune cell types. Interestingly, genes at the <italic>FTO</italic> locus were only implicated in Hi-C datasets (as opposed to Capture C), including 6 metabolic cell types and astrocytes. Most genes at the <italic>FTO</italic> locus were implicated in skeletal myotubes, differentiated osteoblasts, and astrocytes, namely <italic>FTO</italic> and <italic>IRX3</italic>; while <italic>IRX5, CRNDE</italic>, and <italic>AC106738.1</italic> were also implicated in adipocytes and hepatocytes.</p></sec><sec id="s2-4"><title>The most implicated cell types by two sets of analyses</title><p>EndoC-BH1 and myotubes are the two cell types in which we implicated the most effector genes, with 38 and 42, respectively – <xref ref-type="fig" rid="fig3">Figure 3</xref> side panel. This phenomenon is likely proportional in the case of myotubes, given the large number of cREs identified by overlapped Hi-C contact data and ATAC-seq open regions (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), but not for EndoC-BH1. Albeit harboring an average number of cREs compared to other cell types, EndoC-BH1 cells were consistently among the top-ranked heritability estimates for the childhood obesity variants resulting from the EGG consortium GWAS (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and harbored a significant number of implicated genes by the mapping of proxies. Interestingly, the pancreatic alpha cell type – shown above to be the most significant for heritability estimate by LDSC – revealed only six implicated genes contacted by the defined proxies, namely <italic>BDNF</italic> and five lncRNA genes.</p></sec><sec id="s2-5"><title>Pathway analysis</title><p>Of the 111 implicated genes in total, PubMed query revealed functional studies for 66 genes. The remaining were principally lncRNA and miRNA genes with currently undefined functions (<xref ref-type="table" rid="table1">Table 1</xref>). To investigate how our implicated genes could confer obesity risk, we performed several pathway analyses keeping them either separated for each cell type or pooling into the respective metabolic, neural, or immune system sets. <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> shows simple Gene Ontology (GO) biological process terms enrichment results.</p><p>Leveraging the availability of our expression data generated via RNA-seq (available for 46 of 57 cell types), we performed pathway analysis. Given that our gene sets from the variant-to-gene process was stringently mapped, the sparse enrichment from normal direct analyses is not ideal for exploring obesity genetic etiology. Thus, we incorporated two methods from the <italic>pathfindR</italic> package (<xref ref-type="bibr" rid="bib82">Ulgen et al., 2019</xref>) and our customized SPIA (details in Materials and methods, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). The result of 60 enriched KEGG terms is shown in <xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>, with 13 genes in 14 cell types for <italic>pathfindR</italic> and 39 enriched KEGG terms shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>, with 10 genes in 42 cell types for customized SPIA. There were 20 overlapping pathways between the two approaches (yellow rows in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c-d</xref>) including many signaling pathways such as the GnRH (hsa04912), cAMP (hsa04024), HIF-1 (hsa04066), Glucagon (hsa04922), Relaxin (hsa04926), Apelin (hsa04371), and Phospholipase D (hsa04072) signaling pathways. They were all driven by one or more of these 5 genes: <italic>ADCY3</italic>, <italic>ADCY9</italic>, <italic>CREBBP</italic>, <italic>MMP2,</italic> and <italic>NCOA1</italic>. Interestingly, we observed the involvement of natural killer cells in nearly all the enriched KEGG terms from <italic>pathfindR</italic> due to the high expression of the two adenylyl cyclase encoded genes, <italic>ADCY3</italic> and <italic>ADCY9</italic>, along with <italic>CREBBP</italic>. The SPIA approach disregarded the aquaporin genes (given they appear so frequently in so many pathways that involve cellular channels) but highlighted the central role of <italic>BDNF</italic> which single-handedly drove four signaling pathways: the Ras, Neurotrophin, PI3K-Akt, and MAPK signaling pathways. This also revealed the role of <italic>TRAP1</italic> in neurodegeneration.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>KEGG pathways enrichment analysis.</title><p>(<bold>A</bold>) The pathfindR method: Focused on ‘leveraging interaction information from a protein-protein interaction network (PIN) to identify distinct active subnetworks and then perform enrichment analyses on these subnetworks’, thus aiding enriched pathway analyses through the inter-connection between the genes targeted by obesity variants with key genes driving the pathology of the disease. The result with 60 enriched KEGG terms in the main panel (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>), shows 13 genes in 14 cell types and their scaled expression levels in the lower panel. (<bold>B</bold>) The modified SPIA: After applying the adjusted P-value of 0.05 as the filtering threshold, the analysis yielded 39 enriched KEGG terms (full table at <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>) with only 10 genes, but involved up to 42 cell types.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Gene Ontology (GO) biological process terms enrichment.</title><p>(<bold>A</bold>) Due to the limited number of implicated genes, over-representation analysis for GO biological process terms across the cell types showed only a few main clusters. This result mainly emphasized the frequencies of several genes that appeared in many cell types and participated in many biological processes and pathways – namely <italic>BDNF, FAIM2, CALCR</italic>, Aquaporin genes (<italic>AQP2, AQP5, AQP6</italic>), <italic>ASIC1</italic>, and the Adenylate cyclase genes (<italic>ADCY3, ADCY9, BCDIN3D, METTL15</italic>). (<bold>B</bold>) Pooling genes resulting from the 3 systems of metabolic, neural, and immune cell types revealed two clear clusters of processes, segregated by the implicated genes enriched mainly in immune cell types (primarily within the <italic>ADCY3</italic> locus) versus genes enriched on both metabolic and neural cell types. This somewhat reflected the gene clusters in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>The additional metrics scheme.</title><p>To extend the analysis beyond the prerequisite protein-protein networks, but still account for how our genes were weighted within the network architecture of the pathways, we devised a modified SPIA analysis with additional metrics.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>The GnRH signaling pathway: The KEGG graph shows the involvement of <italic>ADCY3</italic> and <italic>MMP2</italic> genes driving the GnRH signaling pathway.</title><p>The four areas in each gene were colored by expression levels of such gene within the corresponding cell types: the hMSC-derived BMP2 differentiated osteoblast, the differentiated osteoblast cell line, the natural killer cell, and the skeletal myotubes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig4-figsupp3-v1.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Cluster dendrogram of weighted genes expression of genes from the variant-to-genes mapping process into three modules, named by the colors.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig4-figsupp4-v1.tif"/></fig></fig-group><p>These two approaches did not discount the role of <italic>FAIM2</italic> and <italic>CALCR</italic>. However, their absence was mainly due to the content of the current KEGG database. On the other hand, these approaches accentuated the role of the <italic>MMP2</italic> gene at the <italic>FTO</italic> locus in skeletal myotubes, given its consistency within the GnRH signaling pathway (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>), which is in line with previous studies linking its expression with obesity (<xref ref-type="bibr" rid="bib20">Derosa et al., 2008</xref>; <xref ref-type="bibr" rid="bib1">Aksoyer Sezgin et al., 2022</xref>; <xref ref-type="bibr" rid="bib55">Nonino et al., 2021</xref>).</p></sec><sec id="s2-6"><title>Supportive evidence by colocalization of target effector genes with eQTLs</title><p>The GTEx consortium has characterized thousands of eQTLs, albeit in heterogeneous bulk tissues (<xref ref-type="bibr" rid="bib60">Pejman, 2017</xref>). To assess how many observed gene-SNP pairs agreed with our physical variant-to-gene mapping approach in our multiple separate cellular settings, we performed colocalization analysis using ColocQuiaL (<xref ref-type="bibr" rid="bib9">Chen et al., 2022</xref>).</p><p>282 genes were reported to be associated with the variants within 13 loci from our variant-to-genes analysis. We found 114 colocalizations for ten of our loci that had high conditioned posterior probabilities (cond.PP.H4.abf≥0.8), involving 44 genes and 41 tissues among the eQTLs. We extracted the posterior probabilities for each SNP within each colocalization and selected the 95% credible set as the likely causal variants (complete list in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>). Despite sensitivity differences and varying cellular settings, when compared with our variant-to-gene mapping results, colocalization analysis yielded consistent identification for 21 pairs of SNP-gene interactions when considering the analyses across all our cell types, composed of 20 SNPs and 7 genes. Details of these SNP-gene pairs are shown in <xref ref-type="fig" rid="fig5">Figure 5A and B</xref>.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Colocalization of target effector genes with eQTLs.</title><p>(<bold>A</bold>) Venn diagram shows the overlaps between sets of genes yielded by ColocQuiaL and the variant-to-gene mapping process. (<bold>B</bold>) Circos plot of the 10 loci demonstrates the differences in the ranges of associations between the two approaches, with long-ranged chromatin contacts between obesity variants and target genes displayed as orange links and short-range eQTLs colocalizations as green links. Two SNPs – rs35796073, and rs35142762 within the <italic>TMEM18</italic> locus, in linkage disequilibrium with rs7579427 – were estimated with high probability (cond.PP.H4=0.78) of colocalizing with the expression of <italic>ALKAL2</italic> gene in subcutaneous adipose tissue. These pairs of SNP-gene were also identified by our variant-to-gene mapping approach in natural killer cells, plasmacytoid dendritic cells, unstimulated PBMC naïve CD4 T cells and astrocytes. The rs7132908 variant at the <italic>FAIM2</italic> locus colocalized with the expression of <italic>AQP6</italic> in thyroid tissue and with <italic>ASIC1</italic> in prostate tissue, not only with high cond.PP.H4 but also with high individual SNP causal probability (SNP.PP.H4&gt;0.95). rs7132908 was the second most consistent observation in our variant-to-gene mapping, namely across 25 different cell types (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) and all three systems plus the other independent cell lines. The pair of rs7132908-contacting-<italic>AQP6</italic> was observed in 15 different cell types - 8 metabolic and 4 neural cell types, and 3 independent cell lines. The pair of rs7132908-contacting-<italic>ASIC1</italic> was observed in 11 different cell types - 8 metabolic and 2 neural cell types, and plasmacytoid dendritic cells. The other eQTL signals that overlapped with our variant-to-gene mapping results were: <italic>BDNF</italic> at the <italic>METTL15</italic> locus with its promoter physically contacted by rs11030197 in 4 cell types and its expression significantly colocalized (cond.PP.H4=0.82) in tibial artery; <italic>ADCY9</italic> at its locus with its promoter physically contacted by rs2531995 in natural killer cells and its expression significantly colocalized in skin tissue (‘Skin_Not_Sun_Exposed_Suprapubic’, cond.PP.H4=0.97). And <italic>ADCY3</italic> in the C panel. (<bold>C</bold>) ColocQuiaL estimated that these SNPs highly colocalize with the expression of <italic>ADCY3</italic> in 11 different tissues, where the overlapping with the 16 cell types is represented, color-coded by the proxies rs numbers.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig5-v1.tif"/></fig><p>Of these 20 SNPs, 15 were at the <italic>ADCY3</italic> locus, in LD with sentinel variant rs4077678, and all implicated <italic>ADCY3</italic> as the effector gene in 29 cell types – 15 metabolic, 6 immune, 4 neural cell types, and 4 independent cell lines (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Indeed, missense mutations have been previously reported for this gene in the context of obesity (<xref ref-type="bibr" rid="bib31">Grarup et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Stergiakouli et al., 2014</xref>) while another member of this gene family, <italic>ADCY5</italic>, has also been extensively implicated in metabolic traits (<xref ref-type="bibr" rid="bib69">Sinnott-Armstrong et al., 2021</xref>).</p></sec><sec id="s2-7"><title>Predicting transcription factors (TFs) binding disruption at implicated genes contributing to obesity risk</title><p>TFs regulate gene expression by binding to DNA motifs at enhancers and silencers, where any disruption by a SNP can potentially cause dysregulation of a target gene. Thus, we used <italic>motifbreakR</italic> (R package) to predict such possible events at the loci identified by our variant-to-gene mapping. Each variant was predicted to disrupt the binding of several different TFs, thus requiring further literature cross-examination to select the most probable effects. For example, rs7132908 (consistently contacting <italic>FAIM2</italic> in 25 cell types) was predicted to disrupt the binding of 12 different transcription factors. Among them, SREBF1 (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) was the only TF that concurred with evidence that it regulates <italic>AQP2</italic> and <italic>FAIM2</italic> at the same enhancer (<xref ref-type="bibr" rid="bib38">Kikuchi et al., 2021</xref>). The full prediction list can be found in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f</xref>.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>motifbreakR vs ATAC-seq footprint analysis.</title><p>(<bold>A</bold>) Genome view at the <italic>FAIM2</italic> locus where rs7132908 is located and can target many genes through many chromatin contacts, presented by arcs (different colors for different cell types). rs7132908 was predicted by <italic>motifBreakR</italic> to disrupt the TF SREBF1’s binding site, thus potentially altering the expression of its implicated genes. (<bold>B</bold>) Mosaic plot shows number of variants that were annotated with disrupt-TF-binding affect by motifBreakR, and the proportions that also overlapped with predicted TF footprint from ATAC-seq TF footprint analysis. Fisher exact test was performed and produced p-value = 1. (<bold>C</bold>) Stacked bar plot for all the variants from variant-to-gene analysis, showing number of transcription factor binding sites each of the variant can disrupt (predicted by <italic>motifbreakR</italic> – green), or simply overlap (analyzed by RGT suite – purple), or both (blue).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>7 variants and the corresponding TF motifs.</title><p>(<bold>A</bold>) At the <italic>CALCR</italic> locus, rs6943527 was predicted by <italic>motifbreakR</italic> to disrupt RBPJ binding in naïve T-cells that got activated for 24 hr. (<bold>B</bold>) From <italic>METTL15</italic> locus, rs11030197 is one of the few variants that only targets one single gene promoter, namely <italic>BDNF</italic> gene, but is implicated in many cell types. It was predicted to disrupt the binding sites of six different TFs in melanocytes and enteroids. (<bold>C</bold>) A variant from <italic>BDNF</italic> locus, rs75707145 is predicted to disrupt at least 14 TFs binding sites, supported by overlaps with cREs-MPBS in pre-adipocytes, pancreatic cells, permissive osteoblasts, EndoC BH1 cell and NCIH716 cell lines. (<bold>D</bold>) At <italic>ADCY3</italic> locus, rs7580081 was predicted to disrupt AHR binding in pre-adipocytes and RXRA binding in adipocytes. (<bold>E</bold>) The ‘regulatory-hub’ variant rs61888800 of <italic>BDNF</italic> locus was found to contact multiple genes across 41 different cell types and was predicted by <italic>motifbreakR</italic> to disrupt binding sites of many TFs. The overlaps with cREs-MPBS only provided support for disruption of binding of PROX1 and PRDM4 in germinal center B cell-like cell line, naïve B cells, naive T cells, and the HEPG2 cell line where it contacts via short-ranged chromatin loops with the <italic>BDNF</italic> promoter, and long-ranged chromatin loops with several lncRNA genes: <italic>AC090833.1</italic>, <italic>AC100773.1</italic>, <italic>AC090791.1</italic> and <italic>AC013714.1</italic>. (<bold>F</bold>) Another variant, rs60802568, at <italic>ADCY3</italic> locus was predicted to disrupt bindings of SREBF1 and SREBF2, which were supported by cREs-MPBS from ATAC-seq footprints from astrocytes, pre-adipocytes, adipocytes and osteocytes derived from mesenchymal stem cells. It was also predicted to disrupt ZBTB4 and NR1H4 with supported cREs-MPBS from ATAC-seq footprints only in osteocytes derived from mesenchymal stem cells. (<bold>G</bold>) At the <italic>TMEM18</italic> locus, rs10865551 was predicted to disrupt the binding site of RREB1, in pancreatic alpha and beta cells (from the single-cell data set) by <italic>motifbreakR</italic>, which were supported by cREs-MPBS from ATAC-seq footprints from these cell types; the target genes through chromatin contact were different between these cell types, where rs10865551 contacts the <italic>AC141930.2</italic> promoter in alpha cells, but contacts <italic>SH3YL1</italic> and <italic>ACP1</italic> promoters in beta cells. About eleven thousand bases upstream from that was rs5017303, which was predicted to disrupt binding sites of BC11A in adipocytes but contacts the same gene <italic>AC141930.2</italic> as in pancreatic alpha cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95411-fig6-figsupp1-v1.tif"/></fig></fig-group><p>To narrow down the list of putative TF binding sites at each variant position, we leveraged the ATAC-seq footprint analysis using the RGT suite (<xref ref-type="bibr" rid="bib43">Li et al., 2019</xref>). The final set of Motif-Predicted Binding Sites (MPBS) within each cell type ATAC-seq footprints was used to overlap with the genomic locations of the OCRs, and then overlapped with our obesity variants, resulting in annotated 29 variants. Mosaic plot in <xref ref-type="fig" rid="fig6">Figure 6B</xref> shows the number and proportions of variants predicted by <italic>motifbreakR</italic> and/or overlapped with MPBS. Insignificant p-value from Fisher’s exact test indicated the independence of the two analyses. Only seven variants were found within the cREs for the same TF motifs predicted to be disrupted by <italic>motifbreakR</italic> (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref> outlines the seven variants that <italic>motifbreakR</italic> and ATAC-seq footprint analysis agreed on the TF bindings they might disrupt.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Given the challenge of uncovering the underlying molecular mechanisms driving such a multifactorial disease as obesity, our approach leveraging GWAS summary statistics, RNA-seq, ATAC-seq, and promoter Capture C / Hi-C offers new insights. This is particularly true as it is becoming increasingly evident that multiple effector genes can operate in a temporal fashion at a given locus depending on cell state, including at the <italic>FTO</italic> locus (<xref ref-type="bibr" rid="bib71">Sobreira et al., 2021</xref>). Our approach offers an opportunity to implicate relevant cis-regulatory regions across different cell types contributing to the genetic etiology of the disease. By assigning GWAS signals to candidate causal variants and corresponding putative effector genes via open chromatin and chromatin contact information, we enhanced the fine-mapping process with an experimental genomic perspective to yield new insights into the biological pathways influencing childhood obesity.</p><p>LD score regression is a valuable method that estimates the relationship between linkage disequilibrium score and the summary statistics of GWAS SNPs to quantify the separate contributions of polygenic effects and various confounding factors that produce SNP-based heritability of disease. The general positive heritability enrichment across our open chromatin features spanning multiple cell types (<xref ref-type="fig" rid="fig1">Figure 1B</xref>.a) reinforces the notion that obesity etiology involves many systems in our body.</p><p>While obesity has long been known to be a risk factor for pancreatitis and pancreatic cancer, the significant enrichment of pancreatic alpha and beta cell related 3D genomic features for childhood obesity GWAS signals demonstrates the bidirectional relationship between obesity and the pancreas; indeed, it is well established that insulin has obesogenic properties. Moreover, the comorbidity of obesity and diabetes (either causal or a result of the overlap between SNPs associated with these two diseases) is tangible. When focusing on genetic annotation of the cREs only, the association with obesity became more diverse across cell types, especially in metabolic cells. Interestingly, the lack of enrichment (only 8 of 57 cell types yielded no degree of enrichment) of obesity SNPs heritability in open gene promoters (<xref ref-type="fig" rid="fig1">Figure 1B</xref>.b) reveals that cRE regions harboring obesity SNPs are more involved in gene regulation than disruption, and therefore potentially contributing more weight to the manifestation of the disease.</p><p>Of course, we should factor in the effective sample sizes of the GWAS efforts that are wide-ranging (2000–24,000 – given that the N for each variant is different within a single dataset, thus contributing to the weights and p-value of each SNP when the algorithm calculates the genome-wide heritability), which could result in noise and negative enrichment observed in the analysis – a methodology limitation of partial linkage regression that has been extensively discussed in the field (<xref ref-type="bibr" rid="bib72">Steinsaltz et al., 2020</xref>). Thus, it is crucial to interpret the enrichment (or lack thereof) of disease variants in a certain cellular setting with an ad hoc biological context.</p><p>From mapping the common proxies of 19 independent sentinel SNPs that were genome-wide significantly associated with childhood obesity to putative effector genes through chromatin contacting cREs, one striking finding was the several potential ‘hubs’ of putatively core effector genes, whose occurrence spread across three human physiological systems. With the data available from so many cell types, our approach connected new candidate causal variants to known obesity-related genes and new implications of cell modality for previously known associations.</p><p>A potential application of this association could be to fine-tune the effect of a drug toward controlling appetite. An example of bringing new aspects to the old is for the signal within the <italic>FTO</italic> locus that contacted <italic>IRX3</italic> and <italic>IRX5</italic>: previous studies have suggested these obesogenic effects operate in adipocytes (<xref ref-type="bibr" rid="bib13">Claussnitzer et al., 2016</xref>), brain (<xref ref-type="bibr" rid="bib70">Smemo et al., 2014</xref>), or pancreas <xref ref-type="bibr" rid="bib62">Ragvin et al., 2010</xref>; here we confirmed this association in adipocytes and uncover the presence of distal chromatin contacts in myotubes for the first time.</p><p>Besides the above-mentioned genes with known associations with obesity, we discovered newly implicated genes. For example, the <italic>LRRIQ3</italic> gene at the <italic>TNNI3K</italic> locus had its open promoter contacted by two SNPs, rs1040070 and rs10493544, in NTERA2 cells only. The published studies (<xref ref-type="bibr" rid="bib36">Johnston et al., 2019</xref>; <xref ref-type="bibr" rid="bib66">Sanchez-Roige et al., 2021</xref>) that associated <italic>LRRIQ3</italic> with major depressive disorder and opioid usage acknowledged the overlapping promoter of this gene, albeit in the opposite direction, with a run-through transcript of <italic>FPGT-TNNI3K</italic> – previously shown to be associated with BMI in European <xref ref-type="bibr" rid="bib30">Graff et al., 2013</xref> and Korean populations (<xref ref-type="bibr" rid="bib42">Lee et al., 2017</xref>).</p><p>It is apparent that not all the implicated genes we report would contribute equally to the susceptibility of obesity pathogenesis. Each locus comprises genes whose functions are obviously related to obesity or similar traits like BMI, fat weight, etc., while other genes are not so directly obvious in their relation to these traits.</p><p>It is encouraging that for implicated genes within these multi-cell-type loci across different physiological systems we could find previous associations to the corresponding cell types or systems. Examples are the two aforementioned genes at the <italic>TMEM18</italic> locus (<italic>SH3YL1</italic> and <italic>ACP1</italic>) (<xref ref-type="bibr" rid="bib23">Fernandes et al., 2019</xref>; <xref ref-type="bibr" rid="bib3">Blessing et al., 2015</xref>; <xref ref-type="bibr" rid="bib39">Kobayashi et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Choi et al., 2021</xref>; <xref ref-type="bibr" rid="bib27">Gaynor et al., 2020</xref>) with the broad spectrum of their functions, <italic>HEPACAM2</italic> implicated in the NCIH716 cell line at the <italic>CALCR</italic> locus <xref ref-type="bibr" rid="bib88">Wu et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Huang et al., 2018</xref>, and <italic>LRRIQ3</italic> in the NTERA2 cell line at the<italic>TNNI3K</italic> locus (<xref ref-type="bibr" rid="bib61">Pleasure and Lee, 1993</xref>).</p><p>Chronic inflammation is an essential characteristic of obesity pathogenesis. Adipose tissue-resident immune cells have been observed, leading to an increased focus in recent years on their potential contribution to metabolic dysfunction. On the other hand, neurological or psychological conditions, such as stress, induce the secretion of both glucocorticoids (increase motivation for food) and insulin (promotes food intake and obesity). Pleasure feeding then reduces activity in the stress-response network, reinforcing the feeding habit. It has been shown that voluntary behaviors, stimulated by external or internal stressors or pleasurable feelings, memories, and habits, can override the basic homeostatic controls of energy balance (<xref ref-type="bibr" rid="bib17">Dallman, 2010</xref>). The potential link between the immune system and metabolic disease, and moreover, through the neural system, was tangible in our findings.</p><p>Two of the three SNPs which ranked the third most consistent in our variant-to-gene mapping (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) – rs35796073 and rs35142762 – contacted the <italic>ALKAL2</italic> promoter (supported by GTEx evidence to colocalize with <italic>ALKAL2</italic> expression). The anaplastic lymphoma kinase (encoded by <italic>ALK</italic> gene) is a receptor tyrosine kinase, belongs to the insulin receptor family, and has been reported to promote nerve cell growth and differentiation (<xref ref-type="bibr" rid="bib35">Iwahara et al., 1997</xref>; <xref ref-type="bibr" rid="bib51">Motegi et al., 2004</xref>). Despite <italic>ALKAL2</italic> (ALK and LTK ligand 2) being studied principally in the context of immunity<italic>,</italic> a recent study using the EGCUT biobank GWAS identified <italic>ALK</italic> as a candidate thinness gene and genetic deletion showed that its expression in hypothalamic neurons acts as a negative regulator in controlling energy expenditure via sympathetic control of adipose tissue lipolysis (<xref ref-type="bibr" rid="bib56">Orthofer et al., 2020</xref>). <italic>ALKAL2 –</italic> encoding a high-affinity agonist of <italic>ALK</italic>/<italic>LTK</italic> receptors – which has been reported to enhance expression in response to inflammatory pain in nociceptors (<xref ref-type="bibr" rid="bib18">Defaye et al., 2022</xref>; <xref ref-type="bibr" rid="bib77">Sun et al., 2023</xref>) - has been recently implicated as a novel candidate gene for childhood BMI by transcriptome-wide association study <xref ref-type="bibr" rid="bib91">Yao et al., 2021</xref>, and achieved genome-wide significance in a GWAS study contrasting persistent healthy thinness with severe early-onset obesity using the STILTS and SCOOP cohorts (<xref ref-type="bibr" rid="bib63">Riveros-McKay et al., 2019</xref>). The finding that overexpression of <italic>ALKAL2</italic> could potentiate neuroblastoma progression in the absence of ALK mutation (<xref ref-type="bibr" rid="bib4">Borenäs et al., 2021</xref>) echoes the relationship between <italic>ADCY3</italic> and <italic>MC4R</italic> (<xref ref-type="bibr" rid="bib67">Siljee et al., 2018</xref>), where a peripheral gene, <italic>ADCY3</italic>, can regulate/impair the function of a core gene, that is <italic>MC4R</italic>, within the energy-regulating melanocortin signaling pathway (<xref ref-type="bibr" rid="bib79">Timshel et al., 2020</xref>).</p><p>Our approach implicates putative target genes based on a mechanism of regulation for these variants to alter gene expression – through regulator TF(s) that bind to these contact sites. A potential limitation of the predictions from <italic>motifbreakR</italic> and matching TF motifs to ATAC-seq footprint by the RGT toolkit is that they were both based on the position probability matrixes of Jaspar and Hocomoco, which come from public motif databases. The ATAC-seq footprint analysis also carries sequence bias that can lead to false positive discovery. Thus, our attempt to call such regulators by predicting TF binding disruption can only serve as nominations – but warrant further functional follow up.</p><p>Another limitation of this work is the diversity in data quality among different samples, since different datasets were sampled and collected at different time points, from different patients, using different protocols, with libraries sequenced at different depths and qualities, and initially preprocessed with different pipelines and parameters. Thus, it is crucial to keep in mind that the discrepancy in data points might have resulted from variations in data quality. Importantly, any association discovered must be validated functionally before effector genes of the genetic variants can be leveraged to develop new therapies. Their putative function(s) must be characterized, together with the mechanism whereby the given variant’s alleles differentially affect the expression of the targeted genes. The next step is to explore how the target genes affect the trait of interest more directly.</p><p>Our results have provided a set of leads for future exploratory experiments in specific cellular settings in order to further expand our knowledge of childhood obesity genomics and hence equip us with more effective means to overcome the burden of this systematic disease.</p><sec id="s3-1"><title>Conclusion</title><p>Our approach of combining RNA-seq, ATAC-seq, and promoter Capture C/Hi-C datasets with GWAS summary statistics offers a systemic view of the multi-cellular nature of childhood obesity, shedding light on potential regulatory regions and effector genes. By leveraging physical properties, such as open chromatin status and chromatin contacts, we enhanced the fine-mapping process and gained new insights into the biological pathways influencing the disease. Although further functional validation is required, our findings provide valuable leads together with their cellular contexts for future research and the development of more effective strategies to address the burden of childhood obesity.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Data and resource</title><p>Datasets used in prior studies are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>. ATAC-seq, RNA-seq, Hi-C, and Capture-C <italic>library generation</italic> for each cell type is provided in their original published study.</p></sec><sec id="s4-2"><title>Cell lines/types resources</title><p>details of each cell type/cell line source were described in their original published study, provided in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>.</p><p>Myotubes (Primary Skeletal Muscle Cells, PCS-950–010), MiaPaCa (CRL-1420), Panc-1 (CRL-1469), microglia (HMC1, CRL-3304), human fetal osteoblastic (hFOB 1.19, CRL-3602), HepG2 hepatocarcinoma (HB-8065) and Colorectal adenocarcinoma ascites derived cells (NCIH716, CCL-251) cell lines were purchased from American Type Cell Center (ATCC, Manassas, Virginia, USA). EndoC-BH1 were purchased from Univercell Biosolutions. Primary Normal Human Astrocytes (NHA) of unknown sex were obtained from Lonza as cryopreserved cells. Human embryonic stem cells (ESC H9, WA09) were obtained from WiCell Research Institute. Melanocytes isolated from foreskin healthy newborn males, were obtained from the Specialized Programs of Research Excellence (SPORE) in Skin Cancer Specimen Resource Core at Yale University. Pancreata from deceased organ donors were obtained by Human Pancreas Analysis Program (HPAP) (<ext-link ext-link-type="uri" xlink:href="https://hpap.pmacs.upenn.edu">https://hpap.pmacs.upenn.edu</ext-link>), a Human Islet Research Network consortium. All were authenticated by the source and confirmed to be mycoplasma negative.</p><p>The rest of the cell types were isolated from samples, obtained from consented human donors, maintained and expanded within corresponding laboratories. Cell identities were verified based on observed global expression variation, marker genes by PCR and immunofluorescence microscopy.</p><p>This study also includes human adipocytes and pre-adipocytes from P. Seale’s lab, hepatocytes from P. Titchnell’s lab, trabecular meshwork cells from J. O’Brien’s lab, which will be described in detail in separate manuscripts currently in preparation.</p></sec><sec id="s4-3"><title>ATAC-seq preprocessing and peaks calling</title><p>The detailed configurations and technical details for each data set are provided in the original studies. In brief, open chromatin regions were called using ENCODE ATAC-seq pipeline as previously described in each study the published data provided. In brief, reads were aligned to the hg19 or hg38 genome using bowtie2; duplicates were removed, alignments from all replicates were pooled, and narrow peaks were called using MACS2. A region was considered open if it overlapped at least 1 bp with ATAC-seq peak. We lifted all coordinates from hg19 to hg38 to ensure consistency between datasets.</p></sec><sec id="s4-4"><title>Promoter Capture-C pre-processing and interaction calling</title><p>in brief, paired-end reads were pre-processed using HICUP pipeline (<xref ref-type="bibr" rid="bib86">Wingett et al., 2015</xref>) with bowtie2 as aligner and hg19 for reference genome. Significant promoters’ interactions were called using unique read pairs from all baits promoter in the reference by CHICAGO (<xref ref-type="bibr" rid="bib8">Cairns et al., 2016</xref>) pipeline. In addition to analysis of individual fragments (1frag), we also binned four fragments to improve long-distance sensitivity in interactions calling (<xref ref-type="bibr" rid="bib75">Su et al., 2021</xref>). Interactions with CHICAGO score &gt;5 in either 1-fragment or 4-fragment resolution were considered significant. These interactions were output as <italic>ibed</italic> format (similar to BEDPE format) in which each line represents one physical contact between fragments. Interactions from both resolutions were merged and their genomic coordinates were lifted from hg19 to hg38.</p></sec><sec id="s4-5"><title>Hi-C pre-processing and interaction calling</title><p>We follow the pipeline as a recent study described (<xref ref-type="bibr" rid="bib76">Su et al., 2022</xref>). Paired-end reads from each replicate were pre-processed using the HICUP pipeline v0.7.4 (<xref ref-type="bibr" rid="bib86">Wingett et al., 2015</xref>), aligned by bowtie2 with hg38 as the reference genome. The alignments files were parsed to pairtools v0.3.0 to process and pairix v0.3.7 to index and compress, then converted to Hi-C matrix binary format.<italic>cool</italic> by cooler v0.8.11 at multiple resolutions (500 bp, 1, 2, 4, 10, 40, 500kbp and 1Mbp) and normalized with ICE method (<xref ref-type="bibr" rid="bib34">Imakaev et al., 2012</xref>). The matrices from different replicates were merged at each resolution using cooler. Mustache v1.0.1 <xref ref-type="bibr" rid="bib64">Roayaei et al., 2020</xref> and Fit-Hi-C2 v2.0.7 (<xref ref-type="bibr" rid="bib37">Kaul et al., 2020</xref>) were used to call significant intra-chromosomal interaction loops from merged replicates matrices at three resolutions 1 kb, 2 kb, and 4 kb, with significance threshold at q-value &lt;0.1 and FDR &lt;1 × 10<sup>−6</sup>, respectively. The identified interaction loops were merged between both tools at each resolution. Lastly, interaction loops from all three resolutions were merged with preference for smaller resolution if overlapped.</p></sec><sec id="s4-6"><title>Definition of cis-regulatory elements (cREs)</title><p>We intersected ATAC-seq open chromatin regions (OCRs) of each cell type with chromatin conformation capture data determined by Hi-C/Capture-C of the same cell type, and with promoters –1,500/+500 bp of TSS, which were referenced by GENCODE v30.</p></sec><sec id="s4-7"><title>Childhood obesity GWAS summary statistics</title><p>Data on childhood obesity from the EGG consortium was downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.egg-consortium.org/">https://www.egg-consortium.org/</ext-link>. We used 8,566,179 European ancestry variants (consisting of 8,613 cases and 12,696 controls in stage I; of 921 cases and 1930 controls in stage II), representing ~55% of the total 15,504,218 variants observed across all ancestries in the original study (<xref ref-type="bibr" rid="bib6">Bradfield et al., 2019</xref>). The sumstats file was reformatted by <italic>munge_sumstats.py</italic> to standardize with the weighted variants from HapMap v3 within the LDSC baseline, which reduced the variants to 1,217,311 (7.8% of total).</p></sec><sec id="s4-8"><title>Cell type specific partitioned heritability</title><p>We used <italic>LDSC</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.github.com/bulik/ldsc">http://www.github.com/bulik/ldsc</ext-link>) <italic>v.1.0.1</italic> (<xref ref-type="bibr" rid="bib24">Finucane et al., 2015</xref>) with <italic>--<monospace>h2</monospace></italic> flag to estimate SNP-based heritability of childhood obesity within 4 defined sets of input genomic regions: (1) OCRs, (2) OCRs at gene promoters, (3) cREs, and (4) cREs with an expanded window of ± 500 bp. The baseline model LD scores, plink filesets, allele frequencies and variants weights files for the European 1000 genomes project phase 3 in hg38 were downloaded from the provided link (<ext-link ext-link-type="uri" xlink:href="https://alkesgroup.broadinstitute.org/LDSCORE/GRCh38/">https://alkesgroup.broadinstitute.org/LDSCORE/GRCh38/</ext-link>). The cREs of each cell type were used to create the annotation, which in turn were used to compute annotation-specific LD scores for each cell types cREs set.</p></sec><sec id="s4-9"><title>Genetic loci included in variant-to-genes mapping</title><p>19 sentinel signals that achieved genome-wide significance in the trans-ancestral meta-analysis study (<xref ref-type="bibr" rid="bib6">Bradfield et al., 2019</xref>) were leveraged for our analyses. Proxies for each sentinel SNP were queried using TopLD <xref ref-type="bibr" rid="bib33">Huang et al., 2022</xref> and LDlinkR tool (<xref ref-type="bibr" rid="bib52">Myers et al., 2020</xref>) with the GRCh38 Genome assembly, 1000 Genomes phase 3 v5 variant set, European population, and LD threshold of r<sup>2</sup> &gt;0.8, which resulted in 771 proxies, including the 21 SNPs from the 99% credible set of the original study (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>).</p></sec><sec id="s4-10"><title>RNA-seq preprocessing and expression profiling</title><p>The detailed configurations, steps, and technical details for each data set are provided in the original studies. In brief, read fragments from fastq files were mapped to genome assembly hg19 or hg38 using STAR, independently for each replicate and condition. We used GENCODE annotation files for feature annotation and htseq-count for raw read count calculation at each feature. Read counts were transformed into TPM (transcript per million) and normalized internally between replicates/conditions in each individual study. For comparative measurements, we transformed all the expression values into 0–100 scale.</p></sec><sec id="s4-11"><title>Differential analysis and clustering of correlated genes</title><p>Normalized transcripts per million (TPM) of all measured genes in 46 of 57 cell types was used to perform differential analysis using <bold><italic>DEseq2</italic></bold> package (<xref ref-type="bibr" rid="bib48">Love et al., 2014</xref>), where cell type and system (immune, metabolic, neural and other) were used as variables for the modeling contrast. Because many of the genes we gathered from the variant-to-gene mapping were lowly expressed in corresponding cell types or others, causing relatively high levels of variability, we used <italic>apeglm</italic> method for effect size (logarithmic fold change estimates) shrinkage <xref ref-type="bibr" rid="bib94">Zhu et al., 2019</xref> to alleviate this phenomenon during the genes ranking. Weighted correlation network analysis (<italic>WGCNA</italic>) package (<xref ref-type="bibr" rid="bib40">Langfelder and Horvath, 2008</xref>) was used to cluster genes from the variant-to-genes mapping process. WGCNA network construction power was chosen based on the analysis of scale-free topology for soft-thresholding. <italic>blockwiseModules</italic> with a power of 10 were used to create the correlation network and cluster genes into 3 modules of similarly expressed genes (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>). The assigned colors were used to identify the gene modules: turquoise, grey, and blue.</p></sec><sec id="s4-12"><title>Pathways enrichment analyses</title><p>We performed three analyses on the set of genes from the variant-to-genes mapping process:</p><p><italic>Gene set over-representation analysis (ORA)</italic> was performed using <italic>clusterProfiler</italic> package <xref ref-type="bibr" rid="bib89">Wu et al., 2021</xref> to identify GO biology process terms (org.Hs.eg.db databese) enriched within our genes set in each cell type. A relaxed p-value cutoff was set at 0.1, and the minimum including genes was set at 2 to ensure the capture of all possible enriched terms. An adjusted p-value of 0.05 was later used to filter the significant terms.</p></sec><sec id="s4-13"><title>Active-subnetwork-oriented gene set enrichment analysis</title><p>We used the <bold><italic>pathfindR</italic></bold> package <xref ref-type="bibr" rid="bib82">Ulgen et al., 2019</xref> to identify active subnetworks in protein-protein interaction networks from Biogrid, KEGG, STRING, GeneMania, and IntAct databases, using the list of genes from the variant-to-genes mapping process. Then we provided the statistic from the differential expression analysis for <bold><italic>pathfindR</italic></bold> to perform enrichment analyses on the identified subnetworks, discovering enriched KEGG pathways.</p></sec><sec id="s4-14"><title>Customized signaling pathway impact analysis (SPIA)</title><p>The original method, proposed by Tarca in 2009 in <bold><italic>SPIA</italic></bold> package (<xref ref-type="bibr" rid="bib78">Tarca et al., 2009</xref>), incorporates ORA with the adjacency matrix to measure the importance of genes within each pathway – genes that are connected to more other genes are likely more important than the downstream end-point genes. This pathway-topology approach measures the actual perturbation on a given pathway under a given condition and given differential effect size. We added more metrics to improve this method: (a) the score of gene impact among networks, (b) the neighborhood of genes that measure the importance of a gene based on its downstream effects, (c) the betweenness puts weight on the genes that act as a gateway for the network flow. The combination of metrics produces two ways of evidence – perturbance and enrichment – for each pathway similar to SPIA. Normal inverse cumulative distribution function was used to combine the p-values of this evidence, then Bonferroni and FDR correction was applied (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>).</p></sec><sec id="s4-15"><title>GWAS-eQTL colocalization</title><p>The summary statistics for the European ancestry subset from the EGG consortium GWAS for childhood obesity was used. Common variants (MAF  ≥ 0.01) from the 1000 Genomes Project v3 samples were used as a reference panel. We used non-overlapped genomic windows of ±250,000 bases extended in both directions from the median genomic position of each of 19 sentinel loci as input. We used ColocQuiaL <xref ref-type="bibr" rid="bib9">Chen et al., 2022</xref> to test genome-wide colocalization of all possible variants included in each inputted window against GTEx v.8 eQTLs associations for all 49 tissues available from <ext-link ext-link-type="uri" xlink:href="https://www.gtexportal.org/home/datasets">https://www.gtexportal.org/home/datasets</ext-link>. A conditional posterior probability of colocalization of 0.8 or greater was imposed.</p></sec><sec id="s4-16"><title>ATAC-seq transcription factor footprint analysis with RGT toolkit</title><p>Bam files of mapped reads from replicates and samples were merged for each cell type. The merged bam files were then used for footprinting by RGT-HINT with parameters: <italic>--<monospace>atac-seq</monospace>, –<monospace>paired-end</monospace>, –organism = hg38</italic>. If bam files were generated on hg19, we performed lift-over using CrossMap.py <italic>bam</italic> and hg19ToHg38.over.chain.gz file. We then used RGT-MOTIFANALYSIS <italic>matching</italic> to scan each footprint for possible transcription binding sites from HOCOMOCO and JASPAR databases for human only with parameter --filter ‘species:sapiens;database:hocomoco,jaspar_vertebrates’. Parameter <italic>–rand-proportion 10</italic> was used to generate random putative binding sites with sizes ten times larger than the input footprints. After performing motif matching, we evaluated which transcription factors were more likely to occur in those footprints than in background regions (generated by the previous command) using RGT-MOTIFANALYSIS <italic>enrichment</italic> with the same filtered databases and default parameters. Output included all the Motif-Predicted Binding Sites (MPBS) that occurred within the identified footprints in each cell type. We overlapped these sites with the loci of our obesity variants.</p></sec><sec id="s4-17"><title>Prediction of variant’s effect on transcription factor binding</title><p>Genomic positions (0-based coordinates) and allele alternatives of each proxy (from <italic>SNPlocs.Hsapiens.dbSNP155.GRCh38</italic> package with matching reference sequence from <italic>BSgenome</italic> package) were used to scan all position frequency matrix databases (from <italic>MotifDb</italic> package) for potential transcription factor binding disruptive effects. The motifbreakR function from <italic>motifBreakR</italic> package was used, with <italic>filterp = TRUE</italic> and setting a p-value <italic>threshold = 0.0005</italic>, information content methods <italic>method='ic'</italic> with even background probabilities of the four nucleotides <italic>bkg = c(A=0.25, C=0.25, G=0.25, T=0.25</italic>) and <italic>BPPARAM = BiocParallel::SerialParam</italic>() to allow serial evaluation.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources</p></fn><fn fn-type="con" id="con7"><p>Resources</p></fn><fn fn-type="con" id="con8"><p>Resources</p></fn><fn fn-type="con" id="con9"><p>Resources</p></fn><fn fn-type="con" id="con10"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Resources</p></fn><fn fn-type="con" id="con12"><p>Resources</p></fn><fn fn-type="con" id="con13"><p>Resources</p></fn><fn fn-type="con" id="con14"><p>Resources</p></fn><fn fn-type="con" id="con15"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con16"><p>Resources</p></fn><fn fn-type="con" id="con17"><p>Resources</p></fn><fn fn-type="con" id="con18"><p>Resources</p></fn><fn fn-type="con" id="con19"><p>Resources</p></fn><fn fn-type="con" id="con20"><p>Resources</p></fn><fn fn-type="con" id="con21"><p>Resources</p></fn><fn fn-type="con" id="con22"><p>Resources</p></fn><fn fn-type="con" id="con23"><p>Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con24"><p>Resources</p></fn><fn fn-type="con" id="con25"><p>Resources, Data curation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con26"><p>Resources, Data curation, Supervision, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con27"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con28"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Supporting data tables.</title><p>(a) Data resources of 57 cell types. (b) Variant-to-gene mapping results (c) 60 enriched KEGG pathways by pathfindR analysis (d) 39 enriched KEGG pathways by customized SPIA analysis (e) Colocalization analysis summary from ColocQuiaL. Highlighted rows are concordance with variant-to-gene mapping (f) Predicted transcription factor binding by motifbreakR to be disrupted by obesity variants (g) 771 proxies in linkage with 19 original sentinel childhood obesity signals, reported by TopLD and Ldlink.</p></caption><media xlink:href="elife-95411-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-95411-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The current manuscript is a computational study, so no data have been generated for this manuscript. Public software packages are available at the citations and URLs listed. Custom code for this analysis has been deposited on <ext-link ext-link-type="uri" xlink:href="https://github.com/BaoKhanhTrang/Grant_Childhood_Obesity_V2G">GitHub</ext-link> (copy archived at <xref ref-type="bibr" rid="bib80">Trang, 2024</xref>).</p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>Trang</surname><given-names>KB</given-names></name><name><surname>Levings</surname><given-names>MK</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility [captureC]</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&amp;acc=GSE272080">GSE272080</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Trang</surname><given-names>KB</given-names></name><name><surname>Levings</surname><given-names>MK</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility [ATAC-seq]</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&amp;acc=GSE272120">GSE272120</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Trang</surname><given-names>KB</given-names></name><name><surname>Levings</surname><given-names>MK</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility [RNA-seq]</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&amp;acc=GSE271957">GSE271957</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Trang</surname><given-names>KB</given-names></name><name><surname>Levings</surname><given-names>MK</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility [HiC]</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&amp;acc=GSE272172">GSE272172</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>Sullivan</surname><given-names>KE</given-names></name><name><surname>Romberg</surname><given-names>N</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE174658">GSE174658</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Romberg</surname><given-names>N</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name><name><surname>Leonard</surname><given-names>M</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Promoter capture-C of primary human T Follicular Helper (TFH) cells and naive CD4-positive helper T cells from tonsils of healthy volunteers</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-6621">E-MTAB-6621</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset7"><person-group person-group-type="author"><name><surname>Manduchi</surname><given-names>E</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Romberg</surname><given-names>N</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Hodge</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>ATAC-seq of primary human T Follicular Helper (TFH) cells and naive CD4-positive helper T cells from tonsils of healthy volunteers</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-6617">E-MTAB-6617</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset8"><person-group person-group-type="author"><name><surname>Romberg</surname><given-names>N</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Le Coz</surname><given-names>C</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Gene expression of primary human T Follicular Helper (TFH) cells and naive CD4-positive helper T cells from tonsils of healthy volunteers</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-6637">E-MTAB-6637</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset9"><person-group person-group-type="author"><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Chromatin conformation dynamics during CD4+ T cell activation implicates 2 autoimmune disease-associated genes and regulatory elements</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230346">GSE230346</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset10"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Leonard</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Hodge</surname><given-names>K</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Promoter capture-C of primary HepG2 cells</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-7144">E-MTAB-7144</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset11"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>ATAC-seq of HepG2 cells</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-7543">E-MTAB-7543</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset12"><person-group person-group-type="author"><name><surname>Caliskan</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Genetic and Epigenetic Fine Mapping of Complex Trait Associated Loci in the Human Liver</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE128072">GSE128072</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset13"><person-group person-group-type="author"><name><surname>Conery</surname><given-names>M</given-names></name><name><surname>Pippin</surname><given-names>JA</given-names></name><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Bioinformatics and single-cell CRISPRi-based screen reveals effector genes and implicates multi-tissue etiology for BMD</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261284">GSE261284</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset14"><person-group person-group-type="author"><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Grant</surname><given-names>SA</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Hankenson</surname><given-names>K</given-names></name><name><surname>Wagley</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Capture-C of primary human mesenchymal stem cells (MSC)-derived osteoblasts from healthy donors (differentiated with BPM2)</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-6862">E-MTAB-6862</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset15"><person-group person-group-type="author"><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Hankenson</surname><given-names>K</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Wagley</surname><given-names>Y</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>ATAC-seq of primary mesenchymal stem cell (MSC)-derived osteoblasts (differentiated with BMP2) from 4 human donors</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-6834">E-MTAB-6834</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset16"><person-group person-group-type="author"><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Hankenson</surname><given-names>K</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Wagley</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>RNA-seq of primary mesenchymal stem cells -derived osteoblasts (differentiated with BMP2) from 3 human donors</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-6835">E-MTAB-6835</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset17"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Pippin</surname><given-names>J</given-names></name><name><surname>Kaestner</surname><given-names>K</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Wells</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>3D chromatin organizations of human pancreatic cells reveal cell-type specific regulatory architectures of diabetes risk</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE188311">GSE188311</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset18"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Pippin</surname><given-names>J</given-names></name><name><surname>Kaestner</surname><given-names>K</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Wells</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Single cell RNAseq and scATACseq data of Human pancreatic islets</data-title><source>Data portal of The Human Pancreas Analysis Program</source><pub-id pub-id-type="accession" xlink:href="https://hpap.pmacs.upenn.edu">PANC-DB</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset19"><person-group person-group-type="author"><name><surname>Ackermann</surname><given-names>AM</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Schug</surname><given-names>J</given-names></name><name><surname>Naji</surname><given-names>A</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76268">GSE76268</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset20"><person-group person-group-type="author"><name><surname>Littleton</surname><given-names>SH</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Trang</surname><given-names>KB</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Variant-to-function analysis of the childhood obesity chr12q13 locus implicates rs7132908 as a causal variant within the 3' UTR of FAIM2</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE241691">GSE241691</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset21"><person-group person-group-type="author"><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Cis-regulatory architecture of human ESC-derived hypothalamic neuron differentiation aids in variant-to-gene mapping of relevant common complex traits</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152098">GSE152098</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset22"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Promoter Capture-C of iPSC-derived NPCs and neurons</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-9159">E-MTAB-9159</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset23"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>ATAC-seq of iPSC-derived NPCs and neurons</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-9087">E-MTAB-9087</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset24"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>RNA-seq of iPSC-derived NPCs and neurons from CHOPWT10 and CHOPWT14 cell lines</data-title><source>EMBL-EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-9085">E-MTAB-9085</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset25"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Identification of 22 novel susceptibility loci associated with testicular germ cell tumors</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE175368">GSE175368</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by National Institutes of Health awards R01 HD056465, R01 DK122586 and UM1 DK126194, and the Daniel B Burke Endowed Chair for Diabetes Research. Given the use of de-identified datasets and biospecimens was not considered human subjects research, ethical oversight was waived by the Institutional Review Board of the Children’s Hospital of Philadelphia.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksoyer Sezgin</surname><given-names>SB</given-names></name><name><surname>Bayoglu</surname><given-names>B</given-names></name><name><surname>Ersoz</surname><given-names>F</given-names></name><name><surname>Sarici</surname><given-names>M</given-names></name><name><surname>Niyazoglu</surname><given-names>M</given-names></name><name><surname>Dirican</surname><given-names>A</given-names></name><name><surname>Cengiz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Downregulation of MMP-2 and MMP-9 genes in obesity patients and their relation with obesity-related phenotypes</article-title><source>Turkish Journal of Biochemistry</source><volume>47</volume><fpage>425</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1515/tjb-2021-0124</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avsec</surname><given-names>Ž</given-names></name><name><surname>Agarwal</surname><given-names>V</given-names></name><name><surname>Visentin</surname><given-names>D</given-names></name><name><surname>Ledsam</surname><given-names>JR</given-names></name><name><surname>Grabska-Barwinska</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>KR</given-names></name><name><surname>Assael</surname><given-names>Y</given-names></name><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Kelley</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Effective gene expression prediction from sequence by integrating long-range interactions</article-title><source>Nature Methods</source><volume>18</volume><fpage>1196</fpage><lpage>1203</lpage><pub-id pub-id-type="doi">10.1038/s41592-021-01252-x</pub-id><pub-id pub-id-type="pmid">34608324</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blessing</surname><given-names>AM</given-names></name><name><surname>Ganesan</surname><given-names>S</given-names></name><name><surname>Rajapakshe</surname><given-names>K</given-names></name><name><surname>Ying Sung</surname><given-names>Y</given-names></name><name><surname>Reddy Bollu</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Cheung</surname><given-names>E</given-names></name><name><surname>Coarfa</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>JT</given-names></name><name><surname>McDonnell</surname><given-names>DP</given-names></name><name><surname>Frigo</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Identification of a novel coregulator, SH3YL1, That interacts with the androgen receptor N-terminus</article-title><source>Molecular Endocrinology</source><volume>29</volume><fpage>1426</fpage><lpage>1439</lpage><pub-id pub-id-type="doi">10.1210/me.2015-1079</pub-id><pub-id pub-id-type="pmid">26305679</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borenäs</surname><given-names>M</given-names></name><name><surname>Umapathy</surname><given-names>G</given-names></name><name><surname>Lai</surname><given-names>WY</given-names></name><name><surname>Lind</surname><given-names>DE</given-names></name><name><surname>Witek</surname><given-names>B</given-names></name><name><surname>Guan</surname><given-names>J</given-names></name><name><surname>Mendoza-Garcia</surname><given-names>P</given-names></name><name><surname>Masudi</surname><given-names>T</given-names></name><name><surname>Claeys</surname><given-names>A</given-names></name><name><surname>Chuang</surname><given-names>TP</given-names></name><name><surname>El Wakil</surname><given-names>A</given-names></name><name><surname>Arefin</surname><given-names>B</given-names></name><name><surname>Fransson</surname><given-names>S</given-names></name><name><surname>Koster</surname><given-names>J</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Gaarder</surname><given-names>J</given-names></name><name><surname>Van den Eynden</surname><given-names>J</given-names></name><name><surname>Hallberg</surname><given-names>B</given-names></name><name><surname>Palmer</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation</article-title><source>The EMBO Journal</source><volume>40</volume><elocation-id>e105784</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2020105784</pub-id><pub-id pub-id-type="pmid">33411331</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchard</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Childhood obesity: are genetic differences involved?</article-title><source>The American Journal of Clinical Nutrition</source><volume>89</volume><fpage>1494S</fpage><lpage>1501S</lpage><pub-id pub-id-type="doi">10.3945/ajcn.2009.27113C</pub-id><pub-id pub-id-type="pmid">19261728</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradfield</surname><given-names>JP</given-names></name><name><surname>Vogelezang</surname><given-names>S</given-names></name><name><surname>Felix</surname><given-names>JF</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Helgeland</surname><given-names>Ø</given-names></name><name><surname>Horikoshi</surname><given-names>M</given-names></name><name><surname>Karhunen</surname><given-names>V</given-names></name><name><surname>Lowry</surname><given-names>E</given-names></name><name><surname>Cousminer</surname><given-names>DL</given-names></name><name><surname>Ahluwalia</surname><given-names>TS</given-names></name><name><surname>Thiering</surname><given-names>E</given-names></name><name><surname>Boh</surname><given-names>ET-H</given-names></name><name><surname>Zafarmand</surname><given-names>MH</given-names></name><name><surname>Vilor-Tejedor</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>CA</given-names></name><name><surname>Joro</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Gauderman</surname><given-names>WJ</given-names></name><name><surname>Pitkänen</surname><given-names>N</given-names></name><name><surname>Parra</surname><given-names>EJ</given-names></name><name><surname>Fernandez-Rhodes</surname><given-names>L</given-names></name><name><surname>Alyass</surname><given-names>A</given-names></name><name><surname>Monnereau</surname><given-names>C</given-names></name><name><surname>Curtin</surname><given-names>JA</given-names></name><name><surname>Have</surname><given-names>CT</given-names></name><name><surname>McCormack</surname><given-names>SE</given-names></name><name><surname>Hollensted</surname><given-names>M</given-names></name><name><surname>Frithioff-Bøjsøe</surname><given-names>C</given-names></name><name><surname>Valladares-Salgado</surname><given-names>A</given-names></name><name><surname>Peralta-Romero</surname><given-names>J</given-names></name><name><surname>Teo</surname><given-names>Y-Y</given-names></name><name><surname>Standl</surname><given-names>M</given-names></name><name><surname>Leinonen</surname><given-names>JT</given-names></name><name><surname>Holm</surname><given-names>J-C</given-names></name><name><surname>Peters</surname><given-names>T</given-names></name><name><surname>Vioque</surname><given-names>J</given-names></name><name><surname>Vrijheid</surname><given-names>M</given-names></name><name><surname>Simpson</surname><given-names>A</given-names></name><name><surname>Custovic</surname><given-names>A</given-names></name><name><surname>Vaudel</surname><given-names>M</given-names></name><name><surname>Canouil</surname><given-names>M</given-names></name><name><surname>Lindi</surname><given-names>V</given-names></name><name><surname>Atalay</surname><given-names>M</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>van Schaik</surname><given-names>BDC</given-names></name><name><surname>Berkowitz</surname><given-names>RI</given-names></name><name><surname>Cole</surname><given-names>SA</given-names></name><name><surname>Voruganti</surname><given-names>VS</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Highland</surname><given-names>HM</given-names></name><name><surname>Comuzzie</surname><given-names>AG</given-names></name><name><surname>Butte</surname><given-names>NF</given-names></name><name><surname>Justice</surname><given-names>AE</given-names></name><name><surname>Gahagan</surname><given-names>S</given-names></name><name><surname>Blanco</surname><given-names>E</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Bonnefond</surname><given-names>A</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Lyytikäinen</surname><given-names>L-P</given-names></name><name><surname>Cruz</surname><given-names>M</given-names></name><name><surname>Kobes</surname><given-names>S</given-names></name><name><surname>Hanson</surname><given-names>RL</given-names></name><name><surname>Zemel</surname><given-names>BS</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Teo</surname><given-names>KK</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Gilliland</surname><given-names>FD</given-names></name><name><surname>Bisgaard</surname><given-names>H</given-names></name><name><surname>Bustamante</surname><given-names>M</given-names></name><name><surname>Bonnelykke</surname><given-names>K</given-names></name><name><surname>Pennell</surname><given-names>CE</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Baier</surname><given-names>LJ</given-names></name><name><surname>Vrijkotte</surname><given-names>TGM</given-names></name><name><surname>Heinrich</surname><given-names>J</given-names></name><name><surname>Sørensen</surname><given-names>TIA</given-names></name><name><surname>Saw</surname><given-names>S-M</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Eriksson</surname><given-names>J</given-names></name><name><surname>Widén</surname><given-names>E</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Njølstad</surname><given-names>PR</given-names></name><name><surname>Power</surname><given-names>C</given-names></name><name><surname>Hyppönen</surname><given-names>E</given-names></name><name><surname>Sebert</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>CD</given-names></name><name><surname>Järvelin</surname><given-names>M-R</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Jaddoe</surname><given-names>VWV</given-names></name><collab>Early Growth Genetics Consortium</collab><name><surname>Grant</surname><given-names>SFA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity</article-title><source>Human Molecular Genetics</source><volume>28</volume><fpage>3327</fpage><lpage>3338</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddz161</pub-id><pub-id pub-id-type="pmid">31504550</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryan</surname><given-names>S</given-names></name><name><surname>Joseph</surname><given-names>A</given-names></name><name><surname>Margaret</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>National health and nutrition examination survey 2017–march 2020 prepandemic data files development of files and prevalence estimates for selected health outcomes</article-title><source>National Health Statistics Reports</source><volume>1</volume><elocation-id>106273</elocation-id><pub-id pub-id-type="doi">10.15620/cdc:106273</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cairns</surname><given-names>J</given-names></name><name><surname>Freire-Pritchett</surname><given-names>P</given-names></name><name><surname>Wingett</surname><given-names>SW</given-names></name><name><surname>Várnai</surname><given-names>C</given-names></name><name><surname>Dimond</surname><given-names>A</given-names></name><name><surname>Plagnol</surname><given-names>V</given-names></name><name><surname>Zerbino</surname><given-names>D</given-names></name><name><surname>Schoenfelder</surname><given-names>S</given-names></name><name><surname>Javierre</surname><given-names>B-M</given-names></name><name><surname>Osborne</surname><given-names>C</given-names></name><name><surname>Fraser</surname><given-names>P</given-names></name><name><surname>Spivakov</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>CHiCAGO: robust detection of DNA looping interactions in Capture Hi-C data</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>127</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0992-2</pub-id><pub-id pub-id-type="pmid">27306882</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>BY</given-names></name><name><surname>Bone</surname><given-names>WP</given-names></name><name><surname>Lorenz</surname><given-names>K</given-names></name><name><surname>Levin</surname><given-names>M</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>ColocQuiaL: a QTL-GWAS colocalization pipeline</article-title><source>Bioinformatics</source><volume>38</volume><fpage>4409</fpage><lpage>4411</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btac512</pub-id><pub-id pub-id-type="pmid">35894642</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherian</surname><given-names>PT</given-names></name><name><surname>Al-Khairi</surname><given-names>I</given-names></name><name><surname>Sriraman</surname><given-names>D</given-names></name><name><surname>Al-Enezi</surname><given-names>A</given-names></name><name><surname>Al-Sultan</surname><given-names>D</given-names></name><name><surname>AlOtaibi</surname><given-names>M</given-names></name><name><surname>Al-Enezi</surname><given-names>S</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Al-Mulla</surname><given-names>F</given-names></name><name><surname>Abubaker</surname><given-names>JA</given-names></name><name><surname>Abu-Farha</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Increased circulation and adipose tissue levels of DNAJC27/RBJ in Obesity and Type 2-Diabetes</article-title><source>Frontiers in Endocrinology</source><volume>9</volume><elocation-id>423</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2018.00423</pub-id><pub-id pub-id-type="pmid">30131766</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Wagley</surname><given-names>Y</given-names></name><name><surname>Johnson</surname><given-names>ME</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Leonard</surname><given-names>ME</given-names></name><name><surname>Hodge</surname><given-names>KM</given-names></name><name><surname>Pippin</surname><given-names>JA</given-names></name><name><surname>Hankenson</surname><given-names>KD</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genome-scale Capture C promoter interactions implicate effector genes at GWAS loci for bone mineral density</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1260</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09302-x</pub-id><pub-id pub-id-type="pmid">30890710</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>GS</given-names></name><name><surname>Min</surname><given-names>HS</given-names></name><name><surname>Cha</surname><given-names>JJ</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Ghee</surname><given-names>JY</given-names></name><name><surname>Yoo</surname><given-names>JA</given-names></name><name><surname>Kim</surname><given-names>KT</given-names></name><name><surname>Kang</surname><given-names>YS</given-names></name><name><surname>Han</surname><given-names>SY</given-names></name><name><surname>Bae</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>SR</given-names></name><name><surname>Yoo</surname><given-names>JY</given-names></name><name><surname>Moon</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Cha</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SH3YL1 protein as a novel biomarker for diabetic nephropathy in type 2 diabetes mellitus</article-title><source>Nutrition, Metabolism, and Cardiovascular Diseases</source><volume>31</volume><fpage>498</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2020.09.024</pub-id><pub-id pub-id-type="pmid">33223406</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claussnitzer</surname><given-names>M</given-names></name><name><surname>Hui</surname><given-names>CC</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>FTO obesity variant and adipocyte browning in humans</article-title><source>The New England Journal of Medicine</source><volume>374</volume><fpage>192</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1513316</pub-id><pub-id pub-id-type="pmid">26760096</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colle</surname><given-names>R</given-names></name><name><surname>Deflesselle</surname><given-names>E</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>David</surname><given-names>DJ</given-names></name><name><surname>Hardy</surname><given-names>P</given-names></name><name><surname>Taranu</surname><given-names>A</given-names></name><name><surname>Falissard</surname><given-names>B</given-names></name><name><surname>Verstuyft</surname><given-names>C</given-names></name><name><surname>Corruble</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients</article-title><source>Pharmacogenomics</source><volume>16</volume><fpage>997</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.2217/pgs.15.56</pub-id><pub-id pub-id-type="pmid">26122862</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cousminer</surname><given-names>DL</given-names></name><name><surname>Wagley</surname><given-names>Y</given-names></name><name><surname>Pippin</surname><given-names>JA</given-names></name><name><surname>Elhakeem</surname><given-names>A</given-names></name><name><surname>Way</surname><given-names>GP</given-names></name><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>McCormack</surname><given-names>SE</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Mitchell</surname><given-names>JA</given-names></name><name><surname>Kindler</surname><given-names>JM</given-names></name><name><surname>Baird</surname><given-names>D</given-names></name><name><surname>Hartley</surname><given-names>A</given-names></name><name><surname>Howe</surname><given-names>L</given-names></name><name><surname>Kalkwarf</surname><given-names>HJ</given-names></name><name><surname>Lappe</surname><given-names>JM</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Leonard</surname><given-names>ME</given-names></name><name><surname>Johnson</surname><given-names>ME</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Gilsanz</surname><given-names>V</given-names></name><name><surname>Shepherd</surname><given-names>JA</given-names></name><name><surname>Oberfield</surname><given-names>SE</given-names></name><name><surname>Greene</surname><given-names>CS</given-names></name><name><surname>Kelly</surname><given-names>A</given-names></name><name><surname>Lawlor</surname><given-names>DA</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Zemel</surname><given-names>BS</given-names></name><name><surname>Hankenson</surname><given-names>KD</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Genome-wide association study implicates novel loci and reveals candidate effector genes for longitudinal pediatric bone accrual</article-title><source>Genome Biology</source><volume>22</volume><elocation-id>1</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-020-02207-9</pub-id><pub-id pub-id-type="pmid">33397451</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couto Alves</surname><given-names>A</given-names></name><name><surname>De Silva</surname><given-names>NMG</given-names></name><name><surname>Karhunen</surname><given-names>V</given-names></name><name><surname>Sovio</surname><given-names>U</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Taal</surname><given-names>HR</given-names></name><name><surname>Warrington</surname><given-names>NM</given-names></name><name><surname>Lewin</surname><given-names>AM</given-names></name><name><surname>Kaakinen</surname><given-names>M</given-names></name><name><surname>Cousminer</surname><given-names>DL</given-names></name><name><surname>Thiering</surname><given-names>E</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Bond</surname><given-names>TA</given-names></name><name><surname>Lowry</surname><given-names>E</given-names></name><name><surname>Brown</surname><given-names>CD</given-names></name><name><surname>Estivill</surname><given-names>X</given-names></name><name><surname>Lindi</surname><given-names>V</given-names></name><name><surname>Bradfield</surname><given-names>JP</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Speed</surname><given-names>D</given-names></name><name><surname>Coin</surname><given-names>LJM</given-names></name><name><surname>Loh</surname><given-names>M</given-names></name><name><surname>Barton</surname><given-names>SJ</given-names></name><name><surname>Beilin</surname><given-names>LJ</given-names></name><name><surname>Bisgaard</surname><given-names>H</given-names></name><name><surname>Bønnelykke</surname><given-names>K</given-names></name><name><surname>Alili</surname><given-names>R</given-names></name><name><surname>Hatoum</surname><given-names>IJ</given-names></name><name><surname>Schramm</surname><given-names>K</given-names></name><name><surname>Cartwright</surname><given-names>R</given-names></name><name><surname>Charles</surname><given-names>M-A</given-names></name><name><surname>Salerno</surname><given-names>V</given-names></name><name><surname>Clément</surname><given-names>K</given-names></name><name><surname>Claringbould</surname><given-names>AAJ</given-names></name><collab>BIOS Consortium</collab><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Moltchanova</surname><given-names>E</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Elks</surname><given-names>C</given-names></name><name><surname>Feenstra</surname><given-names>B</given-names></name><name><surname>Flexeder</surname><given-names>C</given-names></name><name><surname>Franks</surname><given-names>S</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Freathy</surname><given-names>RM</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Widén</surname><given-names>E</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Rodriguez</surname><given-names>A</given-names></name><name><surname>Banterle</surname><given-names>M</given-names></name><name><surname>Heinrich</surname><given-names>J</given-names></name><name><surname>Heude</surname><given-names>B</given-names></name><name><surname>Holloway</surname><given-names>JW</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Hyppönen</surname><given-names>E</given-names></name><name><surname>Inskip</surname><given-names>H</given-names></name><name><surname>Kaplan</surname><given-names>LM</given-names></name><name><surname>Hedman</surname><given-names>AK</given-names></name><name><surname>Läärä</surname><given-names>E</given-names></name><name><surname>Prokisch</surname><given-names>H</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Lawlor</surname><given-names>DA</given-names></name><name><surname>Melbye</surname><given-names>M</given-names></name><name><surname>Ahluwalia</surname><given-names>TS</given-names></name><name><surname>Marinelli</surname><given-names>M</given-names></name><name><surname>Millwood</surname><given-names>IY</given-names></name><name><surname>Palmer</surname><given-names>LJ</given-names></name><name><surname>Pennell</surname><given-names>CE</given-names></name><name><surname>Perry</surname><given-names>JR</given-names></name><name><surname>Ring</surname><given-names>SM</given-names></name><name><surname>Savolainen</surname><given-names>MJ</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Standl</surname><given-names>M</given-names></name><name><surname>Sunyer</surname><given-names>J</given-names></name><name><surname>Tiesler</surname><given-names>CMT</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Schierding</surname><given-names>W</given-names></name><name><surname>O’Sullivan</surname><given-names>JM</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Herzig</surname><given-names>K-H</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>O’Reilly</surname><given-names>P</given-names></name><name><surname>Felix</surname><given-names>JF</given-names></name><name><surname>Buxton</surname><given-names>JL</given-names></name><name><surname>Blakemore</surname><given-names>AIF</given-names></name><name><surname>Ong</surname><given-names>KK</given-names></name><name><surname>Jaddoe</surname><given-names>VWV</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Sebert</surname><given-names>S</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Järvelin</surname><given-names>M-R</given-names></name><collab>Early Growth Genetics (EGG) Consortium</collab></person-group><year iso-8601-date="2019">2019</year><article-title>GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI</article-title><source>Science Advances</source><volume>5</volume><elocation-id>eaaw3095</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aaw3095</pub-id><pub-id pub-id-type="pmid">31840077</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallman</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Stress-induced obesity and the emotional nervous system</article-title><source>Trends in Endocrinology and Metabolism</source><volume>21</volume><fpage>159</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2009.10.004</pub-id><pub-id pub-id-type="pmid">19926299</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Defaye</surname><given-names>M</given-names></name><name><surname>Iftinca</surname><given-names>MC</given-names></name><name><surname>Gadotti</surname><given-names>VM</given-names></name><name><surname>Basso</surname><given-names>L</given-names></name><name><surname>Abdullah</surname><given-names>NS</given-names></name><name><surname>Cuménal</surname><given-names>M</given-names></name><name><surname>Agosti</surname><given-names>F</given-names></name><name><surname>Hassan</surname><given-names>A</given-names></name><name><surname>Flynn</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Soubeyre</surname><given-names>V</given-names></name><name><surname>Poulen</surname><given-names>G</given-names></name><name><surname>Lonjon</surname><given-names>N</given-names></name><name><surname>Vachiery-Lahaye</surname><given-names>F</given-names></name><name><surname>Bauchet</surname><given-names>L</given-names></name><name><surname>Mery</surname><given-names>PF</given-names></name><name><surname>Bourinet</surname><given-names>E</given-names></name><name><surname>Zamponi</surname><given-names>GW</given-names></name><name><surname>Altier</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The neuronal tyrosine kinase receptor ligand ALKAL2 mediates persistent pain</article-title><source>The Journal of Clinical Investigation</source><volume>132</volume><elocation-id>e154317</elocation-id><pub-id pub-id-type="doi">10.1172/JCI154317</pub-id><pub-id pub-id-type="pmid">35608912</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demerath</surname><given-names>EW</given-names></name><name><surname>Choh</surname><given-names>AC</given-names></name><name><surname>Czerwinski</surname><given-names>SA</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>SS</given-names></name><name><surname>Chumlea</surname><given-names>WMC</given-names></name><name><surname>Duren</surname><given-names>D</given-names></name><name><surname>Sherwood</surname><given-names>RJ</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Towne</surname><given-names>B</given-names></name><name><surname>Siervogel</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genetic and environmental influences on infant weight and weight change: the Fels Longitudinal Study</article-title><source>American Journal of Human Biology</source><volume>19</volume><fpage>692</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1002/ajhb.20660</pub-id><pub-id pub-id-type="pmid">17639582</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derosa</surname><given-names>G</given-names></name><name><surname>Ferrari</surname><given-names>I</given-names></name><name><surname>D’Angelo</surname><given-names>A</given-names></name><name><surname>Tinelli</surname><given-names>C</given-names></name><name><surname>Salvadeo</surname><given-names>SAT</given-names></name><name><surname>Ciccarelli</surname><given-names>L</given-names></name><name><surname>Piccinni</surname><given-names>MN</given-names></name><name><surname>Gravina</surname><given-names>A</given-names></name><name><surname>Ramondetti</surname><given-names>F</given-names></name><name><surname>Maffioli</surname><given-names>P</given-names></name><name><surname>Cicero</surname><given-names>AFG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Matrix metalloproteinase-2 and -9 levels in obese patients</article-title><source>Endothelium</source><volume>15</volume><fpage>219</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1080/10623320802228815</pub-id><pub-id pub-id-type="pmid">18663625</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname><given-names>L</given-names></name><name><surname>Girard</surname><given-names>M</given-names></name><name><surname>Girard</surname><given-names>A</given-names></name><name><surname>Tremblay</surname><given-names>R</given-names></name><name><surname>Boivin</surname><given-names>M</given-names></name><name><surname>Pérusse</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genetic and environmental influences on body size in early childhood: a twin birth-cohort study</article-title><source>Twin Research and Human Genetics</source><volume>10</volume><fpage>479</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1375/twin.10.3.479</pub-id><pub-id pub-id-type="pmid">17564506</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elks</surname><given-names>CE</given-names></name><name><surname>den Hoed</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Sharp</surname><given-names>SJ</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Ong</surname><given-names>KK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Variability in the heritability of body mass index: a systematic review and meta-regression</article-title><source>Frontiers in Endocrinology</source><volume>3</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2012.00029</pub-id><pub-id pub-id-type="pmid">22645519</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>SJ</given-names></name><name><surname>Morikawa</surname><given-names>H</given-names></name><name><surname>Ewing</surname><given-names>E</given-names></name><name><surname>Ruhrmann</surname><given-names>S</given-names></name><name><surname>Joshi</surname><given-names>RN</given-names></name><name><surname>Lagani</surname><given-names>V</given-names></name><name><surname>Karathanasis</surname><given-names>N</given-names></name><name><surname>Khademi</surname><given-names>M</given-names></name><name><surname>Planell</surname><given-names>N</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Tsamardinos</surname><given-names>I</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name><name><surname>Piehl</surname><given-names>F</given-names></name><name><surname>Kockum</surname><given-names>I</given-names></name><name><surname>Jagodic</surname><given-names>M</given-names></name><name><surname>Tegnér</surname><given-names>J</given-names></name><name><surname>Gomez-Cabrero</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>11996</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-48493-7</pub-id><pub-id pub-id-type="pmid">31427643</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Bulik-Sullivan</surname><given-names>B</given-names></name><name><surname>Gusev</surname><given-names>A</given-names></name><name><surname>Trynka</surname><given-names>G</given-names></name><name><surname>Reshef</surname><given-names>Y</given-names></name><name><surname>Loh</surname><given-names>P-R</given-names></name><name><surname>Anttila</surname><given-names>V</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Zang</surname><given-names>C</given-names></name><name><surname>Farh</surname><given-names>K</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Day</surname><given-names>FR</given-names></name><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Stahl</surname><given-names>E</given-names></name><name><surname>Lindstrom</surname><given-names>S</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name><collab>ReproGen Consortium</collab><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab><collab>RACI Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Partitioning heritability by functional annotation using genome-wide association summary statistics</article-title><source>Nature Genetics</source><volume>47</volume><fpage>1228</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1038/ng.3404</pub-id><pub-id pub-id-type="pmid">26414678</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>KR</given-names></name><name><surname>Barofsky</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Obesity and health-related quality of life</article-title><source>Obesity Reviews</source><volume>2</volume><fpage>173</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1046/j.1467-789x.2001.00032.x</pub-id><pub-id pub-id-type="pmid">12120102</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Childhood sleep duration modifies the polygenic risk for obesity in youth through leptin pathway: the Beijing Child and Adolescent Metabolic Syndrome cohort study</article-title><source>International Journal of Obesity</source><volume>43</volume><fpage>1556</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1038/s41366-019-0405-1</pub-id><pub-id pub-id-type="pmid">31285522</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaynor</surname><given-names>SC</given-names></name><name><surname>Monson</surname><given-names>ET</given-names></name><name><surname>Gaine</surname><given-names>ME</given-names></name><name><surname>Chimenti</surname><given-names>MS</given-names></name><name><surname>Reichman</surname><given-names>RD</given-names></name><name><surname>Parsons</surname><given-names>M</given-names></name><name><surname>Oonthonpan</surname><given-names>L</given-names></name><name><surname>Zandi</surname><given-names>PP</given-names></name><name><surname>Potash</surname><given-names>JB</given-names></name><name><surname>Willour</surname><given-names>VL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Male-specific association of the 2p25 region with suicide attempt in bipolar disorder</article-title><source>Journal of Psychiatric Research</source><volume>121</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2019.11.009</pub-id><pub-id pub-id-type="pmid">31830721</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazal</surname><given-names>S</given-names></name><name><surname>Weissbrod</surname><given-names>O</given-names></name><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Dey</surname><given-names>KK</given-names></name><name><surname>Nasser</surname><given-names>J</given-names></name><name><surname>Jagadeesh</surname><given-names>KA</given-names></name><name><surname>Weiner</surname><given-names>DJ</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Fulco</surname><given-names>CP</given-names></name><name><surname>O’Connor</surname><given-names>LJ</given-names></name><name><surname>Pasaniuc</surname><given-names>B</given-names></name><name><surname>Engreitz</surname><given-names>JM</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Combining SNP-to-gene linking strategies to identify disease genes and assess disease omnigenicity</article-title><source>Nature Genetics</source><volume>54</volume><fpage>827</fpage><lpage>836</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01087-y</pub-id><pub-id pub-id-type="pmid">35668300</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2015 Obesity Collaborators</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Health Effects of Overweight and Obesity in 195 Countries over 25 Years</article-title><source>The New England Journal of Medicine</source><volume>377</volume><fpage>13</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1614362</pub-id><pub-id pub-id-type="pmid">28604169</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graff</surname><given-names>M</given-names></name><name><surname>Ngwa</surname><given-names>JS</given-names></name><name><surname>Workalemahu</surname><given-names>T</given-names></name><name><surname>Homuth</surname><given-names>G</given-names></name><name><surname>Schipf</surname><given-names>S</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Völzke</surname><given-names>H</given-names></name><name><surname>Wallaschofski</surname><given-names>H</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Edward</surname><given-names>L</given-names></name><name><surname>Francesco</surname><given-names>C</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Scheet</surname><given-names>P</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name><name><surname>Sidore</surname><given-names>C</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Jacobs</surname><given-names>KB</given-names></name><name><surname>Hayes</surname><given-names>RB</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Van Dam</surname><given-names>RM</given-names></name><collab>GIANT Consortium</collab><name><surname>Crout</surname><given-names>RJ</given-names></name><name><surname>Marazita</surname><given-names>ML</given-names></name><name><surname>Shaffer</surname><given-names>JR</given-names></name><name><surname>Atwood</surname><given-names>LD</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Heard-Costa</surname><given-names>NL</given-names></name><name><surname>White</surname><given-names>C</given-names></name><name><surname>Choh</surname><given-names>AC</given-names></name><name><surname>Czerwinski</surname><given-names>SA</given-names></name><name><surname>Demerath</surname><given-names>EW</given-names></name><name><surname>Dyer</surname><given-names>TD</given-names></name><name><surname>Towne</surname><given-names>B</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>Van Duijn</surname><given-names>CM</given-names></name><name><surname>Zillikens</surname><given-names>MC</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Nelis</surname><given-names>M</given-names></name><name><surname>Nikopensius</surname><given-names>T</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Strachan</surname><given-names>DP</given-names></name><name><surname>Monda</surname><given-names>K</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Gordon-Larsen</surname><given-names>P</given-names></name><name><surname>Berndt</surname><given-names>SI</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course</article-title><source>Human Molecular Genetics</source><volume>22</volume><fpage>3597</fpage><lpage>3607</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddt205</pub-id><pub-id pub-id-type="pmid">23669352</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Moltke</surname><given-names>I</given-names></name><name><surname>Andersen</surname><given-names>MK</given-names></name><name><surname>Dalby</surname><given-names>M</given-names></name><name><surname>Vitting-Seerup</surname><given-names>K</given-names></name><name><surname>Kern</surname><given-names>T</given-names></name><name><surname>Mahendran</surname><given-names>Y</given-names></name><name><surname>Jørsboe</surname><given-names>E</given-names></name><name><surname>Larsen</surname><given-names>CVL</given-names></name><name><surname>Dahl-Petersen</surname><given-names>IK</given-names></name><name><surname>Gilly</surname><given-names>A</given-names></name><name><surname>Suveges</surname><given-names>D</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Andersson</surname><given-names>R</given-names></name><name><surname>Bjerregaard</surname><given-names>P</given-names></name><name><surname>Jørgensen</surname><given-names>ME</given-names></name><name><surname>Albrechtsen</surname><given-names>A</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes</article-title><source>Nature Genetics</source><volume>50</volume><fpage>172</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1038/s41588-017-0022-7</pub-id><pub-id pub-id-type="pmid">29311636</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Identification of critical genes and five prognostic biomarkers associated with colorectal cancer</article-title><source>Medical Science Monitor</source><volume>24</volume><fpage>4625</fpage><lpage>4633</lpage><pub-id pub-id-type="doi">10.12659/MSM.907224</pub-id><pub-id pub-id-type="pmid">29973580</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Rosen</surname><given-names>JD</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>MM</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Min</surname><given-names>Y-I</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Conomos</surname><given-names>MP</given-names></name><name><surname>Stilp</surname><given-names>AM</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Manichaikul</surname><given-names>A</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Kenny</surname><given-names>EE</given-names></name><name><surname>Blackwell</surname><given-names>TW</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Jun</surname><given-names>G</given-names></name><name><surname>Sedlazeck</surname><given-names>FJ</given-names></name><name><surname>Metcalf</surname><given-names>G</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><collab>NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium</collab><name><surname>Raffield</surname><given-names>LM</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Auer</surname><given-names>PL</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>TOP-LD: A tool to explore linkage disequilibrium with TOPMed whole-genome sequence data</article-title><source>American Journal of Human Genetics</source><volume>109</volume><fpage>1175</fpage><lpage>1181</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2022.04.006</pub-id><pub-id pub-id-type="pmid">35504290</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imakaev</surname><given-names>M</given-names></name><name><surname>Fudenberg</surname><given-names>G</given-names></name><name><surname>McCord</surname><given-names>RP</given-names></name><name><surname>Naumova</surname><given-names>N</given-names></name><name><surname>Goloborodko</surname><given-names>A</given-names></name><name><surname>Lajoie</surname><given-names>BR</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Mirny</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Iterative correction of Hi-C data reveals hallmarks of chromosome organization</article-title><source>Nature Methods</source><volume>9</volume><fpage>999</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2148</pub-id><pub-id pub-id-type="pmid">22941365</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwahara</surname><given-names>T</given-names></name><name><surname>Fujimoto</surname><given-names>J</given-names></name><name><surname>Wen</surname><given-names>D</given-names></name><name><surname>Cupples</surname><given-names>R</given-names></name><name><surname>Bucay</surname><given-names>N</given-names></name><name><surname>Arakawa</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>S</given-names></name><name><surname>Ratzkin</surname><given-names>B</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system</article-title><source>Oncogene</source><volume>14</volume><fpage>439</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1200849</pub-id><pub-id pub-id-type="pmid">9053841</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>KJA</given-names></name><name><surname>Adams</surname><given-names>MJ</given-names></name><name><surname>Nicholl</surname><given-names>BI</given-names></name><name><surname>Ward</surname><given-names>J</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>McIntosh</surname><given-names>AM</given-names></name><name><surname>Smith</surname><given-names>DJ</given-names></name><name><surname>Bailey</surname><given-names>MES</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Identification of novel common variants associated with chronic pain using conditional false discovery rate analysis with major depressive disorder and assessment of pleiotropic effects of LRFN5</article-title><source>Translational Psychiatry</source><volume>9</volume><elocation-id>310</elocation-id><pub-id pub-id-type="doi">10.1038/s41398-019-0613-4</pub-id><pub-id pub-id-type="pmid">31748543</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaul</surname><given-names>A</given-names></name><name><surname>Bhattacharyya</surname><given-names>S</given-names></name><name><surname>Ay</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Identifying statistically significant chromatin contacts from Hi-C data with FitHiC2</article-title><source>Nature Protocols</source><volume>15</volume><fpage>991</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1038/s41596-019-0273-0</pub-id><pub-id pub-id-type="pmid">31980751</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>H</given-names></name><name><surname>Jung</surname><given-names>HJ</given-names></name><name><surname>Raghuram</surname><given-names>V</given-names></name><name><surname>Leo</surname><given-names>KT</given-names></name><name><surname>Park</surname><given-names>E</given-names></name><name><surname>Yang</surname><given-names>CR</given-names></name><name><surname>Chou</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Knepper</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Bayesian identification of candidate transcription factors for the regulation of <italic>Aqp2</italic> gene expression</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>321</volume><fpage>F389</fpage><lpage>F401</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00204.2021</pub-id><pub-id pub-id-type="pmid">34308668</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Harada</surname><given-names>K</given-names></name><name><surname>Negishi</surname><given-names>M</given-names></name><name><surname>Katoh</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dock4 forms a complex with SH3YL1 and regulates cancer cell migration</article-title><source>Cellular Signalling</source><volume>26</volume><fpage>1082</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2014.01.027</pub-id><pub-id pub-id-type="pmid">24508479</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>WGCNA: an R package for weighted correlation network analysis</article-title><source>BMC Bioinformatics</source><volume>9</volume><elocation-id>559</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id><pub-id pub-id-type="pmid">19114008</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauby-Secretan</surname><given-names>B</given-names></name><name><surname>Scoccianti</surname><given-names>C</given-names></name><name><surname>Loomis</surname><given-names>D</given-names></name><name><surname>Grosse</surname><given-names>Y</given-names></name><name><surname>Bianchini</surname><given-names>F</given-names></name><name><surname>Straif</surname><given-names>K</given-names></name><collab>International Agency for Research on Cancer Handbook Working Group</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Body fatness and cancer--Viewpoint of the IARC Working Group</article-title><source>The New England Journal of Medicine</source><volume>375</volume><fpage>794</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1056/NEJMsr1606602</pub-id><pub-id pub-id-type="pmid">27557308</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Cheong</surname><given-names>HS</given-names></name><name><surname>Shin</surname><given-names>HD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>BMI prediction within a Korean population</article-title><source>PeerJ</source><volume>5</volume><elocation-id>e3510</elocation-id><pub-id pub-id-type="doi">10.7717/peerj.3510</pub-id><pub-id pub-id-type="pmid">28674662</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Schulz</surname><given-names>MH</given-names></name><name><surname>Look</surname><given-names>T</given-names></name><name><surname>Begemann</surname><given-names>M</given-names></name><name><surname>Zenke</surname><given-names>M</given-names></name><name><surname>Costa</surname><given-names>IG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Identification of transcription factor binding sites using ATAC-seq</article-title><source>Genome Biology</source><volume>20</volume><elocation-id>45</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-019-1642-2</pub-id><pub-id pub-id-type="pmid">30808370</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licinio</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Wong</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response</article-title><source>Archives of General Psychiatry</source><volume>66</volume><fpage>488</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.38</pub-id><pub-id pub-id-type="pmid">19414708</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Littleton</surname><given-names>SH</given-names></name><name><surname>Berkowitz</surname><given-names>RI</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genetic determinants of childhood obesity</article-title><source>Molecular Diagnosis &amp; Therapy</source><volume>24</volume><fpage>653</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1007/s40291-020-00496-1</pub-id><pub-id pub-id-type="pmid">33006084</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Littleton</surname><given-names>SH</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Strategies to identify causal common genetic variants and corresponding effector genes for paediatric obesity</article-title><source>Pediatric Obesity</source><volume>17</volume><elocation-id>e12968</elocation-id><pub-id pub-id-type="doi">10.1111/ijpo.12968</pub-id><pub-id pub-id-type="pmid">35971868</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Yeo</surname><given-names>GSH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The genetics of obesity: from discovery to biology</article-title><source>Nature Reviews. Genetics</source><volume>23</volume><fpage>120</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1038/s41576-021-00414-z</pub-id><pub-id pub-id-type="pmid">34556834</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>HH</given-names></name><name><surname>Neale</surname><given-names>MC</given-names></name><name><surname>Eaves</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Genetic and environmental factors in relative body weight and human adiposity</article-title><source>Behavior Genetics</source><volume>27</volume><fpage>325</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1023/a:1025635913927</pub-id><pub-id pub-id-type="pmid">9519560</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohsen G</surname><given-names>A-M</given-names></name><name><surname>Abu-Taweel</surname><given-names>GM</given-names></name><name><surname>Rajagopal</surname><given-names>R</given-names></name><name><surname>Sun-Ju</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>H-J</given-names></name><name><surname>Kim</surname><given-names>YO</given-names></name><name><surname>Mothana</surname><given-names>RA</given-names></name><name><surname>Kadaikunnan</surname><given-names>S</given-names></name><name><surname>Khaled</surname><given-names>JM</given-names></name><name><surname>Siddiqui</surname><given-names>NA</given-names></name><name><surname>Al-Rehaily</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Betulinic acid lowers lipid accumulation in adipocytes through enhanced NCoA1-PPARγ interaction</article-title><source>Journal of Infection and Public Health</source><volume>12</volume><fpage>726</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1016/j.jiph.2019.05.011</pub-id><pub-id pub-id-type="pmid">31133421</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motegi</surname><given-names>A</given-names></name><name><surname>Fujimoto</surname><given-names>J</given-names></name><name><surname>Kotani</surname><given-names>M</given-names></name><name><surname>Sakuraba</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>3319</fpage><lpage>3329</lpage><pub-id pub-id-type="doi">10.1242/jcs.01183</pub-id><pub-id pub-id-type="pmid">15226403</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>TA</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Machiela</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title><italic>LDlinkR</italic>: an r package for rapidly calculating linkage disequilibrium statistics in diverse populations</article-title><source>Frontiers in Genetics</source><volume>11</volume><elocation-id>157</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2020.00157</pub-id><pub-id pub-id-type="pmid">32180801</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasser</surname><given-names>J</given-names></name><name><surname>Bergman</surname><given-names>DT</given-names></name><name><surname>Fulco</surname><given-names>CP</given-names></name><name><surname>Guckelberger</surname><given-names>P</given-names></name><name><surname>Doughty</surname><given-names>BR</given-names></name><name><surname>Patwardhan</surname><given-names>TA</given-names></name><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Nguyen</surname><given-names>TH</given-names></name><name><surname>Ulirsch</surname><given-names>JC</given-names></name><name><surname>Lekschas</surname><given-names>F</given-names></name><name><surname>Mualim</surname><given-names>K</given-names></name><name><surname>Natri</surname><given-names>HM</given-names></name><name><surname>Weeks</surname><given-names>EM</given-names></name><name><surname>Munson</surname><given-names>G</given-names></name><name><surname>Kane</surname><given-names>M</given-names></name><name><surname>Kang</surname><given-names>HY</given-names></name><name><surname>Cui</surname><given-names>A</given-names></name><name><surname>Ray</surname><given-names>JP</given-names></name><name><surname>Eisenhaure</surname><given-names>TM</given-names></name><name><surname>Collins</surname><given-names>RL</given-names></name><name><surname>Dey</surname><given-names>K</given-names></name><name><surname>Pfister</surname><given-names>H</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Epstein</surname><given-names>CB</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Engreitz</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Genome-wide enhancer maps link risk variants to disease genes</article-title><source>Nature</source><volume>593</volume><fpage>238</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03446-x</pub-id><pub-id pub-id-type="pmid">33828297</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>NCD Risk Factor Collaboration (NCD-RisC)</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults</article-title><source>Lancet</source><volume>390</volume><fpage>2627</fpage><lpage>2642</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)32129-3</pub-id><pub-id pub-id-type="pmid">29029897</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonino</surname><given-names>CB</given-names></name><name><surname>Noronha</surname><given-names>NY</given-names></name><name><surname>de Araújo Ferreira-Julio</surname><given-names>M</given-names></name><name><surname>Moriguchi Watanabe</surname><given-names>L</given-names></name><name><surname>Cassia</surname><given-names>KF</given-names></name><name><surname>Ferreira Nicoletti</surname><given-names>C</given-names></name><name><surname>Rossi Welendorf</surname><given-names>C</given-names></name><name><surname>Salgado Junior</surname><given-names>W</given-names></name><name><surname>Rossi Silva Souza</surname><given-names>D</given-names></name><name><surname>Augusta de Souza Pinhel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Differential expression of MMP2 and TIMP2 in Peripheral blood mononuclear cells after Roux-en-Y gastric bypass</article-title><source>Frontiers in Nutrition</source><volume>8</volume><elocation-id>628759</elocation-id><pub-id pub-id-type="doi">10.3389/fnut.2021.628759</pub-id><pub-id pub-id-type="pmid">34722599</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orthofer</surname><given-names>M</given-names></name><name><surname>Valsesia</surname><given-names>A</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Q-P</given-names></name><name><surname>Kaczanowska</surname><given-names>J</given-names></name><name><surname>Kozieradzki</surname><given-names>I</given-names></name><name><surname>Leopoldi</surname><given-names>A</given-names></name><name><surname>Cikes</surname><given-names>D</given-names></name><name><surname>Zopf</surname><given-names>LM</given-names></name><name><surname>Tretiakov</surname><given-names>EO</given-names></name><name><surname>Demetz</surname><given-names>E</given-names></name><name><surname>Hilbe</surname><given-names>R</given-names></name><name><surname>Boehm</surname><given-names>A</given-names></name><name><surname>Ticevic</surname><given-names>M</given-names></name><name><surname>Nõukas</surname><given-names>M</given-names></name><name><surname>Jais</surname><given-names>A</given-names></name><name><surname>Spirk</surname><given-names>K</given-names></name><name><surname>Clark</surname><given-names>T</given-names></name><name><surname>Amann</surname><given-names>S</given-names></name><name><surname>Lepamets</surname><given-names>M</given-names></name><name><surname>Neumayr</surname><given-names>C</given-names></name><name><surname>Arnold</surname><given-names>C</given-names></name><name><surname>Dou</surname><given-names>Z</given-names></name><name><surname>Kuhn</surname><given-names>V</given-names></name><name><surname>Novatchkova</surname><given-names>M</given-names></name><name><surname>Cronin</surname><given-names>SJF</given-names></name><name><surname>Tietge</surname><given-names>UJF</given-names></name><name><surname>Müller</surname><given-names>S</given-names></name><name><surname>Pospisilik</surname><given-names>JA</given-names></name><name><surname>Nagy</surname><given-names>V</given-names></name><name><surname>Hui</surname><given-names>C-C</given-names></name><name><surname>Lazovic</surname><given-names>J</given-names></name><name><surname>Esterbauer</surname><given-names>H</given-names></name><name><surname>Hagelkruys</surname><given-names>A</given-names></name><name><surname>Tancevski</surname><given-names>I</given-names></name><name><surname>Kiefer</surname><given-names>FW</given-names></name><name><surname>Harkany</surname><given-names>T</given-names></name><name><surname>Haubensak</surname><given-names>W</given-names></name><name><surname>Neely</surname><given-names>GG</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Hager</surname><given-names>J</given-names></name><name><surname>Gheldof</surname><given-names>N</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Identification of ALK in thinness</article-title><source>Cell</source><volume>181</volume><fpage>1246</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.034</pub-id><pub-id pub-id-type="pmid">32442405</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>Doege</surname><given-names>CA</given-names></name><name><surname>Hodge</surname><given-names>KM</given-names></name><name><surname>Littleton</surname><given-names>SH</given-names></name><name><surname>Leonard</surname><given-names>ME</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Rausch</surname><given-names>R</given-names></name><name><surname>Pippin</surname><given-names>JA</given-names></name><name><surname>De Rosa</surname><given-names>MC</given-names></name><name><surname>Basak</surname><given-names>A</given-names></name><name><surname>Bradfield</surname><given-names>JP</given-names></name><name><surname>Hammond</surname><given-names>RK</given-names></name><name><surname>Boehm</surname><given-names>K</given-names></name><name><surname>Berkowitz</surname><given-names>RI</given-names></name><name><surname>Lasconi</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>ME</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Leibel</surname><given-names>RL</given-names></name><name><surname>Cousminer</surname><given-names>DL</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cis-regulatory architecture of human ESC-derived hypothalamic neuron differentiation aids in variant-to-gene mapping of relevant complex traits</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>6749</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-27001-4</pub-id><pub-id pub-id-type="pmid">34799566</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>Le Coz</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Thomas</surname><given-names>RM</given-names></name><name><surname>Pippin</surname><given-names>JA</given-names></name><name><surname>Cruz Cabrera</surname><given-names>E</given-names></name><name><surname>Johnson</surname><given-names>ME</given-names></name><name><surname>Leonard</surname><given-names>ME</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Sullivan</surname><given-names>KE</given-names></name><name><surname>Romberg</surname><given-names>N</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types</article-title><source>Genome Biology</source><volume>23</volume><elocation-id>125</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-022-02691-1</pub-id><pub-id pub-id-type="pmid">35659055</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palermo</surname><given-names>J</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Zimmerman</surname><given-names>A</given-names></name><name><surname>Sonti</surname><given-names>S</given-names></name><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>Lasconi</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>EB</given-names></name><name><surname>Pippin</surname><given-names>JA</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Doldur-Balli</surname><given-names>F</given-names></name><name><surname>Mazzotti</surname><given-names>DR</given-names></name><name><surname>Pack</surname><given-names>AI</given-names></name><name><surname>Gehrman</surname><given-names>PR</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Keene</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Variant-to-gene mapping followed by cross-species genetic screening identifies GPI-anchor biosynthesis as a regulator of sleep</article-title><source>Science Advances</source><volume>9</volume><elocation-id>eabq0844</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abq0844</pub-id><pub-id pub-id-type="pmid">36608130</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pejman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic effects on gene expression across human tissues</article-title><source>Nature</source><volume>550</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/nature24277</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pleasure</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell</article-title><source>Journal of Neuroscience Research</source><volume>35</volume><fpage>585</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1002/jnr.490350603</pub-id><pub-id pub-id-type="pmid">8411264</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragvin</surname><given-names>A</given-names></name><name><surname>Moro</surname><given-names>E</given-names></name><name><surname>Fredman</surname><given-names>D</given-names></name><name><surname>Navratilova</surname><given-names>P</given-names></name><name><surname>Drivenes</surname><given-names>Ø</given-names></name><name><surname>Engström</surname><given-names>PG</given-names></name><name><surname>Alonso</surname><given-names>ME</given-names></name><name><surname>de la Calle Mustienes</surname><given-names>E</given-names></name><name><surname>Gómez Skarmeta</surname><given-names>JL</given-names></name><name><surname>Tavares</surname><given-names>MJ</given-names></name><name><surname>Casares</surname><given-names>F</given-names></name><name><surname>Manzanares</surname><given-names>M</given-names></name><name><surname>van Heyningen</surname><given-names>V</given-names></name><name><surname>Molven</surname><given-names>A</given-names></name><name><surname>Njølstad</surname><given-names>PR</given-names></name><name><surname>Argenton</surname><given-names>F</given-names></name><name><surname>Lenhard</surname><given-names>B</given-names></name><name><surname>Becker</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3</article-title><source>PNAS</source><volume>107</volume><fpage>775</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1073/pnas.0911591107</pub-id><pub-id pub-id-type="pmid">20080751</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riveros-McKay</surname><given-names>F</given-names></name><name><surname>Mistry</surname><given-names>V</given-names></name><name><surname>Bounds</surname><given-names>R</given-names></name><name><surname>Hendricks</surname><given-names>A</given-names></name><name><surname>Keogh</surname><given-names>JM</given-names></name><name><surname>Thomas</surname><given-names>H</given-names></name><name><surname>Henning</surname><given-names>E</given-names></name><name><surname>Corbin</surname><given-names>LJ</given-names></name><name><surname>O’Rahilly</surname><given-names>S</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Farooqi</surname><given-names>IS</given-names></name><collab>Understanding Society Scientific Group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Genetic architecture of human thinness compared to severe obesity</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1007603</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007603</pub-id><pub-id pub-id-type="pmid">30677029</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roayaei</surname><given-names>AA</given-names></name><name><surname>Gezer</surname><given-names>HT</given-names></name><name><surname>Lonardi</surname><given-names>S</given-names></name><name><surname>Ay</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mustache: multi-scale detection of chromatin loops from Hi-C and Micro-C maps using scale-space representation</article-title><source>Genome Biology</source><volume>21</volume><elocation-id>256</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-020-02167-0</pub-id><pub-id pub-id-type="pmid">32998764</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollins</surname><given-names>DA</given-names></name><name><surname>Coppo</surname><given-names>M</given-names></name><name><surname>Rogatsky</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolism</article-title><source>Molecular Endocrinology</source><volume>29</volume><fpage>502</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1210/me.2015-1005</pub-id><pub-id pub-id-type="pmid">25647480</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Roige</surname><given-names>S</given-names></name><name><surname>Fontanillas</surname><given-names>P</given-names></name><name><surname>Jennings</surname><given-names>MV</given-names></name><name><surname>Bianchi</surname><given-names>SB</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Hatoum</surname><given-names>AS</given-names></name><name><surname>Sealock</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>LK</given-names></name><name><surname>Elson</surname><given-names>SL</given-names></name><collab>23andMe Research Team</collab><name><surname>Palmer</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry</article-title><source>Molecular Psychiatry</source><volume>26</volume><fpage>6209</fpage><lpage>6217</lpage><pub-id pub-id-type="doi">10.1038/s41380-021-01335-3</pub-id><pub-id pub-id-type="pmid">34728798</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siljee</surname><given-names>JE</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Bernard</surname><given-names>AA</given-names></name><name><surname>Ersoy</surname><given-names>BA</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Marley</surname><given-names>A</given-names></name><name><surname>Von Zastrow</surname><given-names>M</given-names></name><name><surname>Reiter</surname><given-names>JF</given-names></name><name><surname>Vaisse</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Subcellular localization of MC4R with ADCY3 at neuronal primary cilia underlies a common pathway for genetic predisposition to obesity</article-title><source>Nature Genetics</source><volume>50</volume><fpage>180</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1038/s41588-017-0020-9</pub-id><pub-id pub-id-type="pmid">29311635</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>GM</given-names></name><name><surname>Danaei</surname><given-names>G</given-names></name><name><surname>Farzadfar</surname><given-names>F</given-names></name><name><surname>Stevens</surname><given-names>GA</given-names></name><name><surname>Woodward</surname><given-names>M</given-names></name><name><surname>Wormser</surname><given-names>D</given-names></name><name><surname>Kaptoge</surname><given-names>S</given-names></name><name><surname>Whitlock</surname><given-names>G</given-names></name><name><surname>Qiao</surname><given-names>Q</given-names></name><name><surname>Lewington</surname><given-names>S</given-names></name><name><surname>Di Angelantonio</surname><given-names>E</given-names></name><name><surname>Vander Hoorn</surname><given-names>S</given-names></name><name><surname>Lawes</surname><given-names>CMM</given-names></name><name><surname>Ali</surname><given-names>MK</given-names></name><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Ezzati</surname><given-names>M</given-names></name><collab>Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC)</collab><collab>Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE)</collab><collab>Emerging Risk Factor Collaboration (ERFC)</collab><collab>Prospective Studies Collaboration (PSC)</collab></person-group><year iso-8601-date="2013">2013</year><article-title>The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: A pooled analysis</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e65174</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0065174</pub-id><pub-id pub-id-type="pmid">23935815</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinnott-Armstrong</surname><given-names>N</given-names></name><name><surname>Sousa</surname><given-names>IS</given-names></name><name><surname>Laber</surname><given-names>S</given-names></name><name><surname>Rendina-Ruedy</surname><given-names>E</given-names></name><name><surname>Nitter Dankel</surname><given-names>SE</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name><name><surname>Mellgren</surname><given-names>G</given-names></name><name><surname>Karasik</surname><given-names>D</given-names></name><name><surname>Rivas</surname><given-names>M</given-names></name><name><surname>Pritchard</surname><given-names>J</given-names></name><name><surname>Guntur</surname><given-names>AR</given-names></name><name><surname>Cox</surname><given-names>RD</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Hauner</surname><given-names>H</given-names></name><name><surname>Sallari</surname><given-names>R</given-names></name><name><surname>Rosen</surname><given-names>CJ</given-names></name><name><surname>Hsu</surname><given-names>Y-H</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Kiel</surname><given-names>DP</given-names></name><name><surname>Claussnitzer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A regulatory variant at 3q21.1 confers an increased pleiotropic risk for hyperglycemia and altered bone mineral density</article-title><source>Cell Metabolism</source><volume>33</volume><fpage>615</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2021.01.001</pub-id><pub-id pub-id-type="pmid">33513366</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smemo</surname><given-names>S</given-names></name><name><surname>Tena</surname><given-names>JJ</given-names></name><name><surname>Kim</surname><given-names>K-H</given-names></name><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Sakabe</surname><given-names>NJ</given-names></name><name><surname>Gómez-Marín</surname><given-names>C</given-names></name><name><surname>Aneas</surname><given-names>I</given-names></name><name><surname>Credidio</surname><given-names>FL</given-names></name><name><surname>Sobreira</surname><given-names>DR</given-names></name><name><surname>Wasserman</surname><given-names>NF</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Puviindran</surname><given-names>V</given-names></name><name><surname>Tam</surname><given-names>D</given-names></name><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Son</surname><given-names>JE</given-names></name><name><surname>Vakili</surname><given-names>NA</given-names></name><name><surname>Sung</surname><given-names>H-K</given-names></name><name><surname>Naranjo</surname><given-names>S</given-names></name><name><surname>Acemel</surname><given-names>RD</given-names></name><name><surname>Manzanares</surname><given-names>M</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Hui</surname><given-names>C-C</given-names></name><name><surname>Gomez-Skarmeta</surname><given-names>JL</given-names></name><name><surname>Nóbrega</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Obesity-associated variants within FTO form long-range functional connections with IRX3</article-title><source>Nature</source><volume>507</volume><fpage>371</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1038/nature13138</pub-id><pub-id pub-id-type="pmid">24646999</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobreira</surname><given-names>DR</given-names></name><name><surname>Joslin</surname><given-names>AC</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Extensive pleiotropism and allelic heterogeneity mediate metabolic effects of IRX3 and IRX5</article-title><source>Science</source><volume>372</volume><fpage>1085</fpage><lpage>1091</lpage><pub-id pub-id-type="doi">10.1126/science.abf1008</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinsaltz</surname><given-names>D</given-names></name><name><surname>Dahl</surname><given-names>A</given-names></name><name><surname>Wachter</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>On negative heritability and negative estimates of heritability</article-title><source>Genetics</source><volume>215</volume><fpage>343</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1534/genetics.120.303161</pub-id><pub-id pub-id-type="pmid">32291292</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stergiakouli</surname><given-names>E</given-names></name><name><surname>Gaillard</surname><given-names>R</given-names></name><name><surname>Tavaré</surname><given-names>JM</given-names></name><name><surname>Balthasar</surname><given-names>N</given-names></name><name><surname>Loos</surname><given-names>RJ</given-names></name><name><surname>Taal</surname><given-names>HR</given-names></name><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>St Pourcain</surname><given-names>B</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Kemp</surname><given-names>JP</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Ring</surname><given-names>SM</given-names></name><name><surname>Cole</surname><given-names>TJ</given-names></name><name><surname>Jaddoe</surname><given-names>VWV</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-wide association study of height-adjusted BMI in childhood identifies functional variant in ADCY3</article-title><source>Obesity</source><volume>22</volume><fpage>2252</fpage><lpage>2259</lpage><pub-id pub-id-type="doi">10.1002/oby.20840</pub-id><pub-id pub-id-type="pmid">25044758</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>ME</given-names></name><name><surname>Torres</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>RM</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Mehra</surname><given-names>P</given-names></name><name><surname>Le Coz</surname><given-names>C</given-names></name><name><surname>Leonard</surname><given-names>ME</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Hodge</surname><given-names>KM</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Pippin</surname><given-names>J</given-names></name><name><surname>Romberg</surname><given-names>N</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mapping effector genes at lupus GWAS loci using promoter Capture-C in follicular helper T cells</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>3294</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17089-5</pub-id><pub-id pub-id-type="pmid">32620744</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Restriction enzyme selection dictates detection range sensitivity in chromatin conformation capture-based variant-to-gene mapping approaches</article-title><source>Human Genetics</source><volume>140</volume><fpage>1441</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1007/s00439-021-02326-8</pub-id><pub-id pub-id-type="pmid">34405268</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>May</surname><given-names>CL</given-names></name><name><surname>Pippin</surname><given-names>JA</given-names></name><name><surname>Boehm</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Pahl</surname><given-names>MC</given-names></name><name><surname>Golson</surname><given-names>ML</given-names></name><name><surname>Naji</surname><given-names>A</given-names></name><collab>HPAP Consortium</collab><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>3D chromatin maps of the human pancreas reveal lineage-specific regulatory architecture of T2D risk</article-title><source>Cell Metabolism</source><volume>34</volume><fpage>1394</fpage><lpage>1409</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2022.08.014</pub-id><pub-id pub-id-type="pmid">36070683</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Ba</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Transcriptome analysis reveals dysregulation of inflammatory and neuronal function in dorsal root ganglion of paclitaxel-induced peripheral neuropathy rats</article-title><source>Molecular Pain</source><volume>19</volume><elocation-id>17448069221106167</elocation-id><pub-id pub-id-type="doi">10.1177/17448069221106167</pub-id><pub-id pub-id-type="pmid">35610945</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Draghici</surname><given-names>S</given-names></name><name><surname>Khatri</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Mittal</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>CJ</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A novel signaling pathway impact analysis</article-title><source>Bioinformatics</source><volume>25</volume><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btn577</pub-id><pub-id pub-id-type="pmid">18990722</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timshel</surname><given-names>PN</given-names></name><name><surname>Thompson</surname><given-names>JJ</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genetic mapping of etiologic brain cell types for obesity</article-title><source>eLife</source><volume>9</volume><elocation-id>e55851</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.55851</pub-id><pub-id pub-id-type="pmid">32955435</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Trang</surname><given-names>BK</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Grant_Childhood_Obesity_V2G</data-title><version designator="swh:1:rev:bcb91675b950e5d9d18babf751626578b494917d">swh:1:rev:bcb91675b950e5d9d18babf751626578b494917d</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:fb642457f4c7e78a1e7d196b8cdec890a954b718;origin=https://github.com/BaoKhanhTrang/Grant_Childhood_Obesity_V2G;visit=swh:1:snp:97a9b78afc770197fbdd4dc9673ca84256d1bc5c;anchor=swh:1:rev:bcb91675b950e5d9d18babf751626578b494917d">https://archive.softwareheritage.org/swh:1:dir:fb642457f4c7e78a1e7d196b8cdec890a954b718;origin=https://github.com/BaoKhanhTrang/Grant_Childhood_Obesity_V2G;visit=swh:1:snp:97a9b78afc770197fbdd4dc9673ca84256d1bc5c;anchor=swh:1:rev:bcb91675b950e5d9d18babf751626578b494917d</ext-link></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turcot</surname><given-names>V</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Highland</surname><given-names>HM</given-names></name><name><surname>Schurmann</surname><given-names>C</given-names></name><name><surname>Justice</surname><given-names>AE</given-names></name><name><surname>Fine</surname><given-names>RS</given-names></name><name><surname>Bradfield</surname><given-names>JP</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Giri</surname><given-names>A</given-names></name><name><surname>Graff</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Hendricks</surname><given-names>AE</given-names></name><name><surname>Karaderi</surname><given-names>T</given-names></name><name><surname>Lempradl</surname><given-names>A</given-names></name><name><surname>Locke</surname><given-names>AE</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Marouli</surname><given-names>E</given-names></name><name><surname>Sivapalaratnam</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>KL</given-names></name><name><surname>Alfred</surname><given-names>T</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Masca</surname><given-names>NGD</given-names></name><name><surname>Manning</surname><given-names>AK</given-names></name><name><surname>Medina-Gomez</surname><given-names>C</given-names></name><name><surname>Mudgal</surname><given-names>P</given-names></name><name><surname>Ng</surname><given-names>MCY</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Vedantam</surname><given-names>S</given-names></name><name><surname>Willems</surname><given-names>SM</given-names></name><name><surname>Winkler</surname><given-names>TW</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Aben</surname><given-names>KK</given-names></name><name><surname>Alam</surname><given-names>DS</given-names></name><name><surname>Alharthi</surname><given-names>SE</given-names></name><name><surname>Allison</surname><given-names>M</given-names></name><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Asselbergs</surname><given-names>FW</given-names></name><name><surname>Auer</surname><given-names>PL</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Bang</surname><given-names>LE</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Bastarache</surname><given-names>L</given-names></name><name><surname>Benn</surname><given-names>M</given-names></name><name><surname>Bergmann</surname><given-names>S</given-names></name><name><surname>Bielak</surname><given-names>LF</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Boeing</surname><given-names>H</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Böger</surname><given-names>CA</given-names></name><name><surname>Bork-Jensen</surname><given-names>J</given-names></name><name><surname>Bots</surname><given-names>ML</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Brandslund</surname><given-names>I</given-names></name><name><surname>Breen</surname><given-names>G</given-names></name><name><surname>Brilliant</surname><given-names>MH</given-names></name><name><surname>Broer</surname><given-names>L</given-names></name><name><surname>Brumat</surname><given-names>M</given-names></name><name><surname>Burt</surname><given-names>AA</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name><name><surname>Campbell</surname><given-names>PT</given-names></name><name><surname>Cappellani</surname><given-names>S</given-names></name><name><surname>Carey</surname><given-names>DJ</given-names></name><name><surname>Catamo</surname><given-names>E</given-names></name><name><surname>Caulfield</surname><given-names>MJ</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Chen</surname><given-names>Y-DI</given-names></name><name><surname>Chowdhury</surname><given-names>R</given-names></name><name><surname>Christensen</surname><given-names>C</given-names></name><name><surname>Chu</surname><given-names>AY</given-names></name><name><surname>Cocca</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Cook</surname><given-names>JP</given-names></name><name><surname>Corley</surname><given-names>J</given-names></name><name><surname>Corominas Galbany</surname><given-names>J</given-names></name><name><surname>Cox</surname><given-names>AJ</given-names></name><name><surname>Crosslin</surname><given-names>DS</given-names></name><name><surname>Cuellar-Partida</surname><given-names>G</given-names></name><name><surname>D’Eustacchio</surname><given-names>A</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>Bakker</surname><given-names>PIW</given-names></name><name><surname>Groot</surname><given-names>MCH</given-names></name><name><surname>Mutsert</surname><given-names>R</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Demerath</surname><given-names>EW</given-names></name><name><surname>Heijer</surname><given-names>M</given-names></name><name><surname>Hollander</surname><given-names>AI</given-names></name><name><surname>Ruijter</surname><given-names>HM</given-names></name><name><surname>Dennis</surname><given-names>JG</given-names></name><name><surname>Denny</surname><given-names>JC</given-names></name><name><surname>Di Angelantonio</surname><given-names>E</given-names></name><name><surname>Drenos</surname><given-names>F</given-names></name><name><surname>Du</surname><given-names>M</given-names></name><name><surname>Dubé</surname><given-names>M-P</given-names></name><name><surname>Dunning</surname><given-names>AM</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Edwards</surname><given-names>TL</given-names></name><name><surname>Ellinghaus</surname><given-names>D</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Evangelou</surname><given-names>E</given-names></name><name><surname>Farmaki</surname><given-names>A-E</given-names></name><name><surname>Farooqi</surname><given-names>IS</given-names></name><name><surname>Faul</surname><given-names>JD</given-names></name><name><surname>Fauser</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Ferrannini</surname><given-names>E</given-names></name><name><surname>Ferrieres</surname><given-names>J</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Franke</surname><given-names>A</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Friedrich</surname><given-names>N</given-names></name><name><surname>Frikke-Schmidt</surname><given-names>R</given-names></name><name><surname>Galesloot</surname><given-names>TE</given-names></name><name><surname>Gan</surname><given-names>W</given-names></name><name><surname>Gandin</surname><given-names>I</given-names></name><name><surname>Gasparini</surname><given-names>P</given-names></name><name><surname>Gibson</surname><given-names>J</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>Gjesing</surname><given-names>AP</given-names></name><name><surname>Gordon-Larsen</surname><given-names>P</given-names></name><name><surname>Gorski</surname><given-names>M</given-names></name><name><surname>Grabe</surname><given-names>H-J</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Griffiths</surname><given-names>HL</given-names></name><name><surname>Grove</surname><given-names>ML</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Gustafsson</surname><given-names>S</given-names></name><name><surname>Haessler</surname><given-names>J</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Hammerschlag</surname><given-names>AR</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Harris</surname><given-names>KM</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Have</surname><given-names>CT</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Heard-Costa</surname><given-names>NL</given-names></name><name><surname>Heath</surname><given-names>AC</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>Helgeland</surname><given-names>Ø</given-names></name><name><surname>Hernesniemi</surname><given-names>J</given-names></name><name><surname>Hewitt</surname><given-names>AW</given-names></name><name><surname>Holmen</surname><given-names>OL</given-names></name><name><surname>Hovingh</surname><given-names>GK</given-names></name><name><surname>Howson</surname><given-names>JMM</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>PL</given-names></name><name><surname>Huffman</surname><given-names>JE</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Jansson</surname><given-names>J-H</given-names></name><name><surname>Jarvik</surname><given-names>GP</given-names></name><name><surname>Jensen</surname><given-names>GB</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Jørgensen</surname><given-names>ME</given-names></name><name><surname>Jørgensen</surname><given-names>T</given-names></name><name><surname>Jukema</surname><given-names>JW</given-names></name><name><surname>Kahali</surname><given-names>B</given-names></name><name><surname>Kahn</surname><given-names>RS</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Kamstrup</surname><given-names>PR</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Karaleftheri</surname><given-names>M</given-names></name><name><surname>Kardia</surname><given-names>SLR</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Kee</surname><given-names>F</given-names></name><name><surname>Kiemeney</surname><given-names>LA</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Kitajima</surname><given-names>H</given-names></name><name><surname>Komulainen</surname><given-names>P</given-names></name><name><surname>Kooner</surname><given-names>JS</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Korhonen</surname><given-names>T</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Kuivaniemi</surname><given-names>H</given-names></name><name><surname>Kutalik</surname><given-names>Z</given-names></name><name><surname>Kuulasmaa</surname><given-names>K</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Lamparter</surname><given-names>D</given-names></name><name><surname>Lange</surname><given-names>EM</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Larson</surname><given-names>EB</given-names></name><name><surname>Lee</surname><given-names>NR</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Lewis</surname><given-names>CE</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li-Gao</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>K-H</given-names></name><name><surname>Lin</surname><given-names>L-A</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Lindström</surname><given-names>J</given-names></name><name><surname>Linneberg</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>C-T</given-names></name><name><surname>Liu</surname><given-names>DJ</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lo</surname><given-names>KS</given-names></name><name><surname>Lophatananon</surname><given-names>A</given-names></name><name><surname>Lotery</surname><given-names>AJ</given-names></name><name><surname>Loukola</surname><given-names>A</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Lubitz</surname><given-names>SA</given-names></name><name><surname>Lyytikäinen</surname><given-names>L-P</given-names></name><name><surname>Männistö</surname><given-names>S</given-names></name><name><surname>Marenne</surname><given-names>G</given-names></name><name><surname>Mazul</surname><given-names>AL</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>McKean-Cowdin</surname><given-names>R</given-names></name><name><surname>Medland</surname><given-names>SE</given-names></name><name><surname>Meidtner</surname><given-names>K</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Mistry</surname><given-names>V</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Moilanen</surname><given-names>L</given-names></name><name><surname>Moitry</surname><given-names>M</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Mook-Kanamori</surname><given-names>DO</given-names></name><name><surname>Moore</surname><given-names>C</given-names></name><name><surname>Mori</surname><given-names>TA</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Müller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Munroe</surname><given-names>PB</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Narisu</surname><given-names>N</given-names></name><name><surname>Nelson</surname><given-names>CP</given-names></name><name><surname>Neville</surname><given-names>M</given-names></name><name><surname>Nielsen</surname><given-names>SF</given-names></name><name><surname>Nikus</surname><given-names>K</given-names></name><name><surname>Njølstad</surname><given-names>PR</given-names></name><name><surname>Nordestgaard</surname><given-names>BG</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>O’Connel</surname><given-names>JR</given-names></name><name><surname>O’Donoghue</surname><given-names>ML</given-names></name><name><surname>Olde Loohuis</surname><given-names>LM</given-names></name><name><surname>Ophoff</surname><given-names>RA</given-names></name><name><surname>Owen</surname><given-names>KR</given-names></name><name><surname>Packard</surname><given-names>CJ</given-names></name><name><surname>Padmanabhan</surname><given-names>S</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Palmer</surname><given-names>ND</given-names></name><name><surname>Pasterkamp</surname><given-names>G</given-names></name><name><surname>Patel</surname><given-names>AP</given-names></name><name><surname>Pattie</surname><given-names>A</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Peissig</surname><given-names>PL</given-names></name><name><surname>Peloso</surname><given-names>GM</given-names></name><name><surname>Pennell</surname><given-names>CE</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Perry</surname><given-names>JA</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Person</surname><given-names>TN</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Petersen</surname><given-names>ERB</given-names></name><name><surname>Peyser</surname><given-names>PA</given-names></name><name><surname>Pirie</surname><given-names>A</given-names></name><name><surname>Polasek</surname><given-names>O</given-names></name><name><surname>Polderman</surname><given-names>TJ</given-names></name><name><surname>Puolijoki</surname><given-names>H</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Rasheed</surname><given-names>A</given-names></name><name><surname>Rauramaa</surname><given-names>R</given-names></name><name><surname>Reilly</surname><given-names>DF</given-names></name><name><surname>Renström</surname><given-names>F</given-names></name><name><surname>Rheinberger</surname><given-names>M</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Rioux</surname><given-names>JD</given-names></name><name><surname>Rivas</surname><given-names>MA</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Robertson</surname><given-names>NR</given-names></name><name><surname>Robino</surname><given-names>A</given-names></name><name><surname>Rolandsson</surname><given-names>O</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Ruth</surname><given-names>KS</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Sapkota</surname><given-names>Y</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Schoen</surname><given-names>RE</given-names></name><name><surname>Schreiner</surname><given-names>PJ</given-names></name><name><surname>Schulze</surname><given-names>MB</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Segura-Lepe</surname><given-names>MP</given-names></name><name><surname>Shah</surname><given-names>SH</given-names></name><name><surname>Sheu</surname><given-names>WH-H</given-names></name><name><surname>Sim</surname><given-names>X</given-names></name><name><surname>Slater</surname><given-names>AJ</given-names></name><name><surname>Small</surname><given-names>KS</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Southam</surname><given-names>L</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Speliotes</surname><given-names>EK</given-names></name><name><surname>Starr</surname><given-names>JM</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Stirrups</surname><given-names>KE</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Surendran</surname><given-names>P</given-names></name><name><surname>Swift</surname><given-names>AJ</given-names></name><name><surname>Tada</surname><given-names>H</given-names></name><name><surname>Tansey</surname><given-names>KE</given-names></name><name><surname>Tardif</surname><given-names>J-C</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>DJ</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Thuesen</surname><given-names>BH</given-names></name><name><surname>Tönjes</surname><given-names>A</given-names></name><name><surname>Tromp</surname><given-names>G</given-names></name><name><surname>Trompet</surname><given-names>S</given-names></name><name><surname>Tsafantakis</surname><given-names>E</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Tybjaerg-Hansen</surname><given-names>A</given-names></name><name><surname>Tyrer</surname><given-names>JP</given-names></name><name><surname>Uher</surname><given-names>R</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Uusitupa</surname><given-names>M</given-names></name><name><surname>Laan</surname><given-names>SW</given-names></name><name><surname>Duijn</surname><given-names>CM</given-names></name><name><surname>Leeuwen</surname><given-names>N</given-names></name><name><surname>van Setten</surname><given-names>J</given-names></name><name><surname>Vanhala</surname><given-names>M</given-names></name><name><surname>Varbo</surname><given-names>A</given-names></name><name><surname>Varga</surname><given-names>TV</given-names></name><name><surname>Varma</surname><given-names>R</given-names></name><name><surname>Velez Edwards</surname><given-names>DR</given-names></name><name><surname>Vermeulen</surname><given-names>SH</given-names></name><name><surname>Veronesi</surname><given-names>G</given-names></name><name><surname>Vestergaard</surname><given-names>H</given-names></name><name><surname>Vitart</surname><given-names>V</given-names></name><name><surname>Vogt</surname><given-names>TF</given-names></name><name><surname>Völker</surname><given-names>U</given-names></name><name><surname>Vuckovic</surname><given-names>D</given-names></name><name><surname>Wagenknecht</surname><given-names>LE</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Wallentin</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ware</surname><given-names>EB</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Warren</surname><given-names>HR</given-names></name><name><surname>Waterworth</surname><given-names>DM</given-names></name><name><surname>Wessel</surname><given-names>J</given-names></name><name><surname>White</surname><given-names>HD</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Witte</surname><given-names>DR</given-names></name><name><surname>Wood</surname><given-names>AR</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Yaghootkar</surname><given-names>H</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>P</given-names></name><name><surname>Yerges-Armstrong</surname><given-names>LM</given-names></name><name><surname>Young</surname><given-names>R</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Zhan</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zondervan</surname><given-names>KT</given-names></name><collab>CHD Exome+ Consortium</collab><collab>EPIC-CVD Consortium</collab><collab>ExomeBP Consortium</collab><collab>Global Lipids Genetic Consortium</collab><collab>GoT2D Genes Consortium</collab><collab>EPIC InterAct Consortium</collab><collab>INTERVAL Study</collab><collab>ReproGen Consortium</collab><collab>T2D-Genes Consortium</collab><collab>MAGIC Investigators</collab><collab>Understanding Society Scientific Group</collab><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Pospisilik</surname><given-names>JA</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Borecki</surname><given-names>IB</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Lettre</surname><given-names>G</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity</article-title><source>Nature Genetics</source><volume>50</volume><fpage>26</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/s41588-017-0011-x</pub-id><pub-id pub-id-type="pmid">29273807</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulgen</surname><given-names>E</given-names></name><name><surname>Ozisik</surname><given-names>O</given-names></name><name><surname>Sezerman</surname><given-names>OU</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>pathfindR: an r package for comprehensive identification of enriched pathways in omics data through active subnetworks</article-title><source>Frontiers in Genetics</source><volume>10</volume><elocation-id>858</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2019.00858</pub-id><pub-id pub-id-type="pmid">31608109</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogelezang</surname><given-names>S</given-names></name><name><surname>Bradfield</surname><given-names>JP</given-names></name><name><surname>Ahluwalia</surname><given-names>TS</given-names></name><name><surname>Curtin</surname><given-names>JA</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Scholz</surname><given-names>M</given-names></name><name><surname>van der Most</surname><given-names>PJ</given-names></name><name><surname>Monnereau</surname><given-names>C</given-names></name><name><surname>Stergiakouli</surname><given-names>E</given-names></name><name><surname>Heiskala</surname><given-names>A</given-names></name><name><surname>Horikoshi</surname><given-names>M</given-names></name><name><surname>Fedko</surname><given-names>IO</given-names></name><name><surname>Vilor-Tejedor</surname><given-names>N</given-names></name><name><surname>Cousminer</surname><given-names>DL</given-names></name><name><surname>Standl</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>CA</given-names></name><name><surname>Viikari</surname><given-names>J</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Íñiguez</surname><given-names>C</given-names></name><name><surname>Pitkänen</surname><given-names>N</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Bacelis</surname><given-names>J</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Torrent</surname><given-names>M</given-names></name><name><surname>Ntalla</surname><given-names>I</given-names></name><name><surname>Helgeland</surname><given-names>Ø</given-names></name><name><surname>Selzam</surname><given-names>S</given-names></name><name><surname>Vonk</surname><given-names>JM</given-names></name><name><surname>Zafarmand</surname><given-names>MH</given-names></name><name><surname>Heude</surname><given-names>B</given-names></name><name><surname>Farooqi</surname><given-names>IS</given-names></name><name><surname>Alyass</surname><given-names>A</given-names></name><name><surname>Beaumont</surname><given-names>RN</given-names></name><name><surname>Have</surname><given-names>CT</given-names></name><name><surname>Rzehak</surname><given-names>P</given-names></name><name><surname>Bilbao</surname><given-names>JR</given-names></name><name><surname>Schnurr</surname><given-names>TM</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Bønnelykke</surname><given-names>K</given-names></name><name><surname>Beilin</surname><given-names>LJ</given-names></name><name><surname>Carstensen</surname><given-names>L</given-names></name><name><surname>Charles</surname><given-names>MA</given-names></name><name><surname>Chawes</surname><given-names>B</given-names></name><name><surname>Clément</surname><given-names>K</given-names></name><name><surname>Closa-Monasterolo</surname><given-names>R</given-names></name><name><surname>Custovic</surname><given-names>A</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Escribano</surname><given-names>J</given-names></name><name><surname>Groen-Blokhuis</surname><given-names>M</given-names></name><name><surname>Grote</surname><given-names>V</given-names></name><name><surname>Gruszfeld</surname><given-names>D</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Hollensted</surname><given-names>M</given-names></name><name><surname>Hottenga</surname><given-names>JJ</given-names></name><name><surname>Hyppönen</surname><given-names>E</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Joro</surname><given-names>R</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Karhunen</surname><given-names>V</given-names></name><name><surname>Kiess</surname><given-names>W</given-names></name><name><surname>Knight</surname><given-names>BA</given-names></name><name><surname>Koletzko</surname><given-names>B</given-names></name><name><surname>Kühnapfel</surname><given-names>A</given-names></name><name><surname>Landgraf</surname><given-names>K</given-names></name><name><surname>Langhendries</surname><given-names>JP</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Leinonen</surname><given-names>JT</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Lindi</surname><given-names>V</given-names></name><name><surname>Lowry</surname><given-names>E</given-names></name><name><surname>Bustamante</surname><given-names>M</given-names></name><name><surname>Medina-Gomez</surname><given-names>C</given-names></name><name><surname>Melbye</surname><given-names>M</given-names></name><name><surname>Michaelsen</surname><given-names>KF</given-names></name><name><surname>Morgen</surname><given-names>CS</given-names></name><name><surname>Mori</surname><given-names>TA</given-names></name><name><surname>Nielsen</surname><given-names>TRH</given-names></name><name><surname>Niinikoski</surname><given-names>H</given-names></name><name><surname>Oldehinkel</surname><given-names>AJ</given-names></name><name><surname>Pahkala</surname><given-names>K</given-names></name><name><surname>Panoutsopoulou</surname><given-names>K</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Pennell</surname><given-names>CE</given-names></name><name><surname>Power</surname><given-names>C</given-names></name><name><surname>Reijneveld</surname><given-names>SA</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Simpson</surname><given-names>A</given-names></name><name><surname>Sly</surname><given-names>PD</given-names></name><name><surname>Stokholm</surname><given-names>J</given-names></name><name><surname>Teo</surname><given-names>KK</given-names></name><name><surname>Thiering</surname><given-names>E</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>van Beijsterveldt</surname><given-names>CEM</given-names></name><name><surname>van Schaik</surname><given-names>BDC</given-names></name><name><surname>Vaudel</surname><given-names>M</given-names></name><name><surname>Verduci</surname><given-names>E</given-names></name><name><surname>Vinding</surname><given-names>RK</given-names></name><name><surname>Vogel</surname><given-names>M</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Sebert</surname><given-names>S</given-names></name><name><surname>Lind</surname><given-names>MV</given-names></name><name><surname>Brown</surname><given-names>CD</given-names></name><name><surname>Santa-Marina</surname><given-names>L</given-names></name><name><surname>Reischl</surname><given-names>E</given-names></name><name><surname>Frithioff-Bøjsøe</surname><given-names>C</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Ong</surname><given-names>K</given-names></name><name><surname>Nohr</surname><given-names>EA</given-names></name><name><surname>Vrijkotte</surname><given-names>TGM</given-names></name><name><surname>Koppelman</surname><given-names>GH</given-names></name><name><surname>Plomin</surname><given-names>R</given-names></name><name><surname>Njølstad</surname><given-names>PR</given-names></name><name><surname>Dedoussis</surname><given-names>GD</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Sørensen</surname><given-names>TIA</given-names></name><name><surname>Jacobsson</surname><given-names>B</given-names></name><name><surname>Freathy</surname><given-names>RM</given-names></name><name><surname>Zemel</surname><given-names>BS</given-names></name><name><surname>Raitakari</surname><given-names>O</given-names></name><name><surname>Vrijheid</surname><given-names>M</given-names></name><name><surname>Feenstra</surname><given-names>B</given-names></name><name><surname>Lyytikäinen</surname><given-names>LP</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Kirsten</surname><given-names>H</given-names></name><name><surname>Holt</surname><given-names>PG</given-names></name><name><surname>Heinrich</surname><given-names>J</given-names></name><name><surname>Widén</surname><given-names>E</given-names></name><name><surname>Sunyer</surname><given-names>J</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Järvelin</surname><given-names>MR</given-names></name><name><surname>Körner</surname><given-names>A</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Holm</surname><given-names>JC</given-names></name><name><surname>Atalay</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>C</given-names></name><name><surname>Bisgaard</surname><given-names>H</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Jaddoe</surname><given-names>VWV</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Felix</surname><given-names>JF</given-names></name><collab>Early Growth Genetics Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits</article-title><source>PLOS Genetics</source><volume>16</volume><elocation-id>e1008718</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008718</pub-id><pub-id pub-id-type="pmid">33045005</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vujkovic</surname><given-names>M</given-names></name><name><surname>Ramdas</surname><given-names>S</given-names></name><name><surname>Lorenz</surname><given-names>KM</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Darlay</surname><given-names>R</given-names></name><name><surname>Cordell</surname><given-names>HJ</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Gindin</surname><given-names>Y</given-names></name><name><surname>Chung</surname><given-names>C</given-names></name><name><surname>Myers</surname><given-names>RP</given-names></name><name><surname>Schneider</surname><given-names>CV</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>KM</given-names></name><name><surname>Serper</surname><given-names>M</given-names></name><name><surname>Carr</surname><given-names>RM</given-names></name><name><surname>Kaplan</surname><given-names>DE</given-names></name><name><surname>Haas</surname><given-names>ME</given-names></name><name><surname>MacLean</surname><given-names>MT</given-names></name><name><surname>Witschey</surname><given-names>WR</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Tcheandjieu</surname><given-names>C</given-names></name><name><surname>Kember</surname><given-names>RL</given-names></name><name><surname>Kranzler</surname><given-names>HR</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Giri</surname><given-names>A</given-names></name><name><surname>Klarin</surname><given-names>DM</given-names></name><name><surname>Sun</surname><given-names>YV</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Huffman</surname><given-names>JE</given-names></name><name><surname>Creasy</surname><given-names>KT</given-names></name><name><surname>Hand</surname><given-names>NJ</given-names></name><name><surname>Liu</surname><given-names>C-T</given-names></name><name><surname>Long</surname><given-names>MT</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Budoff</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>HJ</given-names></name><name><surname>Chen</surname><given-names>Y-DI</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Chang</surname><given-names>R-K</given-names></name><name><surname>Krauss</surname><given-names>RM</given-names></name><name><surname>Vilarinho</surname><given-names>S</given-names></name><name><surname>Brancale</surname><given-names>J</given-names></name><name><surname>Nielsen</surname><given-names>JB</given-names></name><name><surname>Locke</surname><given-names>AE</given-names></name><name><surname>Jones</surname><given-names>MB</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Baras</surname><given-names>A</given-names></name><name><surname>Reddy</surname><given-names>KR</given-names></name><name><surname>Neuschwander-Tetri</surname><given-names>BA</given-names></name><name><surname>Schwimmer</surname><given-names>JB</given-names></name><name><surname>Sanyal</surname><given-names>AJ</given-names></name><name><surname>Chalasani</surname><given-names>N</given-names></name><name><surname>Ryan</surname><given-names>KA</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Gill</surname><given-names>D</given-names></name><name><surname>Wells</surname><given-names>AD</given-names></name><name><surname>Manduchi</surname><given-names>E</given-names></name><name><surname>Saiman</surname><given-names>Y</given-names></name><name><surname>Mahmud</surname><given-names>N</given-names></name><name><surname>Miller</surname><given-names>DR</given-names></name><name><surname>Reaven</surname><given-names>PD</given-names></name><name><surname>Phillips</surname><given-names>LS</given-names></name><name><surname>Muralidhar</surname><given-names>S</given-names></name><name><surname>DuVall</surname><given-names>SL</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Assimes</surname><given-names>TL</given-names></name><name><surname>Pyarajan</surname><given-names>S</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Edwards</surname><given-names>TL</given-names></name><name><surname>Damrauer</surname><given-names>SM</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Gaziano</surname><given-names>JM</given-names></name><name><surname>O’Donnell</surname><given-names>CJ</given-names></name><name><surname>Khera</surname><given-names>AV</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Brown</surname><given-names>CD</given-names></name><name><surname>Tsao</surname><given-names>PS</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Lotta</surname><given-names>LA</given-names></name><name><surname>Bastarache</surname><given-names>L</given-names></name><name><surname>Anstee</surname><given-names>QM</given-names></name><name><surname>Daly</surname><given-names>AK</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Lynch</surname><given-names>JA</given-names></name><collab>Regeneron Genetics Center</collab><collab>Geisinger-Regeneron DiscovEHR Collaboration</collab><collab>EPoS Consortium</collab><collab>VA Million Veteran Program</collab><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Chang</surname><given-names>K-M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A multiancestry genome-wide association study of unexplained chronic ALT elevation as A proxy for nonalcoholic fatty liver disease with histological and radiological validation</article-title><source>Nature Genetics</source><volume>54</volume><fpage>761</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01078-z</pub-id><pub-id pub-id-type="pmid">35654975</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wardle</surname><given-names>J</given-names></name><name><surname>Carnell</surname><given-names>S</given-names></name><name><surname>Haworth</surname><given-names>CM</given-names></name><name><surname>Plomin</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment</article-title><source>The American Journal of Clinical Nutrition</source><volume>87</volume><fpage>398</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1093/ajcn/87.2.398</pub-id><pub-id pub-id-type="pmid">18258631</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingett</surname><given-names>S</given-names></name><name><surname>Ewels</surname><given-names>P</given-names></name><name><surname>Furlan-Magaril</surname><given-names>M</given-names></name><name><surname>Nagano</surname><given-names>T</given-names></name><name><surname>Schoenfelder</surname><given-names>S</given-names></name><name><surname>Fraser</surname><given-names>P</given-names></name><name><surname>Andrews</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HiCUP: pipeline for mapping and processing Hi-C data</article-title><source>F1000Research</source><volume>4</volume><elocation-id>1310</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.7334.1</pub-id><pub-id pub-id-type="pmid">26835000</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wormser</surname><given-names>D</given-names></name><name><surname>Kaptoge</surname><given-names>S</given-names></name><name><surname>Di Angelantonio</surname><given-names>E</given-names></name><name><surname>Wood</surname><given-names>AM</given-names></name><name><surname>Pennells</surname><given-names>L</given-names></name><name><surname>Thompson</surname><given-names>A</given-names></name><name><surname>Sarwar</surname><given-names>N</given-names></name><name><surname>Kizer</surname><given-names>JR</given-names></name><name><surname>Lawlor</surname><given-names>DA</given-names></name><name><surname>Nordestgaard</surname><given-names>BG</given-names></name><name><surname>Ridker</surname><given-names>P</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Stevens</surname><given-names>J</given-names></name><name><surname>Woodward</surname><given-names>M</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Collins</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Whitlock</surname><given-names>G</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><collab>Emerging Risk Factors Collaboration</collab></person-group><year iso-8601-date="2011">2011</year><article-title>Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies</article-title><source>Lancet</source><volume>377</volume><fpage>1085</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)60105-0</pub-id><pub-id pub-id-type="pmid">21397319</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Ge</surname><given-names>W</given-names></name><name><surname>Shou</surname><given-names>J</given-names></name><name><surname>You</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence</article-title><source>Cancer Medicine</source><volume>7</volume><fpage>2555</fpage><lpage>2566</lpage><pub-id pub-id-type="doi">10.1002/cam4.1484</pub-id><pub-id pub-id-type="pmid">29659199</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Bo</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>clusterProfiler 4.0: A universal enrichment tool for interpreting omics data</article-title><source>Innovation</source><volume>2</volume><elocation-id>100141</elocation-id><pub-id pub-id-type="doi">10.1016/j.xinn.2021.100141</pub-id><pub-id pub-id-type="pmid">34557778</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaghootkar</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Spracklen</surname><given-names>CN</given-names></name><name><surname>Karaderi</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>LO</given-names></name><name><surname>Bradfield</surname><given-names>J</given-names></name><name><surname>Schurmann</surname><given-names>C</given-names></name><name><surname>Fine</surname><given-names>RS</given-names></name><name><surname>Preuss</surname><given-names>MH</given-names></name><name><surname>Kutalik</surname><given-names>Z</given-names></name><name><surname>Wittemans</surname><given-names>LBL</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Metz</surname><given-names>S</given-names></name><name><surname>Willems</surname><given-names>SM</given-names></name><name><surname>Li-Gao</surname><given-names>R</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Molnos</surname><given-names>S</given-names></name><name><surname>Sandoval-Zárate</surname><given-names>AA</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Haesser</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Lyytikäinen</surname><given-names>L-P</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Sitlani</surname><given-names>CM</given-names></name><name><surname>Venturini</surname><given-names>C</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Kacprowski</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>CA</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Broer</surname><given-names>L</given-names></name><name><surname>Robertson</surname><given-names>N</given-names></name><name><surname>Young</surname><given-names>KL</given-names></name><name><surname>Allison</surname><given-names>M</given-names></name><name><surname>Auer</surname><given-names>PL</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Borja</surname><given-names>JB</given-names></name><name><surname>Bork-Jensen</surname><given-names>J</given-names></name><name><surname>Carrasquilla</surname><given-names>GD</given-names></name><name><surname>Christofidou</surname><given-names>P</given-names></name><name><surname>Demirkan</surname><given-names>A</given-names></name><name><surname>Doege</surname><given-names>CA</given-names></name><name><surname>Garcia</surname><given-names>ME</given-names></name><name><surname>Graff</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>K</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Ida Chen</surname><given-names>Y-D</given-names></name><name><surname>Jackson</surname><given-names>R</given-names></name><name><surname>Jakupović</surname><given-names>H</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Justice</surname><given-names>AE</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Kizer</surname><given-names>JR</given-names></name><name><surname>Kriebel</surname><given-names>J</given-names></name><name><surname>LeDuc</surname><given-names>CA</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name><name><surname>Mangino</surname><given-names>M</given-names></name><name><surname>Männistö</surname><given-names>S</given-names></name><name><surname>Martin Carli</surname><given-names>JF</given-names></name><name><surname>Medina-Gomez</surname><given-names>C</given-names></name><name><surname>Mook-Kanamori</surname><given-names>DO</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>de Mutsert</surname><given-names>R</given-names></name><name><surname>Nauck</surname><given-names>M</given-names></name><name><surname>Prokic</surname><given-names>I</given-names></name><name><surname>Pennell</surname><given-names>CE</given-names></name><name><surname>Pradhan</surname><given-names>AD</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Skaaby</surname><given-names>T</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Lye</surname><given-names>S</given-names></name><name><surname>Homuth</surname><given-names>G</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>McKnight</surname><given-names>B</given-names></name><name><surname>Province</surname><given-names>MA</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Adair</surname><given-names>LS</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Ripatti</surname><given-names>S</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Willems van Dijk</surname><given-names>K</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Leibel</surname><given-names>RL</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Kilpeläinen</surname><given-names>TO</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genetic studies of leptin concentrations implicate leptin in the regulation of early adiposity</article-title><source>Diabetes</source><volume>69</volume><fpage>2806</fpage><lpage>2818</lpage><pub-id pub-id-type="doi">10.2337/db20-0070</pub-id><pub-id pub-id-type="pmid">32917775</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>JM</given-names></name><name><surname>Wang</surname><given-names>ZX</given-names></name><name><surname>Ullah</surname><given-names>T</given-names></name><name><surname>Dong</surname><given-names>SS</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transcriptome-wide association study identifies multiple genes associated with childhood body mass index</article-title><source>International Journal of Obesity</source><volume>45</volume><fpage>1105</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1038/s41366-021-00780-y</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Cato</surname><given-names>LD</given-names></name><name><surname>Weng</surname><given-names>C</given-names></name><name><surname>Liggett</surname><given-names>LA</given-names></name><name><surname>Jeon</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Chiang</surname><given-names>CWK</given-names></name><name><surname>Wiemels</surname><given-names>JL</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name><name><surname>de Smith</surname><given-names>AJ</given-names></name><name><surname>Sankaran</surname><given-names>VG</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Variant to function mapping at single-cell resolution through network propagation</article-title><source>Nature Biotechnology</source><volume>40</volume><fpage>1644</fpage><lpage>1653</lpage><pub-id pub-id-type="doi">10.1038/s41587-022-01341-y</pub-id><pub-id pub-id-type="pmid">35668323</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Troyanskaya</surname><given-names>OG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Predicting effects of noncoding variants with deep learning-based sequence model</article-title><source>Nature Methods</source><volume>12</volume><fpage>931</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3547</pub-id><pub-id pub-id-type="pmid">26301843</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>A</given-names></name><name><surname>Ibrahim</surname><given-names>JG</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences</article-title><source>Bioinformatics</source><volume>35</volume><fpage>2084</fpage><lpage>2092</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty895</pub-id><pub-id pub-id-type="pmid">30395178</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95411.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Parker</surname><given-names>Stephen CJ</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Michigan</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study presents genome-wide high-resolution chromatin-based 3D genomic interaction maps for over 50 diverse human cell types and integrates these data with pediatric obesity GWAS. The work provides <bold>convincing</bold> evidence that multiple pancreatic islet cell types are key effector cell types. The authors also perform variant-to-gene mapping to nominate genes underlying several GWAS hits. Overall, the results will be of interest to both the fields of 3D genome architecture and pediatric obesity.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95411.3.sa1</article-id><title-group><article-title>Joint public reviews:</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This paper studies the genetic factors contributing to childhood obesity. Through a comprehensive analysis integrating genome-wide association study (GWAS) data with 3D genomic datasets across 57 human cell types, consisting of Capture-C/Hi-C, ATAC-seq, and RNA-seq, the study identifies significant genetic contributions to obesity using stratified LD score regression, emphasizing the enrichment of genetic signals in pancreatic alpha cells and identification of significant effector genes at obesity-associated loci such as BDNF, ADCY3, TMEM18, and FTO. Additionally, the study implicated ALKAL2, a gene responsive to inflammation in nerve nociceptors, as a novel effector gene at the TMEM18 locus, suggesting a role for inflammatory and neurological pathways in obesity's pathogenesis which was supported through colocalization analysis using eQTL derived from the GTEx dataset. This comprehensive genomic analysis sheds light on the complex genetic architecture of childhood obesity, highlighting the importance of cellular context for future research and the development of more effective strategies.</p><p>Strengths:</p><p>Overall, the paper has several strengths, including leveraging large-scale, multi-modal datasets, using appropriate computational tools, and in-depth discussion of their significant results.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95411.3.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Trang</surname><given-names>Khanh Bao</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Pahl</surname><given-names>Matthew C</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Pippin</surname><given-names>James A</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Su</surname><given-names>Chun</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Littleton</surname><given-names>Sheridan H</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Prabhat</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Kulkarni</surname><given-names>Nikhil N</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Ghanem</surname><given-names>Louis R</given-names></name><role specific-use="author">Author</role><aff><institution>Perelman School of Medicine at the University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Terry</surname><given-names>Natalie A</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>O'Brien</surname><given-names>Joan M</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Wagley</surname><given-names>Yadav</given-names></name><role specific-use="author">Author</role><aff><institution>University of Michigan Medical School</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Hankenson</surname><given-names>Kurt D</given-names></name><role specific-use="author">Author</role><aff><institution>University of Michigan-Ann Arbor</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Jermusyk</surname><given-names>Ashley</given-names></name><role specific-use="author">Author</role><aff><institution>National Cancer Institute</institution><addr-line><named-content content-type="city">Rockville</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Hoskins</surname><given-names>Jason</given-names></name><role specific-use="author">Author</role><aff><institution>National Cancer Institute</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Amundadottir</surname><given-names>Laufey T</given-names></name><role specific-use="author">Author</role><aff><institution>National Cancer Institute</institution><addr-line><named-content content-type="city">Rockville</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Mai</given-names></name><role specific-use="author">Author</role><aff><institution>National Cancer Institute</institution><addr-line><named-content content-type="city">Rockville</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Kevin</given-names></name><role specific-use="author">Author</role><aff><institution>NIH/NCI</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Stewart</given-names></name><role specific-use="author">Author</role><aff><institution>Children's Hospital of Philadelphia/ University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Wenli</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Titchenell</surname><given-names>Paul</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Seale</surname><given-names>Patrick</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Kaestner</surname><given-names>Klaus H</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Cook</surname><given-names>Laura</given-names></name><role specific-use="author">Author</role><aff><institution>University of Melbourne</institution><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff></contrib><contrib contrib-type="author"><name><surname>Levings</surname><given-names>Megan</given-names></name><role specific-use="author">Author</role><aff><institution>BC Children's Hospital Research Institute</institution><addr-line><named-content content-type="city">Vancouver</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Zemel</surname><given-names>Babette S</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Chesi</surname><given-names>Alessandra</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Wells</surname><given-names>Andrew D</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Grant</surname><given-names>Struan FA</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><p>Response to Reviewer’s comments</p><p>We are most grateful for the opportunity to address the reviewer comments. Point-by-point responses are presented below.</p><disp-quote content-type="editor-comment"><p>Overall, the paper has several strengths, including leveraging large-scale, multi-modal datasets, using computational reasonable tools, and having an in-depth discussion of the significant results.</p></disp-quote><p>We thank the reviewer for the very supportive comments.</p><p>Based on the comments and questions, we have grouped the concerns and corresponding responses into three categories.</p><disp-quote content-type="editor-comment"><p>(1) The scope and data selection</p><p>The results are somewhat inconclusive or not validated.</p><p>The overall results are carefully designed, but most of the results are descriptive. While the authors are able to find additional evidence either from the literature or explain the results with their existing knowledge, none of the results have been biologically validated. Especially, the last three result sections (signaling pathways, eQTLs, and TF binding) further extended their findings, but the authors did not put the major results into any of the figures in the main text.”</p></disp-quote><p>The goal of this manuscript is to provide a list of putative childhood obesity target genes to yield new insights and help drive further experimentation. Moreover, the outputs from signaling pathways, eQTLs, and TF binding, although noteworthy and supportive of our method, were not particularly novel. In our manuscript we placed our focus on the novel findings from the analyses. We did, however, report the part of the eQTLs analysis concerning <italic>ADCY3</italic>, which brought new insight to the pathology of obesity, in Figure 4C.</p><disp-quote content-type="editor-comment"><p>The manuscript would benefit from an explanation regarding the rationale behind the selection of the 57 human cell types analyzed. it is essential to clarify whether these cell types have unique functions or relevance to childhood development and obesity.</p></disp-quote><p>We elected to comprehensively investigate the GWAS-informed cellular underpinnings of childhood development and obesity. By including a diverse range of cell types from different tissues and organs, we sought to capture the multifaceted nature of cellular contributions to obesity-related mechanisms, and open new avenues for targeted therapeutic interventions.</p><p>There are clearly cell types that are already established as being key to the pathogenesis of obesity when dysregulated: adipocytes for energy storage, immune cell types regulating inflammation and metabolic homeostasis, hepatocytes regulating lipid metabolism, pancreatic cell types intricately involved in glucose and lipid metabolism, skeletal muscle for glucose uptake and metabolism, and brain cell types in the regulation of appetite, energy expenditure, and metabolic homeostasis.</p><p>While it is practical to focus on cell types already proven to be associated with or relevant to obesity, this approach has its limitations. It confines our understanding to established knowledge and rules out the potential for discovering novel insights from new cellular mechanisms or pathways that could play significant roles in the pathogenesis if obesity. Therefore, it was essential to reflect known biology against the unexplored cell types to expand our overall understanding and potentially identify innovative targets for treatment or prevention.</p><disp-quote content-type="editor-comment"><p>I wonder whether the used epigenome datasets are all from children. Although the authors use literature to support that body weight and obesity remain stable from infancy to adulthood, it remains uncertain whether epigenomic data from other life stages might overlook significant genetic variants that uniquely contribute to childhood obesity.</p></disp-quote><p>The datasets utilized in our study were derived from a combination of sources, both pediatric and adult. We recognize that epigenetic profiles can vary across different life stages but our principal effort was to characterize susceptibility BEFORE disease onset.</p><disp-quote content-type="editor-comment"><p>Given that the GTEx tissue samples are derived from adult donors, there appears to be a mismatch with the study's focus on childhood obesity. If possible, identifying alternative validation strategies or datasets more closely related to the pediatric population could strengthen the study's findings.</p></disp-quote><p>We thank the reviewer for raising this important point. We acknowledge that the GTEx tissue samples are derived from adult donors, which might not perfectly align with the study's focus on childhood obesity. The ideal strategy would be a longitudinal design that follows individuals from childhood into adulthood to bridge the gap between pediatric and adult data, offering systematic insights into how early-life epigenetic markers influencing obesity later in life. In future work, we aim to carry out such efforts, which will represent substantial time and financial commitment.</p><p>Along the same lines, the Developmental Genotype-Tissue Expression (dGTEx) Project is a new effort to study development-specific genetic effects on gene expression at 4 developmental windows spanning from infant to post-puberty (0-18 years). Donor recruitment began in August 2023 and remains ongoing. Tissue characterization and data production are underway. We hope that with the establishment of this resource, our future research in the field of pediatric health will be further enhanced.</p><disp-quote content-type="editor-comment"><p>Figure 1B: in subplots c and d, the results are either from Hi-C or capture-C. Although the authors use different colors to denote them, I cannot help wondering how much difference between Hi-C and capture-C brings in. Did the authors explore the difference between the Hi-C and capture-C?</p></disp-quote><p>Thank you for your comment. It is not within the scope of our paper to explore the differences between the Hi-C and Capture-C methods. In the context of our study, both methods serve the same purpose of detecting chromatin loops that bring putative enhancers to sometimes genomically distant gene promoters. Consequently, our focus was on utilizing these methods to identify relevant chromatin interactions rather than comparing their technical differences.</p><disp-quote content-type="editor-comment"><p>(2) Details on defining different categories of the regions of interest</p><p>Some technical details are missing.</p><p>While the authors described all of their analysis steps, a lot of the time, they did not mention the motivation. Sometimes, the details were also omitted.”</p></disp-quote><p>We have added a section to the revision to address the rationale behind different OCRs categories.</p><disp-quote content-type="editor-comment"><p>Line 129: should &quot;-1,500/+500bp&quot; be &quot;-500/+500bp&quot;?</p></disp-quote><p>A gene promoter was defined as a region 1,500 bases upstream to 500 bases downstream of the TSS. Most transcription factor binding sites are distributes upstream (5’) from TSS, and the assembly of transcription machinery occurs up to 1000 bases 5’ from TSS. Given our interest in SNPs that can potentially disrupt transcription factor binding, this defined promoter length allowed us to capture such SNPs in our analyses.</p><disp-quote content-type="editor-comment"><p>How did the authors define a contact region?</p></disp-quote><p>Chromatin contact regions identified by Hi-C or Capture-C assays are always reported as pairs of chromatin regions. The Supplementary eMethods provide details on the method of processing and interaction calling from the Hi-C and Capture-C data.</p><disp-quote content-type="editor-comment"><p>The manuscript would benefit from a detailed explanation of the methods used to define cREs, particularly the process of intersecting OCRs with chromatin conformation data. The current description does not fully clarify how the cREs are defined.</p><p>In the result section titled &quot;Consistency and diversity of childhood obesity proxy variants mapped to cREs&quot;, the authors introduced the different types of cREs in the context of open chromatin regions and chromatin contact regions, and TSS. Figure 2A is helpful in some way, but more explanation is definitely needed. For example, it seems that the authors introduced three chromatin contacts on purpose, but I did not quite get the overall motivation.</p></disp-quote><p>We apologize for the confusion. Our definition of cREs is consistent throughout the study. Figure 2A will be the first Figure 1A in the revision in order to aid the reader.</p><p>The 3 representative chromatin loops illustrate different ways the chromatin contact regions (pairs of blue regions under blue arcs) can overlap with OCRs (yellow regions under yellow triangles – ATAC peaks) and gene promoters.</p><p>(1) The first chromatin loop has one contact region that overlaps with OCRs at one end and with the gene promoter at the other. This satisfies the formation of cREs; thus, the area under the yellow ATAC-peak triangle is green.</p><p>(2) The second loop only overlapped with OCR at one end, and there was no gene promoter nearby, so it is unqualified as cREs formation.</p><p>(3) The third chromatin loop has OCR and promoter overlapping at one end. We defined this as a special cRE formation; thus, the area under the yellow ATAC-peak triangle is green.</p><p>To avoid further confusion for the reader, we have eliminated this variation in the new illustration for the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Figure 2A: The authors used triangles filled differently to denote different types of cREs but I wonder what the height of the triangles implies. Please specify.</p></disp-quote><p>The triangles are illustrations for ATAC-seq peaks, and the yellow chromatin regions under them are OCRs. The different heights of ATAC-seq peaks are usually quantified as intensity values for OCRs. However, in our study, when an ATAC-seq peak passed the significance threshold from the data pipeline, we only considered their locations, regardless of their intensities. To avoid further confusion for the reader, we have eliminated this variation in the new illustration for the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Figure 1B-c. the title should be &quot;OCRs at putative cREs&quot;. Similarly in Figure 1B-d.</p></disp-quote><p>cREs are a subset of OCRs.</p><disp-quote content-type="editor-comment"><p>- In the section &quot;Cell type specific partitioned heritability&quot;, the authors used &quot;4 defined sets of input genomic regions&quot;. Are you corresponding to the four types of regions in Figure 2A?</p></disp-quote><p>Figure 2A is the first Figure 1A in the revision and is modified to showcase how we define OCRs and cREs.</p><disp-quote content-type="editor-comment"><p>It seems that the authors described the 771 proxies in &quot;Genetic loci included in variant-to-genes mapping&quot; (ln 154), and then somehow narrowed down from 771 to 94 (according to ln 199) because they are cREs. It would be great if the authors could describe the selection procedure together, rather than isolated, which made it quite difficult to understand.</p></disp-quote><p>In the Methods section entitled “Genetic loci included in variant-to-genes mapping,&quot; we described the process of LD expansion to include 771 proxies from 19 sentinel obesity-significantly associated signals. Not all of these proxies are located within our defined cREs. Figure 2B, now Figure 2A in the revision, illustrates different proportions of these proxies located within different types of regions, reducing the proxy list to 94 located within our defined cREs.</p><disp-quote content-type="editor-comment"><p>Figure 2. What's the difference between the 771 and 758 proxies?</p></disp-quote><p>13 out of 771 proxies did not fall within any defined regions. The remaining 758 were located within contact regions of at least one cell type regardless of chromatin state.</p><disp-quote content-type="editor-comment"><p>(3) Typos</p><p>In the paragraph &quot;Childhood obesity GWAS summary statistics&quot;, the authors may want to describe the case/control numbers in two stages differently. &quot;in stage 1&quot; and &quot;921 cases&quot; together made me think &quot;1,921&quot; is one number.</p></disp-quote><p>This has been amended in the revision.</p><disp-quote content-type="editor-comment"><p>Hi-C technology should be spelled as Hi-C. There are many places, it is miss-spelled as &quot;hi-C&quot;. In Figure 1, the author used &quot;hiC&quot; in the legend. Similarly, Capture-C sometime was spelled as &quot;capture-C&quot; in the manuscript.</p><p>At the end of the fifth row in the second paragraph of the Introduction section: &quot;exisit&quot; should be &quot;exist&quot;.</p><p>In Figure 2A: &quot;Within open chromatin contract region&quot; should be &quot;Within open chromatin contact region”</p></disp-quote><p>These typos and terminology inconsistencies have been amended in the revision.</p></body></sub-article></article>